index,trialid,source_register,date_registration,date_enrollement,retrospective_registration,normed_spon_names,recruitment_status,phase,study_type,countries,public_title,study_category,intervention,target_enrollment,primary_completion_date,full_completion_date,web_address,results_type,results_publication_date,results_link,last_refreshed_on,first_seen,cross_registrations
0,ChiCTR2000029953,ChiCTR,2020-02-17,2020-02-01,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,400,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=49217,No Results,No Results,No Results,2020-02-17,2020-08-03,None
1,ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),Drug,Chloroquine,100,Not Available,2021-02-06,http://www.chictr.org.cn/showproj.aspx?proj=49607,No Results,No Results,No Results,2020-02-17,2020-08-03,None
2,ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),ATMP,Plasma,20,Not Available,2022-02-15,http://www.chictr.org.cn/showproj.aspx?proj=49533,No Results,No Results,No Results,2020-02-17,2020-08-03,None
3,ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,False,Children's Hospital of Fudan University,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,30,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49387,No Results,No Results,No Results,2020-02-17,2020-08-03,None
4,ChiCTR2000029805,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49188,No Results,No Results,No Results,2020-02-17,2020-08-03,None
5,ChiCTR2000029949,ChiCTR,2020-02-16,2020-02-16,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,40,Not Available,2020-12-28,http://www.chictr.org.cn/showproj.aspx?proj=49181,No Results,No Results,No Results,2020-02-17,2020-08-03,None
6,ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=49599,No Results,No Results,No Results,2020-02-17,2020-03-18,None
7,NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,True,Guangzhou 8th People's Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug,Lopinavir/ritonavir vs. umifenovir,125,2020-05-30,2020-07-31,https://clinicaltrials.gov/show/NCT04252885,Pre-Print Article,2020-03-23,https://doi.org/10.1101/2020.03.19.20038984,2020-02-17,2020-03-18,None
8,NCT04255940,ClinicalTrials.gov,2020-02-03,2020-01-20,True,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Observational,China,2019-nCoV Outbreak and Cardiovascular Diseases,Clinical Presentation,No Intervention,12000,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04255940,No Results,No Results,No Results,2020-02-17,2020-08-03,None
9,ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,100,Not Available,2021-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49348,No Results,No Results,No Results,2020-02-17,2020-08-03,None
10,ChiCTR2000029782,ChiCTR,2020-02-13,2020-01-30,True,Zhejiang Provincial People's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study for the changes in mental state of medical staff in the department of radiotherapy in a comprehensive tertiary hospital in Zhejiang Province during the epidemic of novel coronavirus infection (COVID-19),Other (psych),No Intervention,27,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49445,No Results,No Results,No Results,2020-02-17,2020-08-03,None
11,ChiCTR2000029896,ChiCTR,2020-02-16,2020-01-31,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49432,No Results,No Results,No Results,2020-02-17,2020-03-18,None
12,ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2021-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49355,No Results,No Results,No Results,2020-02-17,2020-08-03,None
13,ChiCTR2000029810,ChiCTR,2020-02-14,2020-02-16,False,Shenzhen Second People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein,Diagnostics,Diagnostic Test or Assessment,10000,Not Available,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=49407,No Results,No Results,No Results,2020-02-17,2020-08-03,None
14,ChiCTR2000029764,ChiCTR,2020-02-13,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Imaging Features and Mechanisms of Novel Coronavirus Pneumonia (COVID-19): a Multicenter Study,Clinical Presentation,No Intervention,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49388,No Results,No Results,No Results,2020-02-17,2020-08-03,None
15,ChiCTR2000029779,ChiCTR,2020-02-13,2020-02-14,False,Wuxi People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging,Clinical Presentation,No Intervention,0,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49378,No Results,No Results,No Results,2020-02-17,2020-08-03,None
16,ChiCTR2000029695,ChiCTR,2020-02-10,2020-03-01,False,Shenzhen Third People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath,Diagnostics,Diagnostic Test or Assessment,300,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49219,No Results,No Results,No Results,2020-02-17,2020-08-03,None
17,ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,600,Not Available,2020-05-13,http://www.chictr.org.cn/showproj.aspx?proj=49422,No Results,No Results,No Results,2020-02-17,2020-08-03,None
18,NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,True,Beijing 302 Hospital,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection,Traditional Medicine (Unspecified),Traditional Medicine,150,2021-01-22,2021-01-22,https://clinicaltrials.gov/show/NCT04251871,No Results,No Results,No Results,2020-02-17,2020-08-03,None
19,NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Jieming QU,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug,Umifenovir,380,2020-07-01,2020-12-30,https://clinicaltrials.gov/show/NCT04260594,No Results,No Results,No Results,2020-02-17,2020-08-03,None
20,ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,160,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49380,No Results,No Results,No Results,2020-02-17,2020-08-03,None
21,ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,True,The First Affiliated Hospital of Wenzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Polyinosinic-polycytidylic acid,40,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49342,No Results,No Results,No Results,2020-02-17,2020-08-03,None
22,NCT04260308,ClinicalTrials.gov,2020-02-03,2020-02-03,False,Huazhong University of Science and Technology,Recruiting,Not Applicable,Observational,China,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,Other (psych),No Intervention,30000,2020-04-15,2020-04-20,https://clinicaltrials.gov/show/NCT04260308,Pre-Print Article,2020-03-06,https://doi.org/10.1101/2020.03.03.20030874,2020-02-17,2020-03-18,None
23,ChiCTR2000029883,ChiCTR,2020-02-16,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study on the sensitivity of nasopharyngeal and oropharyngeal swabbing for the detection of SARS-CoV-2 by real-time PCR,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49549,No Results,No Results,No Results,2020-02-17,2020-08-03,None
24,ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,False,Wuhan Pulmonary Hosptial,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Corticosteroids,100,Not Available,2020-04-14,http://www.chictr.org.cn/showproj.aspx?proj=49086,No Results,No Results,No Results,2020-02-17,2020-08-03,None
25,ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,True,Huangshi Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49486,No Results,No Results,No Results,2020-02-17,2020-08-03,None
26,ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,90,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49297,No Results,No Results,No Results,2020-02-17,2020-08-03,None
27,ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",Drug,Lopinavir/ritonavir vs. chloroquine,112,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49263,No Results,No Results,No Results,2020-02-17,2020-08-03,None
28,ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,False,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Drug,Carrimycin vs. lopinavir/ritonavir,520,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49514,No Results,No Results,No Results,2020-02-17,2020-08-03,None
29,ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Intestinal microbiome,60,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49530,No Results,No Results,No Results,2020-02-17,2020-08-03,None
30,ChiCTR2000029626,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Basic Science,China,Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in Peripheral Blood of Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,20,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=49170,No Results,No Results,No Results,2020-02-17,2020-08-03,None
31,ChiCTR2000029637,ChiCTR,2020-02-08,2020-02-07,True,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,An observational study for Xin-Guan-1 formula  in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49127,No Results,No Results,No Results,2020-02-17,2020-08-03,None
32,ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,ATMP,Vaccine,40,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=49215,No Results,No Results,No Results,2020-02-17,2020-08-03,None
33,ChiCTR2000029624,ChiCTR,2020-02-07,2020-02-08,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A real world study for traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,500,Not Available,2021-02-07,http://www.chictr.org.cn/showproj.aspx?proj=49132,No Results,No Results,No Results,2020-02-17,2020-08-03,None
34,ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,True,Nanjing Second Hospital,Recruiting,Not Applicable,Interventional,No Country Given,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,Traditional Medicine (Drug),Traditional Medicine,110,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49502,No Results,No Results,No Results,2020-02-17,2020-08-03,None
35,ChiCTR2000029815,ChiCTR,2020-02-14,2020-02-01,True,Guangdong Provincial Hospital of Chinese Medicine,Recruiting,Not Applicable,Observational,China,Psychological survey of frontline medical staff in various regions of China during the epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,800,Not Available,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=49346,No Results,No Results,No Results,2020-02-17,2020-03-18,None
36,ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,72,Not Available,2020-08-14,http://www.chictr.org.cn/showproj.aspx?proj=49425,No Results,No Results,No Results,2020-02-17,2020-08-03,None
37,ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),Drug,PD1 vs. thymosin,120,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49161,No Results,No Results,No Results,2020-02-17,2020-08-03,None
38,NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,ATMP,Immunoglobulin,80,2020-04-30,2020-06-30,https://clinicaltrials.gov/show/NCT04261426,No Results,No Results,No Results,2020-02-17,2020-08-03,None
39,NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,False,The First Affiliated Hospital of Zhejiang University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug,Combination: ASC09 + ritonavir vs. lopinavir/ritonavir,160,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04261907,No Results,No Results,No Results,2020-02-17,2020-08-03,None
40,ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,200,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=49596,No Results,No Results,No Results,2020-02-17,2020-08-03,None
41,ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",Drug,Chloroquine,100,Not Available,2021-02-06,http://www.chictr.org.cn/showproj.aspx?proj=49612,No Results,No Results,No Results,2020-02-17,2020-08-03,None
42,ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,False,Shanghai Pulmonary Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,2020-10-31,http://www.chictr.org.cn/showproj.aspx?proj=49453,No Results,No Results,No Results,2020-02-17,2020-08-03,None
43,ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2020-12-30,http://www.chictr.org.cn/showproj.aspx?proj=49452,No Results,No Results,No Results,2020-02-17,2020-08-03,None
44,ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,True,The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,188,Not Available,2020-05-10,http://www.chictr.org.cn/showproj.aspx?proj=49409,No Results,No Results,No Results,2020-02-17,2020-08-03,None
45,ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Traditional Medicine (Other),Traditional Medicine,400,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=48988,No Results,No Results,No Results,2020-02-17,2020-08-03,None
46,ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Not Applicable,Interventional,China,"An open, prospective, multicenter clinical study for the efficacy and safety of Reduning injection in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49104,No Results,No Results,No Results,2020-02-17,2020-08-03,None
47,ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,False,China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,408,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49408,No Results,No Results,No Results,2020-02-17,2020-08-03,None
48,ChiCTR2000029758,ChiCTR,2020-02-12,2020-02-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients,Clinical Presentation,No Intervention,100,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49295,Pre-Print Article,2020-03-06,https://doi.org/10.1101/2020.03.22.20041277,2020-02-17,2020-08-03,None
49,ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,False,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,238,Not Available,2022-02-15,http://www.chictr.org.cn/showproj.aspx?proj=49222,No Results,No Results,No Results,2020-02-17,2020-08-03,None
50,ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,ATMP,Cells (mononuclear),30,Not Available,2021-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49062,No Results,No Results,No Results,2020-02-17,2020-08-03,None
51,ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,False,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,2021-02-10,http://www.chictr.org.cn/showproj.aspx?proj=49287,No Results,No Results,No Results,2020-02-17,2020-08-03,None
52,ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,False,Sun Yat sen Memorial Hospital of Sun Yat sen University,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,20,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=48968,No Results,No Results,No Results,2020-02-17,2020-08-03,None
53,ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,328,Not Available,2021-02-02,http://www.chictr.org.cn/showproj.aspx?proj=48991,No Results,No Results,No Results,2020-02-17,2020-08-03,None
54,ChiCTR2000029462,ChiCTR,2020-02-02,2020-02-01,True,The First Affiliated Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48922,No Results,No Results,No Results,2020-02-17,2020-08-03,None
55,ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2021-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48911,No Results,No Results,No Results,2020-02-17,2020-08-03,None
56,ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,False,The First Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48884,No Results,No Results,No Results,2020-02-17,2020-08-03,None
57,ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",Traditional Medicine (Unspecified),Traditional Medicine,1000,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49080,No Results,No Results,No Results,2020-02-17,2020-08-03,None
58,ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,42,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=48886,Pre-Print Article,2020-04-01,https://doi.org/10.1101/2020.03.27.20044974,2020-02-17,2020-08-03,None
59,ChiCTR2000029907,ChiCTR,2020-02-16,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients,Clinical Presentation,No Intervention,1000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49587,No Results,No Results,No Results,2020-02-17,2020-08-03,None
60,ChiCTR2000029905,ChiCTR,2020-02-16,2020-02-10,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection,Clinical Presentation,No Intervention,271,Not Available,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49595,No Results,No Results,No Results,2020-02-17,2020-08-03,None
61,ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,140,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=48860,No Results,No Results,No Results,2020-02-17,2020-08-03,None
62,ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",Drug,Combination: Hydrogen + Oxygen vs Oxygen,440,Not Available,2021-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49283,No Results,No Results,No Results,2020-02-17,2020-08-03,None
63,ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,True,"Hunan yuanpin Cell Biotechnology Co., Ltd",Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,ATMP,Cells (mesenchymal),60,Not Available,2020-04-17,http://www.chictr.org.cn/showproj.aspx?proj=49229,No Results,No Results,No Results,2020-02-25,2020-08-03,None
64,ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=48861,No Results,No Results,No Results,2020-02-17,2020-08-03,None
65,ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",Traditional Medicine (Other),Traditional Medicine,90,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48971,No Results,No Results,No Results,2020-02-17,2020-08-03,None
66,ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48931,No Results,No Results,No Results,2020-02-17,2020-08-03,None
67,ChiCTR2000029732,ChiCTR,2020-02-10,2020-02-10,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,156,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49302,No Results,No Results,No Results,2020-02-17,2020-08-03,None
68,ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",Other (psych),No Intervention,192,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=49187,No Results,No Results,No Results,2020-02-17,2020-03-18,None
69,ChiCTR2000029628,ChiCTR,2020-02-07,2020-02-07,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A clinical observational study for Xin-Guan-2 formula in the treatment of suspected novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49155,No Results,No Results,No Results,2020-02-17,2020-08-03,None
70,ChiCTR2000029625,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Diagnostic test,China,Construction of Early Warning and Prediction System for Patients with Severe / Critical Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,80,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=49177,No Results,No Results,No Results,2020-02-17,2020-08-03,None
71,ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,False,The Fifth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,20,Not Available,2020-05-14,http://www.chictr.org.cn/showproj.aspx?proj=49696,No Results,No Results,No Results,2020-02-25,2020-08-03,None
72,ChiCTR2000029870,ChiCTR,2020-02-15,2020-02-15,False,Jiangsu Institute of Parasitic Diseases,Recruiting,Not Applicable,Diagnostic test,China,Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,500,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49563,No Results,No Results,No Results,2020-02-17,2020-08-03,None
73,ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,False,Shenzhen National Medicine Inheritance Medical Research Institute co. LTD,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,120,Not Available,2020-06-29,http://www.chictr.org.cn/showproj.aspx?proj=49594,No Results,No Results,No Results,2020-02-25,2020-08-03,None
74,ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,True,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),16,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49901,No Results,No Results,No Results,2020-02-25,2020-08-03,None
75,ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Clinical Presentation (Epidemiology),No Intervention,600,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=48985,No Results,No Results,No Results,2020-02-17,2020-08-03,None
76,ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Unspecified),Traditional Medicine,180,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49543,No Results,No Results,No Results,2020-02-17,2020-08-03,None
77,ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Combination: Favipiravir + interferon alpha vs. interferon alpha + lopinavir/ritonavir + interferon alpha vs. interferon alpha,90,Not Available,2020-04-29,http://www.chictr.org.cn/showproj.aspx?proj=49042,Journal Article,2020-03-18,https://doi.org/10.1016/j.eng.2020.03.007,2020-02-17,2020-08-03,None
78,ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,False,People's Hospital of Guangshan County,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,20,Not Available,2020-04-16,http://www.chictr.org.cn/showproj.aspx?proj=49532,No Results,No Results,No Results,2020-02-17,2020-08-03,None
79,ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,False,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,ATMP,Cells (mononuclear),30,Not Available,2021-04-30,http://www.chictr.org.cn/showproj.aspx?proj=41760,No Results,No Results,No Results,2020-02-17,2020-08-03,None
80,ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,True,Renmin Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),Drug,Hydroxychloroquine,300,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=48880,Pre-Print Article,2020-03-31,https://doi.org/10.1101/2020.03.22.20040758,2020-02-17,2020-08-03,None
81,ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",Drug,Combination: baloxavir + marboxil vs. favipiravir,30,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49013,No Results,No Results,No Results,2020-02-17,2020-08-03,None
82,ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Combination: darunavir + cobicistat vs. lopinavir/ritonavir,100,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48992,No Results,No Results,No Results,2020-02-17,2020-08-03,None
83,ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,False,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=48965,No Results,No Results,No Results,2020-02-17,2020-08-03,None
84,ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,True,"Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Combination: Lopinavir/ritonavir + emtricitabine + tenofovir vs. lopinavir/ritonavir,120,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=48919,No Results,No Results,No Results,2020-02-17,2020-08-03,None
85,ChiCTR2000029437,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,2021-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48913,No Results,No Results,No Results,2020-02-17,2020-08-03,None
86,ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,False,Wuhan First Hospital,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=48827,No Results,No Results,No Results,2020-02-17,2020-08-03,None
87,ChiCTR2000029430,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the TCM syndrome characteristics of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,600,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48902,No Results,No Results,No Results,2020-02-17,2020-08-03,None
88,ChiCTR2000029839,ChiCTR,2020-02-15,2020-02-10,True,Ningbo First Hospital,Recruiting,Not Applicable,Observational,China,"An observational study on the clinical characteristics, treatment and outcome of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,100,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49439,No Results,No Results,No Results,2020-02-17,2020-08-03,None
89,ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48824,No Results,No Results,No Results,2020-02-17,2020-08-03,None
90,ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,False,Deyang Integrated Traditional Chinese and Western Medicine Hospital,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,Traditional Medicine (Unspecified),Traditional Medicine,400,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=49306,No Results,No Results,No Results,2020-02-17,2020-08-03,None
91,ChiCTR2000030185,ChiCTR,2020-02-24,2020-02-24,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Diagnostic test,China,"The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,40,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50058,No Results,No Results,No Results,2020-02-25,2020-08-03,None
92,ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,True,"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Drug),Traditional Medicine,80,Not Available,2020-08-11,http://www.chictr.org.cn/showproj.aspx?proj=49490,No Results,No Results,No Results,2020-02-17,2020-08-03,None
93,ChiCTR2000029804,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Prognosis,China,Clinical Application of ECMO in the Treatment of Patients with Very Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,100,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49178,No Results,No Results,No Results,2020-02-17,2020-08-03,None
94,ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Interleukin-2,80,Not Available,2020-09-01,http://www.chictr.org.cn/showproj.aspx?proj=49567,No Results,No Results,No Results,2020-02-25,2020-08-03,None
95,ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,False,Enze Hospital of Taizhou Enze Medical Center (Group),Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,40,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49415,No Results,No Results,No Results,2020-02-17,2020-08-03,None
96,ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,False,Tianjin University,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,60,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49947,No Results,No Results,No Results,2020-02-25,2020-08-03,None
97,ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,348,Not Available,2021-12-14,http://www.chictr.org.cn/showproj.aspx?proj=49762,No Results,No Results,No Results,2020-02-25,2020-08-03,None
98,ChiCTR2000030115,ChiCTR,2020-02-23,2020-02-27,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A clinical research for the changes of Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide the application of individualized hormone in severe novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,50,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49964,No Results,No Results,No Results,2020-02-25,2020-08-03,None
99,ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,False,The First Afflicated Hospital of Guangzhou University of Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,72,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=48881,No Results,No Results,No Results,2020-02-17,2020-08-03,None
100,ChiCTR2000030092,ChiCTR,2020-02-23,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques,Clinical Presentation,No Intervention,800,Not Available,2022-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49880,No Results,No Results,No Results,2020-02-25,2020-08-03,None
101,ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,True,Affiliated Zhongshan Hospital of Dalian University,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,45,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48907,Pre-Print Article,2020-04-14,https://doi.org/10.1101/2020.04.07.20054767,2020-02-17,2020-08-03,None
102,ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,Other (exercise),Exercise,400,Not Available,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49910,No Results,No Results,No Results,2020-02-25,2020-08-03,None
103,ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,False,The Second Hospital of Shanxi Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,60,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49932,No Results,No Results,No Results,2020-02-25,2020-08-03,None
104,ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",Drug,Combination: Diammonium glycyrrhizinate + vitamin C,60,Not Available,2020-05-12,http://www.chictr.org.cn/showproj.aspx?proj=49131,No Results,No Results,No Results,2020-02-17,2020-08-03,None
105,ChiCTR2000029754,ChiCTR,2020-02-12,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Study for the Effect of Novel Coronavirus Pneumonia (COVID-19) on the Health of Different People,Clinical Presentation,No Intervention,1500,Not Available,2022-02-10,http://www.chictr.org.cn/showproj.aspx?proj=49370,No Results,No Results,No Results,2020-02-17,2020-08-03,None
106,ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,False,The First Hospital of Shanxi Medical University,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,Other (psych),Psychological,180,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49952,No Results,No Results,No Results,2020-02-25,2020-08-03,None
107,ChiCTR2000029751,ChiCTR,2020-02-12,2020-02-01,True,The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,350,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49354,No Results,No Results,No Results,2020-02-17,2020-08-03,None
108,ChiCTR2000029735,ChiCTR,2020-02-10,2020-01-26,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,500,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49279,No Results,No Results,No Results,2020-02-17,2020-08-03,None
109,ChiCTR2000029734,ChiCTR,2020-02-10,2020-02-08,True,The First People's Hospital of Huaihua,Recruiting,Not Applicable,Observational,China,Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,40,Not Available,2020-08-07,http://www.chictr.org.cn/showproj.aspx?proj=48868,Pre-Print Article,2020-03-06,https://doi.org/10.1101/2020.03.04.20026005,2020-02-17,2020-08-03,None
110,ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,False,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Umifenovir,380,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49165,No Results,No Results,No Results,2020-02-17,2020-08-03,None
111,ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine vs. lopinavir/ritonavir,205,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49145,No Results,No Results,No Results,2020-02-17,2020-08-03,None
112,ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (stem cells),63,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49146,No Results,No Results,No Results,2020-02-17,2020-08-03,None
113,ChiCTR2000029605,ChiCTR,2020-02-07,2020-02-06,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,400,Not Available,2021-02-05,http://www.chictr.org.cn/showproj.aspx?proj=49051,No Results,No Results,No Results,2020-02-17,2020-03-18,None
114,ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,False,Peking University Third Hospital,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49866,No Results,No Results,No Results,2020-02-25,2020-08-03,None
115,ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,False,Renmin Hospital of Wuhan University,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Leflunomide,200,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49831,No Results,No Results,No Results,2020-02-25,2020-08-03,None
116,ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",Drug,Combination: ASCO9 + ritonavir vs. lopinavir/ritonavir,160,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49075,No Results,No Results,No Results,2020-02-17,2020-08-03,None
117,ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,40,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49891,No Results,No Results,No Results,2020-02-25,2020-08-03,None
118,ChiCTR2000030056,ChiCTR,2020-02-22,2020-02-23,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the effect of early endotracheal intubation on the outcome of novel coronavirus pneumonia (COVID-19) patients,Other (physical),Endotracheal Intubation,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49904,No Results,No Results,No Results,2020-02-25,2020-08-03,None
119,ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,Traditional Medicine + Western Medicine,Traditional Medicine,200,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=48792,No Results,No Results,No Results,2020-02-17,2020-08-03,None
120,ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,True,Tongde Hospital of Zhejiang Province,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,132,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49647,No Results,No Results,No Results,2020-02-25,2020-08-03,None
121,ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,False,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,828,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49703,No Results,No Results,No Results,2020-02-25,2020-08-03,None
122,ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Combination: baloxavir + marboxil vs. favipiravir vs. lopinavir/ritonavir,30,Not Available,2020-06-03,http://www.chictr.org.cn/showproj.aspx?proj=49015,No Results,No Results,No Results,2020-02-17,2020-08-03,None
123,ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48927,No Results,No Results,No Results,2020-02-17,2020-08-03,None
124,ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (exercise),Exercise,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48930,No Results,No Results,No Results,2020-02-17,2020-08-03,None
125,ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (physio),Physio,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48929,No Results,No Results,No Results,2020-02-17,2020-08-03,None
126,ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48904,No Results,No Results,No Results,2020-02-17,2020-08-03,None
127,ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,400,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48768,No Results,No Results,No Results,2020-02-17,2020-08-03,None
128,NCT04259892,ClinicalTrials.gov,2020-02-05,2020-02-04,True,INSERM,Recruiting,Not Applicable,Observational,France,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Clinical Presentation,No Intervention,300,2020-10-04,2021-02-04,https://clinicaltrials.gov/show/NCT04259892,No Results,No Results,No Results,2020-02-24,2020-08-03,None
129,NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,False,"Southeast University, China",Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,Drug,PD1 vs. thymosin,120,2020-04-30,2020-10-31,https://clinicaltrials.gov/show/NCT04268537,No Results,No Results,No Results,2020-02-24,2020-08-03,None
130,ChiCTR2000030032,ChiCTR,2020-02-21,2020-02-10,True,Xi'an Chest Hospital,Recruiting,Not Applicable,Observational,China,Study on ultrasonographic manifestations of new type of novel coronavirus pneumonia (covid-19) in non-critical stage of pulmonary lesions,Clinical Presentation,No Intervention,20,Not Available,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49816,No Results,No Results,No Results,2020-02-25,2020-08-03,None
131,ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),ATMP,Plasma,100,Not Available,2020-04-24,http://www.chictr.org.cn/showproj.aspx?proj=50059,No Results,No Results,No Results,2020-02-25,2020-08-03,None
132,ChiCTR2000030164,ChiCTR,2020-02-24,2020-02-24,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,A cross-sectional study of novel coronavirus pneumonia (COVID-19) patients in ICU,Clinical Presentation,No Intervention,10,Not Available,2020-03-24,http://www.chictr.org.cn/showproj.aspx?proj=49983,No Results,No Results,No Results,2020-02-25,2020-08-03,None
133,ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,Drug,Favipiravir vs. ritonavir,30,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49988,No Results,No Results,No Results,2020-02-25,2020-08-03,None
134,ChiCTR2000030096,ChiCTR,2020-02-23,2020-02-17,True,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,Study for establishment of correlation between virological dynamics and clinical features in noveal coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,120,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49794,No Results,No Results,No Results,2020-02-25,2020-08-03,None
135,ChiCTR2000030094,ChiCTR,2020-02-23,2020-03-01,False,Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Effects of novel coronavirus pneumonia (COVID-19) on menstruation, TCM body construction and psychological state for female at different ages",Traditional Medicine (Unspecified),Traditional Medicine,200,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49970,No Results,No Results,No Results,2020-02-25,2020-08-03,None
136,ChiCTR2000030017,ChiCTR,2020-02-20,2020-02-17,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49798,No Results,No Results,No Results,2020-02-25,2020-08-03,None
137,ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,True,Guangxi Medical University,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),ATMP,Vaccine,60,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49799,No Results,No Results,No Results,2020-02-25,2020-08-03,None
138,ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,True,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),ATMP,Plasma,10,Not Available,2020-04-07,http://www.chictr.org.cn/showproj.aspx?proj=49861,Journal Article,2020-04-06,https://doi.org/10.1073/pnas.2004168117,2020-02-25,2020-08-03,None
139,ChiCTR2000030015,ChiCTR,2020-02-20,2020-02-19,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Basic Science,China,Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women,Clinical Presentation,No Intervention,300,Not Available,2020-08-19,http://www.chictr.org.cn/showproj.aspx?proj=49800,Pre-Print Article,2020-03-30,https://doi.org/10.1101/2020.03.26.20043943,2020-02-25,2020-08-03,None
140,ChiCTR2000030030,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for acute kidney injury in novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,2000,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=49841,No Results,No Results,No Results,2020-02-25,2020-08-03,None
141,ChiCTR2000030008,ChiCTR,2020-02-19,2020-02-12,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Correalation between anxiety as well as depression and gut microbiome among staff of hospital during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),No Intervention,100,Not Available,2021-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49426,No Results,No Results,No Results,2020-02-25,2020-08-03,None
142,ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),Drug,G-CSF,200,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49619,No Results,No Results,No Results,2020-02-25,2020-08-03,None
143,ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),Drug,Suramin,20,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49824,No Results,No Results,No Results,2020-02-25,2020-08-03,None
144,ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,60,Not Available,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=49737,No Results,No Results,No Results,2020-02-25,2020-08-03,None
145,ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2021-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49852,No Results,No Results,No Results,2020-02-25,2020-08-03,None
146,NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,True,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,ATMP,Cells (mesenchymal),10,2020-04-30,2020-09-30,https://clinicaltrials.gov/show/NCT04269525,No Results,No Results,No Results,2020-02-24,2020-08-03,None
147,ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,True,Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50025,No Results,No Results,No Results,2020-02-25,2020-08-03,None
148,ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,False,"The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),ATMP,Antibody,20,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49718,No Results,No Results,No Results,2020-02-25,2020-08-03,None
149,ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,True,The Ninth Hospital of Nanchang,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",Traditional Medicine + Western Medicine,Traditional Medicine,50,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49748,No Results,No Results,No Results,2020-02-25,2020-03-18,None
150,ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,True,Health commission of Heilongjiang province,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",Drug,Triazavirin,240,Not Available,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=49723,No Results,No Results,No Results,2020-02-25,2020-08-03,None
151,ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",ATMP,Plasma,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49777,No Results,No Results,No Results,2020-02-25,2020-08-03,None
152,ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,False,Shanghai 10th People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,60,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49717,No Results,No Results,No Results,2020-02-25,2020-03-18,None
153,ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=49618,No Results,No Results,No Results,2020-02-25,2020-08-03,None
154,ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),Drug,Jakotinib,16,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=50017,No Results,No Results,No Results,2020-02-25,2020-08-03,None
155,ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,False,Chinese PLA General Hospital,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),60,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50004,No Results,No Results,No Results,2020-02-25,2020-08-03,None
156,ChiCTR2000030137,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Observational,China,Humanistic Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,130,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=50007,No Results,No Results,No Results,2020-02-25,2020-08-03,None
157,ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",Drug,Favipiravir,60,Not Available,2020-04-20,http://www.chictr.org.cn/showproj.aspx?proj=49510,No Results,No Results,No Results,2020-02-25,2020-08-03,None
158,ChiCTR2000029995,ChiCTR,2020-02-19,2020-02-20,False,Shanghai General Hospital of Shanghai Jiaotong University,Recruiting,Not Applicable,Observational,China,Study on anxiety of different populations under novel coronavirus (COVID-19) infection,Other (psych),No Intervention,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49418,No Results,No Results,No Results,2020-02-25,2020-08-03,None
159,ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-08-19,http://www.chictr.org.cn/showproj.aspx?proj=49309,No Results,No Results,No Results,2020-02-25,2020-08-03,None
160,ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,True,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",Drug,Combination: Chloroquine + hydroxychloroquine,100,Not Available,2020-05-20,http://www.chictr.org.cn/showproj.aspx?proj=49574,No Results,No Results,No Results,2020-02-25,2020-08-03,None
161,ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,True,"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),120,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49674,No Results,No Results,No Results,2020-02-25,2020-03-18,None
162,ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,186,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=49702,No Results,No Results,No Results,2020-02-25,2020-08-03,None
163,ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49639,No Results,No Results,No Results,2020-02-25,2020-08-03,None
164,ChiCTR2000029959,ChiCTR,2020-02-17,2020-01-25,True,"West China Second Hospital, Sichuan University",Recruiting,Not Applicable,Observational,China,Clinical observation and research of  Severe acute respiratory syndrome coronavirus 2(COVID-19) infection in perinatal newborns,Clinical Presentation,No Intervention,30,Not Available,2021-01-01,http://www.chictr.org.cn/showproj.aspx?proj=49636,No Results,No Results,No Results,2020-02-25,2020-08-03,None
165,ChiCTR2000029981,ChiCTR,2020-02-18,2020-02-18,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions,Diagnostics,Diagnostic Test or Assessment,60,Not Available,2020-05-18,http://www.chictr.org.cn/showproj.aspx?proj=49692,Pre-Print Article,2020-03-03,https://doi.org/10.1101/2020.02.26.20028225,2020-02-25,2020-08-03,None
166,ChiCTR2000029866,ChiCTR,2020-02-15,2020-02-17,False,Enze Hospital of Taizhou Enze Medical Center (Group),Recruiting,Not Applicable,Diagnostic test,China,Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics,Genomics,No Intervention,120,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49519,No Results,No Results,No Results,2020-02-25,2020-08-03,None
167,ChiCTR2000029865,ChiCTR,2020-02-15,2020-02-20,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients,Prognosis,No Intervention,1200,Not Available,2020-04-20,http://www.chictr.org.cn/showproj.aspx?proj=49545,No Results,No Results,No Results,2020-02-25,2020-08-03,None
168,ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,130,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=50005,No Results,No Results,No Results,2020-02-25,2020-03-18,None
169,ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,False,"Zhongshan Hospital, Fudan University",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",Supplement,Alpha lipoic acid,68,Not Available,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=49534,Pre-Print Article,2020-04-21,https://doi.org/10.1101/2020.04.15.20066266,2020-02-25,2020-08-03,None
170,ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,True,"Qingdao East Sea Pharmaceutical Co., Ltd.",Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",Supplement,Probiotics,300,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49321,No Results,No Results,No Results,2020-02-25,2020-08-03,None
171,ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,False,Tianjin Huanhu Hospital,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Ozone,180,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49747,No Results,No Results,No Results,2020-02-25,2020-08-03,None
172,ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,False,Shanghai Changzheng Hospital,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Drug,Adalimumab,60,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49889,No Results,No Results,No Results,2020-02-25,2020-08-03,None
173,ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,160,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49138,No Results,No Results,No Results,2020-02-25,2020-08-03,None
174,ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydroxychloroquine vs. Umeprevir,320,Not Available,2021-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49428,No Results,No Results,No Results,2020-02-25,2020-08-03,None
175,ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),40,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49902,No Results,No Results,No Results,2020-02-25,2020-08-03,None
176,ChiCTR2000030087,ChiCTR,2020-02-22,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,800,Not Available,2023-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49919,No Results,No Results,No Results,2020-02-25,2020-08-03,None
177,ChiCTR2000030086,ChiCTR,2020-02-22,2020-02-24,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the effects on medical providers' infection rate and mental health after performing different anesthesia schemes in cesarean section for novel coronavirus pneumonia (COVID-19) puerperae,Clinical Presentation,No Intervention,210,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49934,No Results,No Results,No Results,2020-02-25,2020-08-03,None
178,ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,False,The First Hospital of Peking University,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),Drug,Hydroxychloroquine,78,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49317,No Results,No Results,No Results,2020-02-25,2020-08-03,None
179,ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,160,Not Available,2020-06-09,http://www.chictr.org.cn/showproj.aspx?proj=49220,No Results,No Results,No Results,2020-02-25,2020-08-03,None
180,ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,False,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",Drug,Combination: Chloroquine vs. hydroxychloroquine,100,Not Available,2020-05-21,http://www.chictr.org.cn/showproj.aspx?proj=49869,No Results,No Results,No Results,2020-02-25,2020-08-03,None
181,ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,False,Affiliated Hospital of Xuzhou Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),ATMP,Plasma,90,Not Available,2020-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49544,No Results,No Results,No Results,2020-02-25,2020-08-03,None
182,ChiCTR2000030021,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based analysis for the clinical characteristics of novel coronavirus pneumonia (COVID-19) in immunocompromised patients,Clinical Presentation,No Intervention,10,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49690,No Results,No Results,No Results,2020-02-25,2020-08-03,None
183,ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,True,"Second Hospital of University of South China, Hengyang",Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),20,Not Available,2022-02-05,http://www.chictr.org.cn/showproj.aspx?proj=49812,No Results,No Results,No Results,2020-02-25,2020-08-03,None
184,ChiCTR2000030019,ChiCTR,2020-02-20,2020-02-28,False,"Zhongshan Hospital, Fudan University",Not Recruiting,Not Applicable,Observational,China,"The COVID-19 Mobile Health Study (CMHS), a large-scale clinical observational registration study using nCapp",Clinical Presentation,No Intervention,600,Not Available,2021-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49768,No Results,No Results,No Results,2020-02-25,2020-08-03,None
185,ChiCTR2000030004,ChiCTR,2020-02-19,2020-02-20,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental Health of College Students,Other (psych),No Intervention,150000,Not Available,2023-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49783,No Results,No Results,No Results,2020-02-25,2020-03-18,None
186,NCT04256395,ClinicalTrials.gov,2020-02-01,2020-02-01,False,Beijing Tsinghua Chang Gung Hospital,Recruiting,Not Applicable,Observational,China,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,300000,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04256395,No Results,No Results,No Results,2020-03-02,2020-03-18,None
187,NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug,Thalidomide,100,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04273529,No Results,No Results,No Results,2020-03-02,2020-08-03,None
188,NCT04270383,ClinicalTrials.gov,2020-02-11,2020-02-15,False,Beijing Children's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Clinical Presentation,No Intervention,500,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04270383,No Results,No Results,No Results,2020-03-02,2020-08-03,None
189,NCT04275947,ClinicalTrials.gov,2020-02-17,2020-02-14,True,Chinese Alliance Against Lung Cancer,Recruiting,Not Applicable,Observational,China,The COVID-19 Mobile Health Study (CMHS),Diagnostics,Diagnostic Test or Assessment,450,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04275947,No Results,No Results,No Results,2020-03-02,2020-08-03,None
190,ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,480,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=49770,No Results,No Results,No Results,2020-02-25,2020-08-03,None
191,ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,True,The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Tranilast,60,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=49738,No Results,No Results,No Results,2020-02-25,2020-08-03,None
192,ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),Drug,Interferon alfa,300,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49720,No Results,No Results,No Results,2020-02-25,2020-08-03,None
193,NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,True,Tang-Du Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug,Mepolizumab,20,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04275245,Pre-Print Article,2020-03-24,https://doi.org/10.1101/2020.03.21.20040691,2020-03-02,2020-08-03,None
194,NCT04275388,ClinicalTrials.gov,2020-02-17,2020-02-14,True,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,Traditional Medicine (Drug),Traditional Medicine,348,2020-05-14,2021-12-14,https://clinicaltrials.gov/show/NCT04275388,No Results,No Results,No Results,2020-03-02,2020-03-18,None
195,ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Chloroquine,80,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49218,No Results,No Results,No Results,2020-02-25,2020-08-03,None
196,ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,False,"Institute of Integrative Medicine of Dalian Medical University, Dalian, China",Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Other (psych),Psychological,60,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50286,No Results,No Results,No Results,2020-03-02,2020-08-03,None
197,ChiCTR2000029985,ChiCTR,2020-02-18,2020-02-10,True,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Study for mental health status and influencing factors of nurses during epidemic prevention of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,1853,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49711,No Results,No Results,No Results,2020-02-25,2020-03-18,None
198,NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug,Combination: thalidomide + corticosteroids,40,2020-04-30,2020-05-30,https://clinicaltrials.gov/show/NCT04273581,No Results,No Results,No Results,2020-03-02,2020-08-03,None
199,NCT04279782,ClinicalTrials.gov,2020-02-15,2020-01-20,True,"Third Affiliated Hospital, Sun Yat-Sen University",Recruiting,Not Applicable,Observational,China,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Clinical Presentation,No Intervention,100,2021-01-31,2021-02-28,https://clinicaltrials.gov/show/NCT04279782,No Results,No Results,No Results,2020-03-02,2020-03-18,None
200,ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Other (physical),Ultra short wave electrotherapy,40,Not Available,2020-05-17,http://www.chictr.org.cn/showproj.aspx?proj=49664,No Results,No Results,No Results,2020-02-25,2020-08-03,None
201,ChiCTR2000030390,ChiCTR,2020-03-01,2020-01-01,True,Key Laboratory of Ministry of Industry and Information Technology of Biomedical Engineering and Translational Medicine,Recruiting,Not Applicable,Diagnostic test,China,Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology,Diagnostics,Diagnostic Test or Assessment,3000,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=50224,No Results,No Results,No Results,2020-03-02,2020-08-03,None
202,ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-02-10,http://www.chictr.org.cn/showproj.aspx?proj=49402,No Results,No Results,No Results,2020-02-25,2020-08-03,None
203,NCT04279795,ClinicalTrials.gov,2020-02-19,2020-01-20,True,"Third Affiliated Hospital, Sun Yat-Sen University",Recruiting,Not Applicable,Observational,China,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Clinical Presentation,No Intervention,20,2021-01-31,2021-02-28,https://clinicaltrials.gov/show/NCT04279795,No Results,No Results,No Results,2020-03-02,2020-03-18,None
204,ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",Drug (+ATMP +Other (renal)),Combination: Tocilizumab + immunoglobulin + renal replacement therapy,100,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=50380,No Results,No Results,No Results,2020-03-02,2020-03-18,None
205,ChiCTR2000030363,ChiCTR,2020-02-29,2020-02-23,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Novel Coronavirus Infected Disease (COVID-19) in children: epidemiology, clinical features and treatment outcome",Clinical Presentation (Epidemiology),No Intervention,120,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49984,No Results,No Results,No Results,2020-03-02,2020-08-03,None
206,NCT04279899,ClinicalTrials.gov,2020-02-18,2020-02-01,True,Children's Hospital of Fudan University,Recruiting,Not Applicable,Observational,China,The Investigation of the Neonates With or With Risk of COVID-19,Clinical Presentation,No Intervention,100,2020-11-30,2020-12-31,https://clinicaltrials.gov/show/NCT04279899,No Results,No Results,No Results,2020-03-02,2020-03-18,None
207,ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),Other (physio),Physio,80,Not Available,2020-10-01,http://www.chictr.org.cn/showproj.aspx?proj=50273,No Results,No Results,No Results,2020-03-02,2020-08-03,None
208,ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio,80,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50341,No Results,No Results,No Results,2020-03-02,2020-08-03,None
209,ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,False,Henan Provincial People's Hospital,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,30,Not Available,2022-05-02,http://www.chictr.org.cn/showproj.aspx?proj=50174,No Results,No Results,No Results,2020-03-02,2020-08-03,None
210,ChiCTR2000030391,ChiCTR,2020-03-01,2020-03-01,False,Lishui Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=30796,No Results,No Results,No Results,2020-03-02,2020-08-03,None
211,ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,False,Hunan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,1000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50323,No Results,No Results,No Results,2020-03-02,2020-03-18,None
212,ChiCTR2000030382,ChiCTR,2020-02-17,2020-03-01,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet,Traditional Medicine (Other),Traditional Medicine,50,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50325,No Results,No Results,No Results,2020-03-02,2020-03-18,None
213,NCT04279197,ClinicalTrials.gov,2020-02-15,2020-02-15,False,ShuGuang Hospital,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu,Traditional Medicine (Drug),Traditional Medicine,136,2022-12-01,2022-12-01,https://clinicaltrials.gov/show/NCT04279197,No Results,No Results,No Results,2020-03-02,2020-08-03,None
214,NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,Drug,Fingolimod,30,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04280588,No Results,No Results,No Results,2020-03-02,2020-08-03,None
215,ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,Other (physio),Physio,80,Not Available,2020-08-27,http://www.chictr.org.cn/showproj.aspx?proj=50268,No Results,No Results,No Results,2020-03-02,2020-08-03,None
216,ChiCTR2000030322,ChiCTR,2020-02-28,2020-02-01,True,Xinyang Central Hospital,Recruiting,Not Applicable,Observational,China,Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,210,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50240,No Results,No Results,No Results,2020-03-02,2020-08-03,None
217,ChiCTR2000030327,ChiCTR,2020-02-28,2020-01-21,True,The Second Affiliated hospital of Anhui Medical University,Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50214,No Results,No Results,No Results,2020-03-02,2020-08-03,None
218,ChiCTR2000030325,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Observational,China,A survey of mental health of first-line medical service providers and construction of crisis intervention model for novel coronavirus pneumonia (COVID-19) in Xiangyang,Other (psych),No Intervention,500,Not Available,2020-04-28,http://www.chictr.org.cn/showproj.aspx?proj=50227,No Results,No Results,No Results,2020-03-02,2020-08-03,None
219,ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,40,Not Available,2020-04-28,http://www.chictr.org.cn/showproj.aspx?proj=50248,No Results,No Results,No Results,2020-03-02,2020-03-18,None
220,ChiCTR2000030334,ChiCTR,2020-02-28,2020-02-19,True,Nanjing Second Hospital,Recruiting,Not Applicable,Diagnostic test,China,microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19),Diagnostics,Diagnostic Test or Assessment,25,Not Available,2020-06-19,http://www.chictr.org.cn/showproj.aspx?proj=49491,No Results,No Results,No Results,2020-03-02,2020-08-03,None
221,ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,40,Not Available,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=50231,No Results,No Results,No Results,2020-03-02,2020-08-03,None
222,ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",Drug,Bismuth potassium citrate,340,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50173,No Results,No Results,No Results,2020-03-02,2020-08-03,None
223,ChiCTR2000030389,ChiCTR,2020-03-01,2020-02-29,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,120,Not Available,2020-08-23,http://www.chictr.org.cn/showproj.aspx?proj=50278,No Results,No Results,No Results,2020-03-02,2020-08-03,None
224,ChiCTR2000030333,ChiCTR,2020-02-28,2020-03-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",Drug,Pirfenidone,292,Not Available,2020-07-07,http://www.chictr.org.cn/showproj.aspx?proj=48801,No Results,No Results,No Results,2020-03-02,2020-08-03,None
225,ChiCTR2000030305,ChiCTR,2020-02-28,2020-03-09,False,Li Caixia,Not Recruiting,Not Applicable,Observational,China,Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,20,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50223,No Results,No Results,No Results,2020-03-02,2020-08-03,None
226,ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,Other (physical),Gastroscope mask,300,Not Available,2021-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50247,No Results,No Results,No Results,2020-03-02,2020-08-03,None
227,ChiCTR2000030387,ChiCTR,2020-03-01,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical observation and research of multiple organs injury in severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,130,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50329,No Results,No Results,No Results,2020-03-02,2020-08-03,None
228,ChiCTR2000030315,ChiCTR,2020-02-28,2020-01-01,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50255,No Results,No Results,No Results,2020-03-02,2020-08-03,None
229,ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-01,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical study for combination of anti-viral drugs and type I interferon and inflammation inhibitor TFF2 in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Combination: interferon kappa + trefoil factor 2 (a gene-derived protein),30,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50136,No Results,No Results,No Results,2020-03-02,2020-08-03,None
230,ChiCTR2000030263,ChiCTR,2020-02-26,2020-02-20,True,Beijing Geriatric Hospital,Not Recruiting,Not Applicable,Epidemiological research,China,Investigation and analysis of psychological status of hospital staff during the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,200,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=50140,No Results,No Results,No Results,2020-03-02,2020-03-18,None
231,ChiCTR2000030283,ChiCTR,2020-02-27,2020-02-27,False,Xianning Central Hospital,Recruiting,Not Applicable,Observational,China,Correlation between imaging characteristics and laboratory tests of new coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50119,No Results,No Results,No Results,2020-03-02,2020-08-03,None
232,ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,True,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),Other (renal),Renal replacement therapy,30,Not Available,2021-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49691,No Results,No Results,No Results,2020-03-02,2020-08-03,None
233,ChiCTR2000030264,ChiCTR,2020-02-26,2020-02-28,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,ICU healthcare personnel burnout investigation during the fight against novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,1000,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=50161,No Results,No Results,No Results,2020-03-02,2020-08-03,None
234,ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,False,Wuxi Fifth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),26,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49963,No Results,No Results,No Results,2020-03-02,2020-08-03,None
235,ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,Other (nutrition),Nutrition,20,Not Available,2021-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50130,No Results,No Results,No Results,2020-03-02,2020-08-03,None
236,ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=50089,No Results,No Results,No Results,2020-03-02,2020-08-03,None
237,ChiCTR2000030253,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Phase 1,Diagnostic test,China,Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid,Diagnostics,Diagnostic Test or Assessment,30,Not Available,2021-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50143,No Results,No Results,No Results,2020-03-02,2020-08-03,None
238,ChiCTR2000030293,ChiCTR,2020-02-27,2020-03-01,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Clinical observation and research plan of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,300,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50195,No Results,No Results,No Results,2020-03-02,2020-08-03,None
239,ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,False,"The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),Traditional Medicine (Drug),Traditional Medicine,120,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50107,No Results,No Results,No Results,2020-03-02,2020-08-03,None
240,ChiCTR2000030290,ChiCTR,2020-02-27,2020-02-11,True,Xiamen University,Not Recruiting,Not Applicable,Observational,China,Health related quality of life and its influencing factors among front line nurses caring patients with new coronavirus pneumonia (COVID-19) from two hospitals in China,Other (psych),No Intervention,2000,Not Available,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=50175,No Results,No Results,No Results,2020-03-02,2020-08-03,None
241,ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,True,Central South Hospital of Wuhan University,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,60,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49883,No Results,No Results,No Results,2020-03-02,2020-08-03,None
242,ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,True,Shanghai Changzheng Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",Drug,Combination: Danoprevir + ritonavir,60,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49918,No Results,No Results,No Results,2020-03-02,2020-08-03,None
243,ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,True,The Fourth Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Hydrogen,60,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=49887,No Results,No Results,No Results,2020-03-02,2020-08-03,None
244,ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50110,No Results,No Results,No Results,2020-03-02,2020-08-03,None
245,ChiCTR2000030257,ChiCTR,2020-02-26,2020-03-09,False,Puren Hospital of Wuhan City,Not Recruiting,Not Applicable,Observational,China,The coagulation function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50006,No Results,No Results,No Results,2020-03-02,2020-08-03,None
246,ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Anhui Medical University,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-05-22,http://www.chictr.org.cn/showproj.aspx?proj=49797,No Results,No Results,No Results,2020-03-02,2020-08-03,None
247,ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,Drug,Interferon alfa,450,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49796,No Results,No Results,No Results,2020-03-02,2020-08-03,None
248,ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,True,The Fifth People's Hospital of Ganzhou,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),Drug,Lopinavir/ritonavir (+ Tradtional Medicine),80,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=50115,No Results,No Results,No Results,2020-03-02,2020-08-03,None
249,ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,False,The First Affiliated Hospital of Nanchang University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,72,Not Available,2020-07-18,http://www.chictr.org.cn/showproj.aspx?proj=49666,No Results,No Results,No Results,2020-03-02,2020-08-03,None
250,ChiCTR2000030226,ChiCTR,2020-02-26,2020-02-01,True,The Fourth Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,China,"The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study",Prognosis,No Intervention,40,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49855,No Results,No Results,No Results,2020-03-02,2020-08-03,None
251,ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,120,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49301,No Results,No Results,No Results,2020-03-02,2020-08-03,None
252,ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,186,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49945,No Results,No Results,No Results,2020-03-02,2020-08-03,None
253,ChiCTR2000029728,ChiCTR,2020-02-10,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,500,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49250,No Results,No Results,No Results,2020-03-02,2020-08-03,None
254,ChiCTR2000030223,ChiCTR,2020-02-26,2020-02-20,True,No Sponsor Name Given,Recruiting,Not Applicable,Health services research,China,Quality of life among Chinese residents during and after novel coronavirus pneumonia (COVID19) outbreak: an online survey,Other (psych),No Intervention,5000,Not Available,2022-05-19,http://www.chictr.org.cn/showproj.aspx?proj=50026,No Results,No Results,No Results,2020-03-02,2020-03-18,None
255,ChiCTR2000029900,ChiCTR,2020-02-16,2020-02-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Research for Risks Associated with Novel Coronavirus Pneumonia (COVID-19) in the Hospital Workers and Nosocomial  Prevention and Control Strategy,Clinical Presentation,No Intervention,200,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49377,No Results,No Results,No Results,2020-03-02,2020-08-03,None
256,ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),Other (exercise),Exercise,200,Not Available,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49914,No Results,No Results,No Results,2020-03-02,2020-08-03,None
257,ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,False,The First Hospital of Jilin University,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,10,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49592,No Results,No Results,No Results,2020-03-02,2020-08-03,None
258,ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,True,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",Drug,"Combination: ribavirin + interferon alfa
vs. lopinavir/ritonavir + interferon alfa
vs. ribavirin + interferon alfa vs. lopinavir/ritonavir",108,Not Available,2021-01-25,http://www.chictr.org.cn/showproj.aspx?proj=48782,No Results,No Results,No Results,2020-03-02,2020-08-03,None
259,ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",Drug,Combination: hydroxychloroquine vs. chloroquine,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49536,No Results,No Results,No Results,2020-03-02,2020-08-03,None
260,ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,False,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,Drug,Corticosteroids,48,Not Available,2021-01-29,http://www.chictr.org.cn/showproj.aspx?proj=48777,No Results,No Results,No Results,2020-03-02,2020-08-03,None
261,ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",Drug,Combination: hydroxychloroquine vs. chloroquine,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49482,No Results,No Results,No Results,2020-03-02,2020-08-03,None
262,ChiCTR2000030552,ChiCTR,2020-03-07,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Critical ultrasound in evaluating cardiopulmonary function in critical patients infected with 2019 novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,70,Not Available,2020-05-08,http://www.chictr.org.cn/showproj.aspx?proj=49708,No Results,No Results,No Results,2020-03-09,2020-08-03,None
263,ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,True,Wuhan Red Cross Hospital,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,Drug,Combination: Ebastine + interferon alpha + lopinavir vs. interferon alpha + lopinavir,100,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=49790,No Results,No Results,No Results,2020-03-09,2020-08-03,None
264,NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,True,"Beijing You'an Hospital, Capital Medical University",Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug,Carrimycin vs. lopinavir/ritonavir or Umifenovir or chloroquine,520,2021-02-28,2021-02-28,https://clinicaltrials.gov/show/NCT04286503,No Results,No Results,No Results,2020-03-09,2020-08-03,None
265,ChiCTR2000030581,ChiCTR,2020-03-08,2020-02-02,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,The immediate psychological impact of novel coronavirus pneumonia (COVID-19) outbreak on medical students in anesthesiology and how the cope,Other (psych),No Intervention,192,Not Available,2021-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50394,No Results,No Results,No Results,2020-03-09,2020-08-03,None
266,ChiCTR2000030574,ChiCTR,2020-03-07,2020-03-08,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Research on peripheral immunity function monitoring and its clinical application in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,500,Not Available,2021-03-08,http://www.chictr.org.cn/showproj.aspx?proj=49953,No Results,No Results,No Results,2020-03-09,2020-08-03,None
267,ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,False,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-09-09,http://www.chictr.org.cn/showproj.aspx?proj=44213,No Results,No Results,No Results,2020-03-09,2020-08-03,None
268,ChiCTR2000030556,ChiCTR,2020-03-07,2020-03-15,False,Anhui Cancer Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study of nano-nose and its extended technology in diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=50672,No Results,No Results,No Results,2020-03-09,2020-08-03,None
269,ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,Traditional Medicine (Other),Traditional Medicine,60,Not Available,2022-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49632,No Results,No Results,No Results,2020-03-09,2020-08-03,None
270,ChiCTR2000030542,ChiCTR,2020-03-06,2020-03-09,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,"A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",Genomics,No Intervention,600,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=50608,Pre-Print Article,2020-03-21,https://doi.org/10.1101/2020.03.18.20035816,2020-03-09,2020-08-03,None
271,ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,Other (renal),Renal replacement therapy,152,Not Available,2020-06-08,http://www.chictr.org.cn/showproj.aspx?proj=50658,No Results,No Results,No Results,2020-03-09,2020-08-03,None
272,NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,True,Ruijin Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,ATMP,Cells (mesenchymal),30,2020-05-31,2020-07-31,https://clinicaltrials.gov/show/NCT04276987,No Results,No Results,No Results,2020-03-09,2020-03-18,None
273,ChiCTR2000030593,ChiCTR,2020-03-08,2020-03-10,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Observational,China,"Novel coronavirus pneumonia (COVID-19) antiviral related liver dysfunction: a multicenter, retrospective, observational study",Clinical Presentation,No Intervention,150,Not Available,2020-04-09,http://www.chictr.org.cn/showproj.aspx?proj=50228,No Results,No Results,No Results,2020-03-09,2020-08-03,None
274,NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,True,Affiliated Hospital to Academy of Military Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostics,Diagnostic Test or Assessment,230,2020-03-01,2020-03-01,https://clinicaltrials.gov/show/NCT04281693,No Results,No Results,No Results,2020-03-09,2020-03-18,None
275,NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,True,Huilan Zhang,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug,Pirfenidone,294,2020-04-30,2020-06-01,https://clinicaltrials.gov/show/NCT04282902,No Results,No Results,No Results,2020-03-09,2020-03-18,None
276,ChiCTR2000030492,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Retrospective study for integrate Chinese and conventional medicine  treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,200,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50549,No Results,No Results,No Results,2020-03-09,2020-08-03,None
277,ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,10,Not Available,2020-05-04,http://www.chictr.org.cn/showproj.aspx?proj=50507,No Results,No Results,No Results,2020-03-09,2020-08-03,None
278,ChiCTR2000030559,ChiCTR,2020-03-07,2020-03-07,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,12,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50583,No Results,No Results,No Results,2020-03-09,2020-08-03,None
279,ChiCTR2000030485,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for timing of mechanical ventilation for critically ill patients with novel coronavirus pneumonia (COVID-19): A medical records based retrospective Cohort study,Other (physical),Mechanical ventilation,90,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50459,No Results,No Results,No Results,2020-03-09,2020-08-03,None
280,ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Combination: diammonium glycyrrhizinate + hydrogen,100,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50487,No Results,No Results,No Results,2020-03-09,2020-08-03,None
281,ChiCTR2000030557,ChiCTR,2020-03-07,2020-03-10,False,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Observational,China,"A retrospective study on virus typing, Hematological Immunology and case Review of novel coronavirus infected and convalescent patients (COVID-19)",Clinical Presentation,No Intervention,1030,Not Available,2021-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50667,No Results,No Results,No Results,2020-03-09,2020-08-03,None
282,ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,True,Shenyang Sixth People's Hospital,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,20,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49753,No Results,No Results,No Results,2020-03-09,2020-08-03,None
283,ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,Drug,Corticosteroids,200,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50453,No Results,No Results,No Results,2020-03-09,2020-08-03,None
284,ChiCTR2000030543,ChiCTR,2020-03-06,2020-02-14,True,Central Theater General Hospital of PLA,Recruiting,Not Applicable,Observational,China,Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,35,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50541,No Results,No Results,No Results,2020-03-09,2020-08-03,None
285,ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,False,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,394,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50421,No Results,No Results,No Results,2020-03-09,2020-08-03,None
286,ChiCTR2000030541,ChiCTR,2020-03-06,2020-03-06,False,"Xiamen Medical College,Shijiazhuang Medical College",Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) epidemic survey of medical students in various provinces and municipalities throughout the country,Clinical Presentation,No Intervention,1300,Not Available,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50623,No Results,No Results,No Results,2020-03-09,2020-08-03,None
287,NCT04284046,ClinicalTrials.gov,2020-02-22,2020-01-31,True,Shanghai General Hospital of Shanghai Jiaotong University,Not Recruiting,Not Applicable,Observational,China,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Prognosis,No Intervention,39,2020-02-18,2020-02-18,https://clinicaltrials.gov/show/NCT04284046,No Results,No Results,No Results,2020-03-09,2020-03-18,None
288,NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,False,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Traditional Medicine (Drug),Traditional Medicine,120,2020-06-15,2020-09-15,https://clinicaltrials.gov/show/NCT04285190,No Results,No Results,No Results,2020-03-09,2020-03-18,None
289,ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,True,"Dalian Medical University, Dalian, China.",Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Traditional Medicine + Western Medicine,Traditional Medicine,60,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50378,No Results,No Results,No Results,2020-03-09,2020-08-03,None
290,ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,ATMP,Plasma,30,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=50727,No Results,No Results,No Results,2020-03-09,2020-08-03,None
291,ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,True,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,96,Not Available,2020-05-27,http://www.chictr.org.cn/showproj.aspx?proj=50082,No Results,No Results,No Results,2020-03-09,2020-08-03,None
292,ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,True,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50586,No Results,No Results,No Results,2020-03-09,2020-08-03,None
293,ChiCTR2000030468,ChiCTR,2020-03-02,2020-02-28,True,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation,Traditional Medicine (Unspecified),Traditional Medicine,950,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=50390,No Results,No Results,No Results,2020-03-09,2020-08-03,None
294,ChiCTR2000030579,ChiCTR,2020-03-08,2020-02-15,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Risk Factors for Outcomes of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50692,No Results,No Results,No Results,2020-03-09,2020-08-03,None
295,ChiCTR2000030491,ChiCTR,2020-03-04,2020-03-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,A medical records based study for Comparing Differences of Clinical Features and Outcomes of Novel Coronavirus Pneumonia (COVID-19) Patients between Sichuan Province and Wuhan City,Clinical Presentation,No Intervention,100,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50552,No Results,No Results,No Results,2020-03-09,2020-08-03,None
296,ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,40,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50690,No Results,No Results,No Results,2020-03-09,2020-08-03,None
297,ChiCTR2000030453,ChiCTR,2020-03-02,2020-03-02,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,Clinical study for the effects of ACEIs/ARBs on the infection of novel coronavirus pneumonia (CoVID-19),Drug,ACE inhibitors or ARBs,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50381,No Results,No Results,No Results,2020-03-09,2020-08-03,None
298,ChiCTR2000030489,ChiCTR,2020-03-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Epidemiological research,China,Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases,Clinical Presentation,No Intervention,1000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50490,Pre-Print Article,2020-03-16,https://doi.org/10.1101/2020.03.12.20034678,2020-03-09,2020-08-03,None
299,ChiCTR2000030564,ChiCTR,2020-03-07,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Psychological Intervention of Children with Novel Coronavirus Disease (COVID-19),Other (psych),Psychological,120,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50653,No Results,No Results,No Results,2020-03-09,2020-08-03,None
300,ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,True,Hubei Shiyan Taihe hospital,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),90,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50263,No Results,No Results,No Results,2020-03-09,2020-03-18,None
301,ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",Drug (+ATMP),Ruxolimab + Cells (mesenchymal),70,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49088,No Results,No Results,No Results,2020-03-09,2020-08-03,None
302,ChiCTR2000030304,ChiCTR,2020-02-28,2020-03-10,False,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Observational,China,Protective factors of mental resilience in first-line nurses with novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,300,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49653,No Results,No Results,No Results,2020-03-09,2020-08-03,None
303,ChiCTR2000030544,ChiCTR,2020-03-06,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the risk factors of critically ill patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,1500,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50134,No Results,No Results,No Results,2020-03-09,2020-08-03,None
304,ChiCTR2000030482,ChiCTR,2020-03-03,2020-03-06,False,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,"A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,8000,Not Available,2023-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50353,No Results,No Results,No Results,2020-03-09,2020-08-03,None
305,ChiCTR2000030493,ChiCTR,2020-03-04,2020-03-04,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Survey for sleep, anxiety and depression status of Chinese residents during the outbreak of novel coronavirus infected disases (COVID-19)",Other (psych),No Intervention,1300,Not Available,2020-09-03,http://www.chictr.org.cn/showproj.aspx?proj=50547,No Results,No Results,No Results,2020-03-09,2020-03-18,None
306,ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,300,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=48775,No Results,No Results,No Results,2020-03-09,2020-03-18,None
307,ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Other (physical),Extracorporeal blood purification ,19,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=50452,No Results,No Results,No Results,2020-03-09,2020-08-03,None
308,ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon alfa,328,Not Available,2020-07-03,http://www.chictr.org.cn/showproj.aspx?proj=50470,No Results,No Results,No Results,2020-03-09,2020-08-03,None
309,ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,400,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=49014,No Results,No Results,No Results,2020-03-09,2020-08-03,None
310,ChiCTR2000030464,ChiCTR,2020-03-02,2020-03-03,False,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Epidemiological research,No Country Given,Study for the clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=50382,No Results,No Results,No Results,2020-03-09,2020-08-03,None
311,ChiCTR2000030163,ChiCTR,2020-02-24,2020-02-25,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Observational,China,A Medical Based Retrospective Real World Study for Assessment of Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,256,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50031,No Results,No Results,No Results,2020-03-09,2020-08-03,None
312,ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2021-02-25,http://www.chictr.org.cn/showproj.aspx?proj=50450,No Results,No Results,No Results,2020-03-09,2020-08-03,None
313,ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia (COVID-19) in the Community Population,Traditional Medicine (Unspecified),Traditional Medicine,20000,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=48773,No Results,No Results,No Results,2020-03-09,2020-08-03,None
314,ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,19,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=50458,No Results,No Results,No Results,2020-03-09,2020-08-03,None
315,ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,40,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=49435,No Results,No Results,No Results,2020-03-09,2020-08-03,None
316,ChiCTR2000030436,ChiCTR,2020-03-01,2020-03-06,False,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50297,No Results,No Results,No Results,2020-03-09,2020-08-03,None
317,ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,24,Not Available,2021-03-30,http://www.chictr.org.cn/showproj.aspx?proj=51028,No Results,No Results,No Results,2020-03-16,2020-03-18,None
318,ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",Drug,Interferon,100,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=49224,No Results,No Results,No Results,2020-03-09,2020-08-03,None
319,ChiCTR2000029958,ChiCTR,2020-02-17,2020-02-17,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the clinical characteristics of anesthesia novel coronavirus pneumonia (COVID-19) patients during perioperative period and assessment of infection and mental health of Anesthesiology Department,Clinical Presentation,No Intervention,260,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49635,No Results,No Results,No Results,2020-03-09,2020-08-03,None
320,ChiCTR2000030895,ChiCTR,2020-03-16,2020-03-14,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Retrospective and Prospective Study for Nosocomial infection in Stomatology Department under the Background of novel coronavirus pneumonia (COVID-19) epidemic period,Clinical Presentation,No Intervention,1000,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51034,No Results,No Results,No Results,2020-03-16,2020-03-18,None
321,NCT04292327,ClinicalTrials.gov,2020-02-23,2020-01-01,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Presentation,No Intervention,400,2020-04-30,2020-07-31,https://clinicaltrials.gov/show/NCT04292327,No Results,No Results,No Results,2020-03-16,2020-03-18,None
322,NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Traditional Medicine (Drug),Traditional Medicine,80,2020-07-14,2021-04-14,https://clinicaltrials.gov/show/NCT04295551,No Results,No Results,No Results,2020-03-16,2020-08-03,None
323,ChiCTR2000029579,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance,Clinical Presentation,No Intervention,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49045,No Results,No Results,No Results,2020-03-09,2020-08-03,None
324,ChiCTR2000030894,ChiCTR,2020-03-16,2020-03-01,True,Peking University First Hospital,Recruiting,Phase 4,Interventional,China,"Favipiravir Combined With Tocilizumab in the Treatment of novel coronavirus pneumonia (COVID-19) - A Multicenter, Randomized, Controlled Trial",Drug,Combination: Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,150,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51126,No Results,No Results,No Results,2020-03-16,2020-03-18,None
325,ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,False,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,ATMP,Plasma,200,Not Available,2021-02-05,http://www.chictr.org.cn/showproj.aspx?proj=49081,No Results,No Results,No Results,2020-03-09,2020-08-03,None
326,ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,160,Not Available,2021-01-10,http://www.chictr.org.cn/showproj.aspx?proj=48684,Journal Article,2020-03-18,doi.org/10.1056/NEJMoa2001282,2020-03-09,2020-08-03,None
327,ChiCTR2000030893,ChiCTR,2020-03-16,2020-03-19,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for effects of crisis intervention based on positive psychology for medical staffs working in the novel coronavirus pneumonia (COVID-19) field,Other (psych),Psychological,50,Not Available,2021-03-11,http://www.chictr.org.cn/showproj.aspx?proj=51073,No Results,No Results,No Results,2020-03-16,2020-03-18,None
328,ChiCTR2000030863,ChiCTR,2020-03-16,2020-01-22,True,"Jinling Hospital, Medical School of Nanjing University",Recruiting,Not Applicable,Observational,China,Clinical and CT imaging Characteristics of novel coronavirus pneumonia (COVID-19): An Multicenter Cohort Study,Clinical Presentation,No Intervention,5000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50767,No Results,No Results,No Results,2020-03-16,2020-03-18,None
329,ChiCTR2000030862,ChiCTR,2020-03-16,2020-01-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Correlation analysis of blood eosinophil cell levels and clinical type category of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,Clinical Presentation,No Intervention,150,Not Available,2020-06-16,http://www.chictr.org.cn/showproj.aspx?proj=51107,No Results,No Results,No Results,2020-03-16,2020-03-18,None
330,NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,False,McMaster University,Not Recruiting,Not Applicable,Interventional,No Country Given,Medical Masks vs N95 Respirators for COVID-19,Other (device),Masks,576,2020-12-01,2021-01-01,https://clinicaltrials.gov/show/NCT04296643,No Results,No Results,No Results,2020-03-16,2020-03-18,None
331,NCT04299711,ClinicalTrials.gov,2020-03-04,2020-10-15,False,University of Macau,Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Other (psych),No Intervention,3428,2020-11-15,2022-03-15,https://clinicaltrials.gov/show/NCT04299711,No Results,No Results,No Results,2020-03-16,2020-03-18,None
332,NCT04298814,ClinicalTrials.gov,2020-02-26,2020-03-07,False,Tongji Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Other (physical),Endotracheal Intubation,120,2020-05-30,2020-07-30,https://clinicaltrials.gov/show/NCT04298814,No Results,No Results,No Results,2020-03-16,2020-03-18,None
333,ChiCTR2000030898,ChiCTR,2020-03-16,2020-01-27,True,The Affiliated Hospital to Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,1000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50780,No Results,No Results,No Results,2020-03-16,2020-03-18,None
334,NCT04292340,ClinicalTrials.gov,2020-02-25,2020-02-01,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,ATMP,Plasma,15,2020-07-31,2020-12-31,https://clinicaltrials.gov/show/NCT04292340,No Results,No Results,No Results,2020-03-16,2020-03-18,None
335,NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,False,Tongji Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2 in the Treatment of Novel Coronavirus Patients,Drug,Interferon alfa,328,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04293887,No Results,No Results,No Results,2020-03-16,2020-03-18,None
336,ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,20,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50462,No Results,No Results,No Results,2020-03-16,2020-03-18,None
337,ChiCTR2000030866,ChiCTR,2020-03-16,2020-02-01,True,The First Hospital of Changsha,Recruiting,Not Applicable,Observational,China,"Open-label, observational study of human umbilical cord derived mesenchymal stem cells in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",ATMP,Cells (mesenchymal),30,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50299,No Results,No Results,No Results,2020-03-16,2020-03-18,None
338,ChiCTR2000030861,ChiCTR,2020-03-16,2019-02-27,True,The First Affiliated Hospital of the Guangzhou Medical University,Recruiting,Not Applicable,Health services research,No Country Given,Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling,Other (physical),Other,90,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=51103,No Results,No Results,No Results,2020-03-16,2020-03-18,None
339,ChiCTR2000030902,ChiCTR,2020-03-16,2020-02-10,True,Jingzhou Mental Health Center,Recruiting,Not Applicable,Observational,China,Analysis for the mental health status of residents in Jingzhou during the outbreak of the novel coronavirus pneumonia (COVID-19) and corresponding influencing factors,Other (psych),No Intervention,1000,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51130,No Results,No Results,No Results,2020-03-16,2020-03-18,None
340,ChiCTR2000030860,ChiCTR,2020-03-16,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for investigation of dynamic profile of RT-PCR test for SARS-CoV-2 nucleic acid of novel coronavirus pneumonia (COVID-19) patients,Diagnostics,Diagnostic Test or Assessment,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51102,No Results,No Results,No Results,2020-03-16,2020-03-18,None
341,ChiCTR2000030901,ChiCTR,2020-03-16,2020-03-09,True,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of epidemiology and transmission dynamics of patients confirmed with Coronavirus Disease (COVID-19) in Hong Kong,Clinical Presentation ,No Intervention,100,Not Available,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=51064,No Results,No Results,No Results,2020-03-16,2020-03-18,None
342,ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,50,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=50662,No Results,No Results,No Results,2020-03-16,2020-03-18,None
343,ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,Drug,Pirfenidone,40,Not Available,2020-12-30,http://www.chictr.org.cn/showproj.aspx?proj=51118,No Results,No Results,No Results,2020-03-16,2020-03-18,None
344,ChiCTR2000030854,ChiCTR,2020-03-16,2020-01-22,True,Li Lanjuan,Not Recruiting,Not Applicable,Observational,China,"A clinical multicenter study for the occurrence, development and prognosis of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,237,Not Available,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51083,No Results,No Results,No Results,2020-03-16,2020-03-18,None
345,ChiCTR2000030812,ChiCTR,2020-03-15,2020-01-31,True,Shanghai Ninth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for the virus molecular evolution which driven the immune-pathological responses and the protection mechanisms of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,50,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50947,No Results,No Results,No Results,2020-03-16,2020-03-18,None
346,ChiCTR2000030859,ChiCTR,2020-03-16,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,A medical based analysis for influencing factors of death of novel coronavirus pneumonia (COVID-19) patients in Wuhan third hospital,Prognosis,No Intervention,1305,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=51025,No Results,No Results,No Results,2020-03-16,2020-03-18,None
347,ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),Drug,Dexmedetomidine,200,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51081,No Results,No Results,No Results,2020-03-16,2020-03-18,None
348,ChiCTR2000030883,ChiCTR,2020-03-16,2020-02-18,True,"Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University",Recruiting,Not Applicable,Observational,China,Clinical research and preparation development of qingfei detoxification decoction (mixture) for prevention and treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50960,No Results,No Results,No Results,2020-03-16,2020-03-18,None
349,ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,True,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50986,No Results,No Results,No Results,2020-03-16,2020-03-18,None
350,ChiCTR2000030865,ChiCTR,2020-03-16,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Establishment of an early warning model for maternal and child vertical transmission of COVID-19 infection,Clinical Presentation,No Intervention,200,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49933,No Results,No Results,No Results,2020-03-16,2020-03-18,None
351,ChiCTR2000030852,ChiCTR,2020-03-16,2020-01-27,True,"Beijing An Zhen Hospital, Capital Medical University",Not Recruiting,Not Applicable,Observational,China,Factors associated with death in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,150,Not Available,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=51077,Journal Article,2020-03-11,https://doi.org/10.1016/S0140-6736(20)30566-3,2020-03-16,2020-03-18,None
352,ChiCTR2000030857,ChiCTR,2020-03-16,2020-03-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for bronchoscopic alveolar lavage in the treatment of critically trachea intubation patients with new coronavirus pneumonia (COVID-19),Other (physical),Bronchoscopic lavage,30,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51040,No Results,No Results,No Results,2020-03-16,2020-03-18,None
353,ChiCTR2000030858,ChiCTR,2020-03-16,2020-02-06,True,Hubei Cancer Hospital,Recruiting,Not Applicable,Observational,China,"Clinical characteristics and outcomes of 483 mild patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China during the outbreak: A single-center, retrospective study from the mobile cabin hospital",Clinical Presentation,No Intervention,483,Not Available,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51097,No Results,No Results,No Results,2020-03-16,2020-03-18,None
354,ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,200,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=51090,No Results,No Results,No Results,2020-03-16,2020-03-18,None
355,ChiCTR2000030838,ChiCTR,2020-03-15,2020-01-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,Development of warning system with clinical differential diagnosis and prediction for severe type of novel coronavirus pneumonia (COVID-19) patients based on artificial intelligence and CT images,Diagnostics,Diagnostic Test or Assessment,1000,Not Available,2020-05-06,http://www.chictr.org.cn/showproj.aspx?proj=51071,No Results,No Results,No Results,2020-03-16,2020-03-18,None
356,ChiCTR2000030809,ChiCTR,2020-03-15,2020-02-22,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical outcomes and follow-up of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,1000,Not Available,2021-03-30,http://www.chictr.org.cn/showproj.aspx?proj=51015,No Results,No Results,No Results,2020-03-16,2020-03-18,None
357,ChiCTR2000030856,ChiCTR,2020-03-16,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,An artificial intelligence assistant system for suspected novel coronavirus pneumonia (COVID-19) based on chest CT,Diagnostics,Diagnostic Test or Assessment,600,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=51091,No Results,No Results,No Results,2020-03-16,2020-03-18,None
358,ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51054,No Results,No Results,No Results,2020-03-16,2020-03-18,None
359,ChiCTR2000030850,ChiCTR,2020-03-15,2020-03-15,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the physical and mental health status of medical workers under the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,226,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51056,No Results,No Results,No Results,2020-03-16,2020-03-18,None
360,ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,True,The First Affiliated Hospital of Xinxiang Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),20,Not Available,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=51050,No Results,No Results,No Results,2020-03-16,2020-03-18,None
361,ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,Other (psych),No Intervention,81,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51086,No Results,No Results,No Results,2020-03-16,2020-03-18,None
362,ChiCTR2000030833,ChiCTR,2020-03-15,2020-03-22,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit,Diagnostics,Diagnostic Test or Assessment,400,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51035,No Results,No Results,No Results,2020-03-16,2020-03-18,None
363,ChiCTR2000030834,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Epidemiological Characteristics and Antibody Levels of novel coronavirus pneumonia (COVID-19) of Pediatric Medical Staff working in Quarantine Area,Clinical Presentation (Epidemiology),No Intervention,500,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51047,No Results,No Results,No Results,2020-03-16,2020-03-18,None
364,ChiCTR2000030795,ChiCTR,2020-03-15,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,90,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50982,No Results,No Results,No Results,2020-03-16,2020-03-18,None
365,ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),ATMP,Immunoglobulin,10,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51072,No Results,No Results,No Results,2020-03-16,2020-03-18,None
366,ChiCTR2000030839,ChiCTR,2020-03-15,2020-03-01,True,"Tongren Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Screening,China,Preliminary screening of novel coronavirus pneumonia (COVID-19) by special laboratory examination and CT imaging before surgery,Diagnostics,Diagnostic Test or Assessment,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50904,No Results,No Results,No Results,2020-03-16,2020-03-18,None
367,ChiCTR2000030831,ChiCTR,2020-03-15,2020-01-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The analysis of related factors on improving oxygenation status by endotracheal intubation ventilation in severe patients suffered from novel coronavirus pneumonia (COVID-19): a single center and descriptive study in Wuhan,Prognosis,No Intervention,75,Not Available,2020-06-15,http://www.chictr.org.cn/showproj.aspx?proj=51036,No Results,No Results,No Results,2020-03-16,2020-03-18,None
368,ChiCTR2000030778,ChiCTR,2020-03-14,2020-01-20,True,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for epidemic and clinical features of novel coronavirus pneumonia (COVID-19) in Ningbo First Hospital,Clinical Presentation,No Intervention,40,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=50987,No Results,No Results,No Results,2020-03-16,2020-03-18,None
369,ChiCTR2000030819,ChiCTR,2020-03-15,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,"Retrospective analysis of digestive system symptoms in 600 cases of novel coronavirus pneumonia (COVID-19) in Guanggu district, Wuhan",Clinical Presentation,No Intervention,600,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51039,No Results,No Results,No Results,2020-03-16,2020-03-18,None
370,ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,800,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=51044,No Results,No Results,No Results,2020-03-16,2020-03-18,None
371,ChiCTR2000030816,ChiCTR,2020-03-15,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Nutritional risk assessment and outcome prediction of critically ill novel coronavirus pneumonia (COVID-19) patients,Prognosis,No Intervention,200,Not Available,2021-02-23,http://www.chictr.org.cn/showproj.aspx?proj=51048,No Results,No Results,No Results,2020-03-16,2020-03-18,None
372,ChiCTR2000030818,ChiCTR,2020-03-15,2020-01-31,True,"The First Affiliated Hospital, Henan Traditional Chinese Medicine University",Not Recruiting,Not Applicable,Observational,China,A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,10,Not Available,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=51037,No Results,No Results,No Results,2020-03-16,2020-03-18,None
373,ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,70,Not Available,2020-05-17,http://www.chictr.org.cn/showproj.aspx?proj=49284,No Results,No Results,No Results,2020-03-16,2020-03-18,None
374,ChiCTR2000030814,ChiCTR,2020-03-15,2020-02-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based analysis of clinical evidence of human-to-human transmission of 2019 novel coronavirus pneumonia (COVID-19) by conjunctival route,Clinical Presentation,No Intervention,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51042,No Results,No Results,No Results,2020-03-16,2020-03-18,None
375,ChiCTR2000030830,ChiCTR,2020-03-15,2020-01-01,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Observational,China,Development and application of novel coronavirus pneumonia (COVID-19) intelligent image classification system based on deep learning,Diagnostics,Diagnostic Test or Assessment,150,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51009,No Results,No Results,No Results,2020-03-16,2020-03-18,None
376,ChiCTR2000030807,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical characteristics and prognosis of cancer patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=51019,No Results,No Results,No Results,2020-03-16,2020-03-18,None
377,ChiCTR2000030806,ChiCTR,2020-03-15,2020-02-01,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,20,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51029,No Results,No Results,No Results,2020-03-16,2020-03-18,None
378,ChiCTR2000030758,ChiCTR,2020-03-13,2020-03-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified sedation and analgesia,200,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50590,No Results,No Results,No Results,2020-03-16,2020-03-18,None
379,ChiCTR2000030805,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,Quantitative CT characteristic estimate the severity of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51026,No Results,No Results,No Results,2020-03-16,2020-03-18,None
380,ChiCTR2000030803,ChiCTR,2020-03-15,2020-01-31,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,No Country Given,Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,400,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51007,No Results,No Results,No Results,2020-03-16,2020-03-18,None
381,ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,True,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,Traditional Medicine (Drug),Traditional Medicine,128,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51018,No Results,No Results,No Results,2020-03-16,2020-03-18,None
382,ChiCTR2000030757,ChiCTR,2020-03-13,2020-03-13,False,Shenzhen-Peking University; The Hong Kong University of Science & Technology Medical Center,Not Recruiting,Not Applicable,Observational,China,Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers,Other (psych),No Intervention,100,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50648,No Results,No Results,No Results,2020-03-16,2020-03-18,None
383,ChiCTR2000030798,ChiCTR,2020-03-15,2020-02-10,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50994,No Results,No Results,No Results,2020-03-16,2020-03-18,None
384,ChiCTR2000030802,ChiCTR,2020-03-15,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified Drug,2000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51004,No Results,No Results,No Results,2020-03-16,2020-03-18,None
385,ChiCTR2000030756,ChiCTR,2020-03-13,2020-02-20,True,Shenzhen Hospital of Southern Medical University,Recruiting,Not Applicable,Observational,China,Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation ,No Intervention,60,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=50705,Pre-Print Article,2020-03-30,https://doi.org/10.1101/2020.03.26.20044198,2020-03-16,2020-03-18,None
386,ChiCTR2000030796,ChiCTR,2020-03-15,2020-01-29,True,The Second Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,No Country Given,Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,500,Not Available,2022-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50991,No Results,No Results,No Results,2020-03-16,2020-03-18,None
387,ChiCTR2000030801,ChiCTR,2020-03-15,2020-01-23,True,The Third Hospital of Wuhan,Recruiting,Not Applicable,Observational,China,Analysis of risk factors affecting prognosis of elderly patients infected with novel coronavirus pneumonia (COVID-19): a single-center retrospective observational study,Prognosis,No Intervention,100,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=50998,No Results,No Results,No Results,2020-03-16,2020-03-18,None
388,ChiCTR2000030799,ChiCTR,2020-03-15,2020-01-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19),Prognosis,No Intervention,1000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50995,No Results,No Results,No Results,2020-03-16,2020-03-18,None
389,ChiCTR2000030782,ChiCTR,2020-03-14,2020-02-01,True,Cangzhou People's Hospital,Recruiting,Not Applicable,Observational,No Country Given,"The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)",Prognosis,No Intervention,20,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50976,No Results,No Results,No Results,2020-03-16,2020-03-18,None
390,ChiCTR2000030797,ChiCTR,2020-03-15,2020-03-07,True,"Shanghai Fifth People's Hospital, Fudan University",Recruiting,Not Applicable,Observational,China,clinical study for hemodynamics and cardiac arrhythmia of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,100,Not Available,2021-07-07,http://www.chictr.org.cn/showproj.aspx?proj=50988,No Results,No Results,No Results,2020-03-16,2020-03-18,None
391,ChiCTR2000030742,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)",Clinical Presentation,No Intervention,200,Not Available,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=50857,No Results,No Results,No Results,2020-03-16,2020-03-18,None
392,ChiCTR2000030784,ChiCTR,2020-03-14,2020-01-17,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Recruiting,Not Applicable,Observational,China,A study for clinical characteristics of novel coronavirus pneumonia (COVID-19) patients follow-up in Guangxi,Clinical Presentation,No Intervention,150,Not Available,2020-01-17,http://www.chictr.org.cn/showproj.aspx?proj=50307,No Results,No Results,No Results,2020-03-16,2020-03-18,None
393,ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,True,Huashan Hospital; Fudan Universtiy,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,20,Not Available,2020-07-12,http://www.chictr.org.cn/showproj.aspx?proj=50934,No Results,No Results,No Results,2020-03-16,2020-03-18,None
394,ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,False,Shanghai Changzheng Hospital,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50973,No Results,No Results,No Results,2020-03-16,2020-03-18,None
395,ChiCTR2000030764,ChiCTR,2020-03-13,2020-03-07,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Observational,China,"Research for the influence of epidemic of novel coronavirus pneumonia (COVID-19) on sleep, psychological and chronic diseases among different populations",Clinical Presentation,No Intervention,2800,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=50852,No Results,No Results,No Results,2020-03-16,2020-03-18,None
396,ChiCTR2000030768,ChiCTR,2020-03-14,2020-02-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Epidemiological research,China,Study for the Psychological Status of Medical Staff of Otolaryngology Head and Neck Surgery in Hubei Province under the Epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,450,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50968,No Results,No Results,No Results,2020-03-16,2020-03-18,None
397,ChiCTR2000030763,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A Medical Records Based analysis for Risk Factors for Outcomes After Respiratory Support in Patients with ARDS Due to Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50921,No Results,No Results,No Results,2020-03-16,2020-03-18,None
398,ChiCTR2000030741,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with  Novel Coronavirus Pneumonia (COVID-19),Other (physical),Mechanical ventilation,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50907,No Results,No Results,No Results,2020-03-16,2020-03-18,None
399,ChiCTR2000030762,ChiCTR,2020-03-13,2019-12-01,True,The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine,Not Recruiting,Not Applicable,Epidemiological research,China,Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)'',Traditional Medicine (Other),Traditional Medicine,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50950,No Results,No Results,No Results,2020-03-16,2020-03-18,None
400,ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,True,Affiliated Hospital of Inner Mongolia University for the Nationalities,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2020-12-25,http://www.chictr.org.cn/showproj.aspx?proj=50941,No Results,No Results,No Results,2020-03-16,2020-03-18,None
401,ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,False,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,Other (renal),Renal replacement therapy,20,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=50956,No Results,No Results,No Results,2020-03-16,2020-03-18,None
402,ChiCTR2000030760,ChiCTR,2020-03-13,2020-03-13,False,Zhejiang Hospital,Not Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Zhejiang province, China",Clinical Presentation,No Intervention,74,Not Available,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50955,No Results,No Results,No Results,2020-03-16,2020-03-18,None
403,ChiCTR2000030740,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).,Clinical Presentation,No Intervention,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50900,No Results,No Results,No Results,2020-03-16,2020-03-18,None
404,ChiCTR2000030755,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"A medical records based study for characteristics, prognosis of ederly patients with Novel Coronavirus Pneumonia (COVID-19) in Wuhan area",Prognosis,No Intervention,400,Not Available,2020-09-15,http://www.chictr.org.cn/showproj.aspx?proj=50945,No Results,No Results,No Results,2020-03-16,2020-03-18,None
405,ChiCTR2000030753,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,No Status Given,Not Applicable,Observational,China,A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50901,No Results,No Results,No Results,2020-03-16,2020-03-18,None
406,ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,80,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=50843,No Results,No Results,No Results,2020-03-16,2020-03-18,None
407,ChiCTR2000030708,ChiCTR,2020-03-11,2020-03-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cross sectional study of dialysis treatment and mental status under the outbreak of novel coronavirus pneumonia (COVID-2019) in China,Other (renal),Dialysis,1000,Not Available,2020-04-02,http://www.chictr.org.cn/showproj.aspx?proj=50083,No Results,No Results,No Results,2020-03-16,2020-03-18,None
408,ChiCTR2000030754,ChiCTR,2020-03-13,2020-03-11,True,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Diagnostic test,China,Medical records based study for the accuracy of SARS-CoV-2 IgM antibody screening for diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,30,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50824,No Results,No Results,No Results,2020-03-16,2020-03-18,None
409,ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,30,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50910,No Results,No Results,No Results,2020-03-16,2020-03-18,None
410,ChiCTR2000030717,ChiCTR,2020-03-11,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for risk assessment and treatment timing of invasive fungal infection in novel coronavirus pneumonia (COVID-19) critical patients,Clinical Presentation,No Intervention,260,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50860,No Results,No Results,No Results,2020-03-16,2020-03-18,None
411,ChiCTR2000030707,ChiCTR,2020-03-11,2020-03-20,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,Retrospective study on novel coronavirus pneumonia (COVID-19) in Tibetan Plateau,Clinical Presentation,No Intervention,78,Not Available,2022-03-19,http://www.chictr.org.cn/showproj.aspx?proj=50160,No Results,No Results,No Results,2020-03-16,2020-03-18,None
412,ChiCTR2000030752,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A medical records based analysis for risk factors for death in patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,500,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50925,No Results,No Results,No Results,2020-03-16,2020-03-18,None
413,ChiCTR2000030739,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Exploration of the Clinical Characteristics of Patients with Novel Coronavirus Pneumonia (COVID-19) and Its Differences from Patients with Severe Influenza A and MERS,Clinical Presentation,No Intervention,100,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50896,No Results,No Results,No Results,2020-03-16,2020-03-18,None
414,ChiCTR2000030716,ChiCTR,2020-03-11,2020-03-05,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Shedding of SARS-CoV-2 in human semen and evaluation of reproductive health of novel coronavirus pneumonia (COVID-19) male patients,Clinical Presentation,No Intervention,150,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50850,No Results,No Results,No Results,2020-03-16,2020-03-18,None
415,ChiCTR2000030721,ChiCTR,2020-03-12,2020-03-16,False,Affiliated Hospital of Guangdong Medical University,Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study for the sensitivity of induced sputum and throat swabs for the detection of SARS-CoV-2 by real-time PCR in patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,50,Not Available,2020-04-26,http://www.chictr.org.cn/showproj.aspx?proj=50759,No Results,No Results,No Results,2020-03-16,2020-03-18,None
416,ChiCTR2000030719,ChiCTR,2020-03-11,2020-03-01,True,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Recruiting,Not Applicable,Observational,China,A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan,Traditional Medicine + Western Medicine,Traditional Medicine,1071,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50867,No Results,No Results,No Results,2020-03-16,2020-03-18,None
417,ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,False,The Third People's Hospital of Shenzhen,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",Drug,LMWH (Enoxaparin),60,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=50795,No Results,No Results,No Results,2020-03-16,2020-03-18,None
418,ChiCTR2000030747,ChiCTR,2020-03-13,2020-02-22,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A prospective cohort  study for comprehensive treatment of Chinese medicine in the treatment of convalescent patients of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,1500,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=50000,No Results,No Results,No Results,2020-03-16,2020-03-18,None
419,ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",Drug,"Combination: Ixekizumab + up to three of interferon-alfa, lopinavir/ritonavir, chloroquine, ribavirin, umifenovir",40,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50251,No Results,No Results,No Results,2020-03-16,2020-03-18,None
420,ChiCTR2000030690,ChiCTR,2020-03-10,2020-02-10,True,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Basic Science,China,Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2021-02-10,http://www.chictr.org.cn/showproj.aspx?proj=50261,Pre-Print Article,2020-03-31,https://doi.org/10.1101/2020.03.23.20039362,2020-03-16,2020-03-18,None
421,ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,Drug,LMWH (Enoxaparin),60,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=50786,No Results,No Results,No Results,2020-03-16,2020-03-18,None
422,ChiCTR2000030722,ChiCTR,2020-03-12,2020-03-09,True,Shanghai First People's Hospital,Not Recruiting,Not Applicable,Observational,China,Auscultatory characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50338,No Results,No Results,No Results,2020-03-16,2020-03-18,None
423,ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,True,Shanghai General Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,Adamumab,60,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50693,No Results,No Results,No Results,2020-03-16,2020-08-03,None
424,ChiCTR2000030687,ChiCTR,2020-03-09,2020-02-01,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Not Recruiting,Not Applicable,Basic Science,China,Novel coronavirus pneumonia (COVID-19) associated kidney injury in children,Clinical Presentation,No Intervention,120,Not Available,2020-10-31,http://www.chictr.org.cn/showproj.aspx?proj=50572,No Results,No Results,No Results,2020-03-16,2020-03-18,None
425,ChiCTR2000030683,ChiCTR,2020-03-09,2020-03-09,False,The Sixth Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Diagnostic test,China,The prediction value of prognosis of novel coronavirus pneumonia (COVID-19) in elderly patients by modified early warning score (MEWS): a medical records based retrospective observational study,Prognosis,No Intervention,234,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50633,No Results,No Results,No Results,2020-03-16,2020-03-18,None
426,ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,Prognosis,No Intervention,120,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50793,No Results,No Results,No Results,2020-03-16,2020-03-18,None
427,ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50126,No Results,No Results,No Results,2020-03-16,2020-08-03,None
428,ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,False,Liaocheng People's Hospital,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,Other (physical),Extubation,240,Not Available,2021-11-16,http://www.chictr.org.cn/showproj.aspx?proj=50763,No Results,No Results,No Results,2020-03-16,2020-03-18,None
429,ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,True,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,ATMP,Plasma,50,Not Available,2020-08-15,http://www.chictr.org.cn/showproj.aspx?proj=50537,No Results,No Results,No Results,2020-03-16,2020-03-18,None
430,ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,True,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50306,No Results,No Results,No Results,2020-03-16,2020-08-03,None
431,ChiCTR2000030619,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Bengbu Medical College,Not Recruiting,Not Applicable,Observational,China,A medical records based real world study for the characteristics and correlation mechanism of traditional Chinese medicine combined with western medicine in the treatment of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,160,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50656,No Results,No Results,No Results,2020-03-16,2020-08-03,None
432,ChiCTR2000030697,ChiCTR,2020-03-10,2020-03-10,False,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,"A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals",Other (psych),Psychological,1500,Not Available,2021-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50781,Pre-Print Article,No Results,"https://doi.org/10.1101/2020.03.13.20033290

https://doi.org/10.1101/2020.03.22.20040899",2020-03-16,2020-03-18,None
433,ChiCTR2000030114,ChiCTR,2020-02-23,2020-02-24,False,Peking University People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,"Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,150,Not Available,2020-08-24,http://www.chictr.org.cn/showproj.aspx?proj=49987,No Results,No Results,No Results,2020-03-16,2020-03-18,None
434,ChiCTR2000030055,ChiCTR,2020-02-22,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Prognosis,China,Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19),Drug,Dipyridamole,460,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49864,Pre-Print Article,2020-02-29,https://doi.org/10.1101/2020.02.27.20027557,2020-03-16,2020-08-03,None
435,ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,False,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir,60,Not Available,2020-03-25,http://www.chictr.org.cn/showproj.aspx?proj=50057,No Results,No Results,No Results,2020-03-16,2020-08-03,None
436,ChiCTR2000030686,ChiCTR,2020-03-09,2020-03-03,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,The effects of prevention and control measures on treatment and psychological status of cancer patients during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,300,Not Available,2020-07-03,http://www.chictr.org.cn/showproj.aspx?proj=50714,No Results,No Results,No Results,2020-03-16,2020-03-18,None
437,ChiCTR2000030005,ChiCTR,2020-02-19,2020-02-21,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Nucleic acid analysis of novel coronavirus pneumonia (COVID-19) in morning sputum samples and pharyngeal swabs-a prospectively diagnostic test,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-04-21,http://www.chictr.org.cn/showproj.aspx?proj=49669,No Results,No Results,No Results,2020-03-16,2020-08-03,None
438,ChiCTR2000029592,ChiCTR,2020-02-05,2020-02-07,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical Study of Arbidol Hydrochloride Using for Post-exposure Prophylaxis of 2019-nCoV in High-risk Population Including Medical Staff,Drug (Chemoprophylaxis),Umifenovir,1000,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49069,No Results,No Results,No Results,2020-03-16,2020-08-03,None
439,ChiCTR2000030679,ChiCTR,2020-03-09,2020-01-28,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Recruiting,Not Applicable,Observational,China,Cohort study of Novel Coronavirus Infected Diseases (COVID-19) in children,Clinical Presentation,No Intervention,500,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50730,No Results,No Results,No Results,2020-03-16,2020-03-18,None
440,ChiCTR2000030606,ChiCTR,2020-03-08,2020-03-09,False,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,120,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50713,No Results,No Results,No Results,2020-03-16,2020-03-18,None
441,ChiCTR2000030597,ChiCTR,2020-03-08,2020-03-09,False,China Academy of Chinese Medical Science,Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,150,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50702,No Results,No Results,No Results,2020-03-16,2020-08-03,None
442,ChiCTR2000030528,ChiCTR,2020-03-06,2020-03-06,False,The Second Clinical College of Guangzhou University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Application of TCM Nursing Scheme in Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,60,Not Available,2020-05-25,http://www.chictr.org.cn/showproj.aspx?proj=50641,No Results,No Results,No Results,2020-03-16,2020-08-03,None
443,ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,False,"Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,200,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=50455,No Results,No Results,No Results,2020-03-16,2020-08-03,None
444,NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,False,"CAR-T (Shanghai) Biotechnology Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),24,2021-06-30,2021-07-30,https://clinicaltrials.gov/show/NCT04302519,No Results,No Results,No Results,2020-03-23,2020-03-18,None
445,ChiCTR2000031163,ChiCTR,2020-03-23,2020-02-16,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Not Recruiting,Not Applicable,Observational,China,The relationship between Vitamin D andnovel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,2022-02-16,http://www.chictr.org.cn/showproj.aspx?proj=51390,No Results,No Results,No Results,2020-03-23,2020-03-25,None
446,NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,False,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Drug,Vitamin C,140,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04264533,No Results,No Results,No Results,2020-03-23,2020-08-03,None
447,NCT04308187,ClinicalTrials.gov,2020-03-12,2020-03-11,True,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,France,Influence of the COvid-19 Epidemic on STRESS,Other (psych),No Intervention,50000,2022-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04308187,No Results,No Results,No Results,2020-03-23,2020-03-18,None
448,NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,False,Asan Medical Center,Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Drug,Lopinavir/ritonavir vs. hydroxychloroquine,150,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04307693,No Results,No Results,No Results,2020-03-23,2020-03-18,None
449,ChiCTR2000031104,ChiCTR,2020-03-22,2020-02-05,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,200,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=51185,No Results,No Results,No Results,2020-03-23,2020-03-25,None
450,ChiCTR2000031140,ChiCTR,2020-03-22,2020-02-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the impact on fetus and neonates of vertical transmission of 2019-nCoV,Clinical Presentation,No Intervention,300,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50605,No Results,No Results,No Results,2020-03-23,2020-03-25,None
451,ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,True,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),Drug,Pirfenidone,40,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51416,No Results,No Results,No Results,2020-03-23,2020-03-25,None
452,ChiCTR2000031115,ChiCTR,2020-03-22,2020-05-01,False,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study of peripheral blood T lymphocyte subsets in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51032,No Results,No Results,No Results,2020-03-23,2020-03-25,None
453,ChiCTR2000031088,ChiCTR,2020-03-22,2020-02-09,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Observational,China,A prognosis study of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,314,Not Available,2022-02-09,http://www.chictr.org.cn/showproj.aspx?proj=51132,No Results,No Results,No Results,2020-03-23,2020-03-25,None
454,ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,False,Ningbo Kangning Hospital,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,60,Not Available,2022-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51148,No Results,No Results,No Results,2020-03-23,2020-03-25,None
455,ChiCTR2000030992,ChiCTR,2020-03-20,2020-03-10,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Diagnostic test,No Country Given,A medical records based study for the diagnosis and prognosis prediction AI model of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,1000,Not Available,2023-02-28,http://www.chictr.org.cn/showproj.aspx?proj=51338,No Results,No Results,No Results,2020-03-23,2020-03-25,None
456,ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,False,Beijing Normal University,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,Other (psych),Psychological,76,Not Available,2020-08-08,http://www.chictr.org.cn/showproj.aspx?proj=51331,No Results,No Results,No Results,2020-03-23,2020-03-25,None
457,ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,Traditional Medicine (Other),Traditional Medicine,60,Not Available,2020-10-26,http://www.chictr.org.cn/showproj.aspx?proj=51349,No Results,No Results,No Results,2020-03-23,2020-03-25,None
458,ChiCTR2000029770,ChiCTR,2020-02-13,2020-02-13,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,500,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49412,No Results,No Results,No Results,2020-03-16,2020-08-03,None
459,ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,True,Hu'nan Cancer Hospital,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,Prognosis,No Intervention,320,Not Available,2020-05-16,http://www.chictr.org.cn/showproj.aspx?proj=50984,No Results,No Results,No Results,2020-03-23,2020-03-25,None
460,ChiCTR2000030941,ChiCTR,2020-03-18,2020-01-28,True,"Hu'nan Provincial People's Hospital, Hu'nan Normal University",Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical features and prognosis of severe patients with novel coronavirus pneumonia (COVID-19) in Huanggan, Hubei in Huanggang.",Clinical Presentation,No Intervention,200,Not Available,2020-12-15,http://www.chictr.org.cn/showproj.aspx?proj=51000,No Results,No Results,No Results,2020-03-23,2020-03-25,None
461,ChiCTR2000030986,ChiCTR,2020-03-20,2020-03-20,False,Shenzhen Third People's Hospital,Recruiting,Not Applicable,Observational,China,Correlation of T lymphocytes level and clinical severity in novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,Clinical Presentation,No Intervention,200,Not Available,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51316,No Results,No Results,No Results,2020-03-23,2020-03-25,None
462,ChiCTR2000031014,ChiCTR,2020-03-21,2020-03-19,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Not Recruiting,Not Applicable,Observational,China,A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients,Clinical Presentation,No Intervention,100,Not Available,2020-09-19,http://www.chictr.org.cn/showproj.aspx?proj=51348,No Results,No Results,No Results,2020-03-23,2020-03-25,None
463,ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,True,PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Gene-derived protein,10,Not Available,2020-10-01,http://www.chictr.org.cn/showproj.aspx?proj=51059,No Results,No Results,No Results,2020-03-23,2020-03-25,None
464,ChiCTR2000030947,ChiCTR,2020-03-19,2020-02-11,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,34,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51267,No Results,No Results,No Results,2020-03-23,2020-03-25,None
465,ChiCTR2000030961,ChiCTR,2020-03-20,2020-01-01,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Observational,No Country Given,"A Medical Records Based Retrospective Study for Clinical Characteristics, Treatments and Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) in WuHan",Clinical Presentation,No Intervention,2000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51291,No Results,No Results,No Results,2020-03-23,2020-03-25,None
466,ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,True,Foshan First People's Hospital,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",Drug,Combination: Interferon + ribavirin vs. umifenovir + ribavirin,30,Not Available,2020-08-26,http://www.chictr.org.cn/showproj.aspx?proj=51141,No Results,No Results,No Results,2020-03-23,2020-03-25,None
467,NCT04285801,ClinicalTrials.gov,2020-02-24,2020-02-14,True,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Clinical Presentation,No Intervention,8,2020-02-25,2020-02-25,https://clinicaltrials.gov/show/NCT04285801,No Results,No Results,No Results,2020-03-23,2020-08-03,None
468,NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,True,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,ATMP,Plasma,100,2023-07-31,2024-12-31,https://clinicaltrials.gov/show/NCT04299724,No Results,No Results,No Results,2020-03-23,2020-03-18,None
469,ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),Drug,LMWH,120,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=51265,No Results,No Results,No Results,2020-03-23,2020-03-25,None
470,ChiCTR2000030952,ChiCTR,2020-03-19,2020-01-18,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Myocardial injury and arrythmias in the novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,93,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=51278,No Results,No Results,No Results,2020-03-23,2020-03-25,None
471,ChiCTR2000030950,ChiCTR,2020-03-19,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Basic Science,China,Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design,Clinical Presentation,No Intervention,50,Not Available,2022-02-10,http://www.chictr.org.cn/showproj.aspx?proj=51272,No Results,No Results,No Results,2020-03-23,2020-03-25,None
472,ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,False,The First Affiliated Hospital of Nanchang University,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,108,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51184,No Results,No Results,No Results,2020-03-23,2020-03-25,None
473,ChiCTR2000030943,ChiCTR,2020-03-18,2020-03-31,False,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Venous Thrombosis Risk of novel coronavirus pneumonia (COVID-19) Patients: A Prospective Study,Prognosis,No Intervention,200,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50898,No Results,No Results,No Results,2020-03-23,2020-03-25,None
474,ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),ATMP,Adenovirus vector,108,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51154,No Results,No Results,No Results,2020-03-23,2020-03-25,None
475,NCT04302688,ClinicalTrials.gov,2020-03-07,2019-12-10,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Accurate Classification System for Patients With COVID-19 Pneumonitis,Prognosis,No Intervention,669,2020-02-10,2020-03-04,https://clinicaltrials.gov/show/NCT04302688,No Results,No Results,No Results,2020-03-23,2020-03-18,None
476,ChiCTR2000031150,ChiCTR,2020-03-23,2020-04-01,False,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Health services research,China,Application of radiology in the prevention and control system of emergency respiratory infectious diseases,Other (radiology),Radiology,150,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51021,No Results,No Results,No Results,2020-03-23,2020-03-25,None
477,ChiCTR2000030932,ChiCTR,2020-03-18,2020-02-01,True,Anqing Municipal Hospital,Recruiting,Not Applicable,Observational,China,Correlation between virological negative conversion and clinical factors and prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51230,No Results,No Results,No Results,2020-03-23,2020-03-25,None
478,ChiCTR2000030934,ChiCTR,2020-03-18,2020-03-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV),Other (software),No Intervention,90,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=51160,No Results,No Results,No Results,2020-03-23,2020-03-25,None
479,ChiCTR2000030519,ChiCTR,2020-03-05,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,40,Not Available,2021-03-05,http://www.chictr.org.cn/showproj.aspx?proj=50604,No Results,No Results,No Results,2020-03-23,2020-08-03,None
480,ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),ATMP,Cells (stem cells),20,Not Available,2021-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51404,No Results,No Results,No Results,2020-03-23,2020-03-25,None
481,ChiCTR2000030931,ChiCTR,2020-03-18,2020-03-23,False,HuiZhou Municipal Central Hospital,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Characteristic and Outcomes of Hospitalized Patients With Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,60,Not Available,2020-05-22,http://www.chictr.org.cn/showproj.aspx?proj=51212,No Results,No Results,No Results,2020-03-23,2020-03-25,None
482,ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",ATMP,Plasma,60,Not Available,2020-06-16,http://www.chictr.org.cn/showproj.aspx?proj=50696,No Results,No Results,No Results,2020-03-23,2020-03-25,None
483,ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirusinfected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",Drug,Favipiravir vs. Umifenovir,240,Not Available,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=50137,Pre-Print Article,2020-03-27,https://doi.org/10.1101/2020.03.17.20037432,2020-03-23,2020-08-03,None
484,ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,True,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51136,No Results,No Results,No Results,2020-03-23,2020-03-25,None
485,ChiCTR2000030993,ChiCTR,2020-03-20,2020-03-12,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,A medical records based study for the value of Upper Respiratory Tract Virus Detection in the assessment of rehabilitation of novel coronavirus pneumonia (COVID-19) patient,Prognosis,No Intervention,300,Not Available,2020-06-12,http://www.chictr.org.cn/showproj.aspx?proj=51342,No Results,No Results,No Results,2020-03-23,2020-03-25,None
486,ChiCTR2000030771,ChiCTR,2020-03-14,2020-03-01,True,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Diagnostic test,China,Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies,Genomics,No Intervention,30,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50961,No Results,No Results,No Results,2020-03-23,2020-03-25,None
487,ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50476,No Results,No Results,No Results,2020-03-23,2020-03-25,None
488,ChiCTR2000029955,ChiCTR,2020-02-17,2020-03-01,False,"West China Second Hospital, Sichuan University",Not Recruiting,Not Applicable,Diagnostic test,China,Evaluation of myocardial injury of novel coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging,Clinical Presentation,No Intervention,80,Not Available,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=49531,No Results,No Results,No Results,2020-03-23,2020-08-03,None
489,ChiCTR2000030987,ChiCTR,2020-03-20,2020-03-05,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,A Randomized Controlled Trial for Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Combination: Favipiravir + chloroquine vs. favipiravir,150,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=51329,No Results,No Results,No Results,2020-03-23,2020-03-25,None
490,ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,False,Central Theater General Hospital of PLA,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,60,Not Available,2020-04-06,http://www.chictr.org.cn/showproj.aspx?proj=49074,Correspondence,2020-03-19,https://doi.org/10.1016/j.bja.2020.02.020,2020-03-23,2020-08-03,None
491,ChiCTR2000029830,ChiCTR,2020-02-15,2020-02-14,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,"A study for the psychological status, social support, and care needs of tumor patients admitted to a general hospital during the novel coronavirus pneumonia (COVID-19) outbreak",Other (psych),No Intervention,400,Not Available,2020-04-12,http://www.chictr.org.cn/showproj.aspx?proj=49511,No Results,No Results,No Results,2020-03-23,2020-03-18,None
492,ChiCTR2000030985,ChiCTR,2020-03-20,2020-03-04,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Psychological Responses of Medical Staff during the Metaphase of novel coronavirus pneumonia (COVID-19) Outbreak in Hubei, China",Other (psych),No Intervention,1300,Not Available,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=51311,No Results,No Results,No Results,2020-03-23,2020-03-25,None
493,ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",ATMP,Gene-derived protein,480,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49065,No Results,No Results,No Results,2020-03-23,2020-08-03,None
494,ChiCTR2000030951,ChiCTR,2020-03-19,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Developing and evaluating of artificial intelligence triage system for suspected novel coronavirus pneumonia (COVID-19): a retrospective study,Other (software),No Intervention,2500,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51283,No Results,No Results,No Results,2020-03-23,2020-03-25,None
495,ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,True,The First Hospital of Changsha; The Second Xiangya Hospital of Central South University,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",ATMP,Gene-derived protein,90,Not Available,2021-01-29,http://www.chictr.org.cn/showproj.aspx?proj=48809,No Results,No Results,No Results,2020-03-23,2020-08-03,None
496,ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,False,The Second Affiliated Hospital of Nanchang University,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),ATMP,"Cells, (mesenchymal/NK)",20,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50199,No Results,No Results,No Results,2020-03-23,2020-03-25,None
497,ChiCTR2000030942,ChiCTR,2020-03-18,2020-01-20,True,Shanghai Kongjiang Hospital,Not Recruiting,Not Applicable,Observational,China,Combined diagnostic value of novel coronavirus (2019-CoV) infection detected by NLR and CRP,Diagnostics,Diagnostic Test or Assessment,191,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50981,No Results,No Results,No Results,2020-03-23,2020-03-25,None
498,NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Tongji Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug,Corticosteroids,100,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04263402,No Results,No Results,No Results,2020-03-30,2020-08-03,None
499,NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,False,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug,Combination: Bromhexine + Umifenovir + Interferon alpha vs. Umifenovir + interferon alpha,60,2020-04-15,2020-04-30,https://clinicaltrials.gov/show/NCT04273763,No Results,No Results,No Results,2020-03-30,2020-08-03,None
500,EUCTR2020-000890-25-FR,EU Clinical Trials Register,2020-03-10,2020-03-05,True,Fondation Mditerrane Infection (FMI) - IHU Mditerrane Infection,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,Drug,Hydroxychloroquine,25,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,Journal Article,2020-03-20,https://doi.org/10.1016/j.ijantimicag.2020.105949,2020-03-23,2020-03-25,None
501,ChiCTR2000030919,ChiCTR,2020-03-17,2020-03-20,False,Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,An observational study for cardiac and pulmonary ultrasound and evaluation of treatment of severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51149,No Results,No Results,No Results,2020-03-23,2020-03-25,None
502,NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,False,The Second Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,ATMP,Intestinal microbiome,Not Available,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04251767,No Results,No Results,No Results,2020-03-30,2020-08-03,None
503,NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Tongji Hospital,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug,Combination: Interferon + Umifenovir vs. Umifenovir,100,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04254874,No Results,No Results,No Results,2020-03-30,2020-08-03,None
504,ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,Drug,Hydrogen peroxide,40,Not Available,2021-03-05,http://www.chictr.org.cn/showproj.aspx?proj=50660,No Results,No Results,No Results,2020-03-23,2020-08-03,None
505,ChiCTR2000030095,ChiCTR,2020-02-23,2020-02-23,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Observational,China,A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia,Clinical Presentation,No Intervention,94,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=49845,No Results,No Results,No Results,2020-03-23,2020-03-18,None
506,JPRN-UMIN000039686,JPRN,2020-03-06,2020-02-01,True,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Japan, Australia, Asia, Europe",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease,Drug,Oxygen,500,Not Available,2021-08-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045268,No Results,No Results,No Results,2020-03-23,2020-03-25,None
507,ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",Drug,Hydroxychloroquine,360,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49524,Pre-Print Article,2020-04-14,https://doi.org/10.1101/2020.04.10.20060558,2020-03-23,2020-08-03,None
508,NCT04283396,ClinicalTrials.gov,2020-02-13,2020-02-21,False,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Study for Novel Coronavirus Pneumonia (NCP),Clinical Presentation,No Intervention,2000,2020-05-30,2020-07-30,https://clinicaltrials.gov/show/NCT04283396,No Results,No Results,No Results,2020-03-30,2020-03-18,None
509,NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,Not Available,2020-04-01,2020-04-01,https://clinicaltrials.gov/show/NCT04287686,No Results,No Results,No Results,2020-03-30,2020-03-18,None
510,NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Tongji Hospital,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug,Umeprevir vs. Oseltamivir vs. lopinavir/ritonavir,400,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04255017,No Results,No Results,No Results,2020-03-30,2020-08-03,None
511,NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,True,Tongji Hospital,Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug,Combination: ASCO9F + ritonavir vs ritonavir + oseltamivir vs. oseltamivir,60,2020-05-01,2020-07-01,https://clinicaltrials.gov/show/NCT04261270,No Results,No Results,No Results,2020-03-30,2020-08-03,None
512,JPRN-jRCTs041190120,JPRN,2020-03-02,2020-03-02,False,Doi Yohei,Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,Drug,Favipiravir,86,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,No Results,No Results,No Results,2020-03-23,2020-03-25,None
513,NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,False,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,ATMP,Vaccine,100,2023-07-31,2024-12-31,https://clinicaltrials.gov/show/NCT04276896,No Results,No Results,No Results,2020-03-30,2020-03-18,None
514,NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,False,Tongji Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,550,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04291053,No Results,No Results,No Results,2020-03-30,2020-03-18,None
515,NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,ATMP,Immunoglobulin,10,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04264858,No Results,No Results,No Results,2020-03-30,2020-08-03,None
516,NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,False,China Academy of Chinese Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Traditional Medicine (Drug),Traditional Medicine,300,2021-01-01,2021-01-01,https://clinicaltrials.gov/show/NCT04278963,No Results,No Results,No Results,2020-03-30,2020-08-03,None
517,JPRN-UMIN000039873,JPRN,2020-03-19,2020-03-19,False,National Center for Global Health and Medicine,Recruiting,Not Applicable,Observational,Japan,COVID-19 Registry,Clinical Presentation,No Intervention,9999,Not Available,2021-01-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,No Results,No Results,No Results,2020-03-23,2020-03-25,None
518,NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,False,Puren Hospital Affiliated to Wuhan University of Science and Technology,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,ATMP,Cells (mesenchymal),Not Available,2020-02-25,2020-02-25,https://clinicaltrials.gov/show/NCT04293692,No Results,No Results,No Results,2020-03-30,2020-03-18,None
519,NCT04305574,ClinicalTrials.gov,2020-03-08,2020-03-08,False,Jean Liu,Recruiting,Not Applicable,Observational,Singapore,Social Media Use During COVID-19,Other,No Intervention,5000,2020-05-31,2020-05-31,https://clinicaltrials.gov/show/NCT04305574,No Results,No Results,No Results,2020-03-30,2020-03-18,None
520,NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,False,Henan Provincial People's Hospital,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,Drug,Tetrandrine,60,2021-03-01,2021-05-01,https://clinicaltrials.gov/show/NCT04308317,No Results,No Results,No Results,2020-03-30,2020-03-25,None
521,NCT04312464,ClinicalTrials.gov,2020-03-04,2020-01-01,True,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Myocardial Damage in COVID-19,Clinical Presentation,No Intervention,500,2020-03-15,2020-03-18,https://clinicaltrials.gov/show/NCT04312464,No Results,No Results,No Results,2020-03-30,2020-03-25,None
522,NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Stem Cells Arabia,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),5,2020-06-30,2020-09-30,https://clinicaltrials.gov/show/NCT04313322,No Results,No Results,No Results,2020-03-30,2020-03-25,None
523,NCT04272710,ClinicalTrials.gov,2020-02-12,2020-01-25,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,Drug,ACE inhibitors,Not Available,2020-03-31,2020-04-30,https://clinicaltrials.gov/show/NCT04272710,No Results,No Results,No Results,2020-03-30,2020-08-03,None
524,NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,True,Tongji Hospital,Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,Drug,Sildenafil,10,2020-03-01,2020-11-09,https://clinicaltrials.gov/show/NCT04304313,No Results,No Results,No Results,2020-03-30,2020-03-18,None
525,NCT04306705,ClinicalTrials.gov,2020-03-08,2020-02-20,True,Tongji Hospital,Recruiting,Not Applicable,Observational,China,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Drug,Tocilizumab,120,2020-05-30,2020-06-20,https://clinicaltrials.gov/show/NCT04306705,No Results,No Results,No Results,2020-03-30,2020-03-18,None
526,NCT04292964,ClinicalTrials.gov,2020-03-01,2020-03-01,False,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,201,2020-03-13,2020-03-13,https://clinicaltrials.gov/show/NCT04292964,Pre-Print Article,2020-03-10,https://doi.org/10.1101/2020.03.07.20031575,2020-03-30,2020-03-18,None
527,NCT04306497,ClinicalTrials.gov,2020-03-01,2020-03-02,False,"Jiangsu Famous Medical Technology Co., Ltd.",Recruiting,Not Applicable,Observational,China,Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19.,Traditional Medicine (Unspecified),Traditional Medicine,340,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04306497,No Results,No Results,No Results,2020-03-30,2020-03-18,None
528,NCT04312100,ClinicalTrials.gov,2020-03-13,2020-02-01,True,Henan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Drug,Oxygen,30,2020-10-01,2021-02-01,https://clinicaltrials.gov/show/NCT04312100,No Results,No Results,No Results,2020-03-30,2020-03-25,None
529,NCT04310865,ClinicalTrials.gov,2020-03-15,2020-03-20,False,Zhong Wang,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Traditional Medicine (Drug),Traditional Medicine,116,2021-03-30,2021-06-30,https://clinicaltrials.gov/show/NCT04310865,No Results,No Results,No Results,2020-03-30,2020-03-25,None
530,NCT04311398,ClinicalTrials.gov,2020-03-14,2020-03-14,False,Huashan Hospital,Not Recruiting,Not Applicable,Observational,China,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Diagnostics,Diagnostic Test or Assessment,100,2020-06-01,2020-12-01,https://clinicaltrials.gov/show/NCT04311398,No Results,No Results,No Results,2020-03-30,2020-03-25,None
531,ChiCTR2000031366,ChiCTR,2020-03-29,2020-04-01,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Observational,China,Causes of fever in outpatient outside Wuhan during novel coronavirus pneumonia pandemic: a medical records based retrospective analysis,Clinical Presentation,No Intervention,5000,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51692,No Results,No Results,No Results,2020-03-30,2020-04-01,None
532,ChiCTR2000031365,ChiCTR,2020-03-29,2020-01-17,True,Westlake University,Recruiting,Not Applicable,Diagnostic test,China,To explore the pathogenesis and course prediction of novel coronavirus pneumonia (COVID-19) severe patients,Prognosis,No Intervention,0,Not Available,2022-01-31,http://www.chictr.org.cn/showproj.aspx?proj=51694,Pre-Print Article,2020-04-07,https://doi.org/10.1101/2020.04.07.20054585,2020-03-30,2020-04-01,None
533,NCT04314232,ClinicalTrials.gov,2020-03-17,2020-03-23,False,"University Hospital, Akershus",Not Recruiting,Not Applicable,Observational,No Country Given,Mechanisms to Morbidity and Mortality for Covid-19,Prognosis,No Intervention,200,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04314232,No Results,No Results,No Results,2020-03-30,2020-03-25,None
534,NCT04314817,ClinicalTrials.gov,2020-03-17,2020-03-17,False,Groupe Hospitalier Piti Salptrire,Recruiting,Not Applicable,Observational,France,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Traditional Medicine (Unspecified),Traditional Medicine,1000,2021-01-01,2023-01-01,https://clinicaltrials.gov/show/NCT04314817,No Results,No Results,No Results,2020-03-30,2020-03-25,None
535,NCT04316884,ClinicalTrials.gov,2020-03-13,2020-03-12,True,Uppsala University,Recruiting,Not Applicable,Observational,Sweden,Mechanisms for Organ Dysfunction in Covid-19,Clinical Presentation,No Intervention,100,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04316884,No Results,No Results,No Results,2020-03-30,2020-03-25,None
536,NCT04318418,ClinicalTrials.gov,2020-03-19,2020-03-23,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Observational,Italy,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Drug,ACE inhibitors or ARBs,5000,2020-04-10,2020-04-30,https://clinicaltrials.gov/show/NCT04318418,No Results,No Results,No Results,2020-03-30,2020-04-01,None
537,ChiCTR2000031356,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the changes of the brain structure and function in healed patients of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,600,Not Available,2021-04-04,http://www.chictr.org.cn/showproj.aspx?proj=51499,No Results,No Results,No Results,2020-03-30,2020-04-01,None
538,NCT04314271,ClinicalTrials.gov,2020-03-16,2020-03-20,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Clinical Presentation,No Intervention,80,2020-05-01,2020-05-31,https://clinicaltrials.gov/show/NCT04314271,No Results,No Results,No Results,2020-03-30,2020-03-25,None
539,NCT04315870,ClinicalTrials.gov,2020-03-18,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Presentation,No Intervention,20,2020-04-20,2020-04-30,https://clinicaltrials.gov/show/NCT04315870,No Results,No Results,No Results,2020-03-30,2020-03-25,None
540,ChiCTR2000031361,ChiCTR,2020-03-28,2020-03-31,False,Hubei Maternal and Child Health Care Hospital,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of anesthesia management of emergency cesarean section in non-pneumonia hospital of Wuhan during pandemic of novel coronavirus pneumonia (COVID-19),Drug,Other,2000,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51385,No Results,No Results,No Results,2020-03-30,2020-04-01,None
541,ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),20,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=51647,No Results,No Results,No Results,2020-03-30,2020-04-01,None
542,ChiCTR2000031330,ChiCTR,2020-03-27,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,Analysis for prevention and control effects of orthokeratology lens on myopia adolescents during the novel coronavirus pneumonia (COVID-19) pandemic situation,Other (device),Orthokeratology lens,160,Not Available,2021-06-18,http://www.chictr.org.cn/showproj.aspx?proj=51504,No Results,No Results,No Results,2020-03-30,2020-04-01,None
543,ChiCTR2000031336,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,1000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51517,No Results,No Results,No Results,2020-03-30,2020-04-01,None
544,ChiCTR2000031329,ChiCTR,2020-03-27,2020-03-11,True,Guangdong Second Provincial General Hospital,Recruiting,Not Applicable,Observational,No Country Given,"Influence of novel coronavirus pneumonia (COVID-19) on disease activity, medical and mental condition of patients with rheumatic diseases",Clinical Presentation,No Intervention,120,Not Available,2023-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51667,No Results,No Results,No Results,2020-03-30,2020-04-01,None
545,ChiCTR2000031324,ChiCTR,2020-03-27,2020-04-10,False,Nanjing University Medical College Affiliated Drum Tower Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The investigation on medical adhesive-related skin injury caused by protective dressings of medical staffs during the period of novel coronavirus pneumonia (COVID-19),Other (device),No Intervention,300,Not Available,2021-01-01,http://www.chictr.org.cn/showproj.aspx?proj=51668,No Results,No Results,No Results,2020-03-30,2020-04-01,None
546,ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,Other,Sleep aids,60,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51425,No Results,No Results,No Results,2020-03-30,2020-04-01,None
547,NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,True,"Centro Studi Internazionali, Italy",Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag  COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,200,2020-09-01,2020-11-01,https://clinicaltrials.gov/show/NCT04316728,No Results,No Results,No Results,2020-03-30,2020-03-25,None
548,ChiCTR2000031337,ChiCTR,2020-03-28,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,"The relationship between habits of using eyes, degree of visual fatigue and myopia progression in students during the novel coronavirus pneumonia (COVID-19) pandemic",Clinical Presentation,No Intervention,400,Not Available,2021-06-18,http://www.chictr.org.cn/showproj.aspx?proj=51170,No Results,No Results,No Results,2020-03-30,2020-04-01,None
549,ChiCTR2000031296,ChiCTR,2020-03-27,2020-01-14,True,Yichang Central People's Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death,Clinical Presentation,No Intervention,200,Not Available,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51584,Pre-Print Article,2020-03-30,https://doi.org/10.1101/2020.03.26.20041426,2020-03-30,2020-04-01,None
550,ChiCTR2000031327,ChiCTR,2020-03-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records,Clinical Presentation,No Intervention,120,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=51669,No Results,No Results,No Results,2020-03-30,2020-04-01,None
551,ChiCTR2000031293,ChiCTR,2020-03-27,2020-03-16,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Epidemiological study of novel coronavirus infection (COVID-19) in children at medium/low risk,Clinical Presentation (Epidemiology),No Intervention,240,Not Available,2020-05-16,http://www.chictr.org.cn/showproj.aspx?proj=51629,No Results,No Results,No Results,2020-03-30,2020-04-01,None
552,ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,True,China European International Business School (CEIBS),Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,110,Not Available,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=51455,No Results,No Results,No Results,2020-03-30,2020-04-01,None
553,ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,False,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51194,No Results,No Results,No Results,2020-03-30,2020-04-01,None
554,ChiCTR2000031301,ChiCTR,2020-03-27,2020-02-01,True,China-Japan Union Hospital of Jilin Unversity,Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical characteristics and prognosis of novel coronavirus pneumonia (COVID-19) patients with myocardial injury,Prognosis,No Intervention,100,Not Available,2020-04-27,http://www.chictr.org.cn/showproj.aspx?proj=51603,No Results,No Results,No Results,2020-03-30,2020-04-01,None
555,ChiCTR2000031252,ChiCTR,2020-03-25,2020-02-10,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Outcomes and infectivity of patients with asymptomatic novel coronavirus (COVID-19) infection,Clinical Presentation,No Intervention,60,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51559,No Results,No Results,No Results,2020-03-30,2020-04-01,None
556,ChiCTR2000031247,ChiCTR,2020-03-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,No Country Given,Study on the mental state of medical staff  during the epidemic period of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,500,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51540,No Results,No Results,No Results,2020-03-30,2020-04-01,None
557,ChiCTR2000031245,ChiCTR,2020-03-25,2020-01-25,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Epidemiologic and Clinical Characteristics of novel coronavirus pneumonia (COVID-19) in surgical patients: a medical records based retrospective study,Clinical Presentation (Epidemiology),No Intervention,2000,Not Available,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=51518,No Results,No Results,No Results,2020-03-30,2020-04-01,None
558,ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,True,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine,300,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49420,No Results,No Results,No Results,2020-03-30,2020-04-01,None
559,ChiCTR2000031246,ChiCTR,2020-03-25,2020-02-01,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Epidemiological survey of close contacts of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,68,Not Available,2021-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51535,No Results,No Results,No Results,2020-03-30,2020-04-01,None
560,ChiCTR2000031187,ChiCTR,2020-03-23,2020-03-23,False,Wuhan Third Hospital; Tongren Hospital of Wuhan University,Not Recruiting,Not Applicable,Epidemiological research,China,A medical records based retrospective study for novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,1292,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51442,No Results,No Results,No Results,2020-03-30,2020-04-01,None
561,ChiCTR2000031227,ChiCTR,2020-03-25,2020-03-26,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,No Country Given,"Clinical features and prognosis of invasive echanicalventilation patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China: a single-centered, retrospective, observational study",Other (physical),Mechanical ventilation,40,Not Available,2020-04-06,http://www.chictr.org.cn/showproj.aspx?proj=51473,No Results,No Results,No Results,2020-03-30,2020-04-01,None
562,ChiCTR2000031214,ChiCTR,2020-03-24,2020-03-31,False,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis,Prognosis,No Intervention,60,Not Available,2022-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51509,No Results,No Results,No Results,2020-03-30,2020-04-01,None
563,ChiCTR2000031244,ChiCTR,2020-03-25,2020-03-25,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Shedding virus and functional prognosis in patients with novel coronavirus pneumonia (COVID-19): a medical records based study,Prognosis,No Intervention,200,Not Available,2020-08-25,http://www.chictr.org.cn/showproj.aspx?proj=51486,No Results,No Results,No Results,2020-03-30,2020-04-01,None
564,ChiCTR2000031198,ChiCTR,2020-03-23,2020-04-01,False,Nothern Jiangsu People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,150,Not Available,2022-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51488,No Results,No Results,No Results,2020-03-30,2020-04-01,None
565,ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,28,Not Available,2022-02-28,http://www.chictr.org.cn/showproj.aspx?proj=51030,No Results,No Results,No Results,2020-03-30,2020-04-01,None
566,ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,2840,Not Available,2020-05-10,http://www.chictr.org.cn/showproj.aspx?proj=51100,No Results,No Results,No Results,2020-03-30,2020-03-25,None
567,ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,True,The 5th Medical Center Chinese PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,Drug,Combination: Lopinavir/ritonavir + Interferon,90,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51112,No Results,No Results,No Results,2020-03-30,2020-04-01,None
568,ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,76,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51061,No Results,No Results,No Results,2020-03-30,2020-03-25,None
569,ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,True,Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,400,Not Available,2020-04-16,http://www.chictr.org.cn/showproj.aspx?proj=51139,No Results,No Results,No Results,2020-03-30,2020-03-25,None
570,ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",Traditional Medicine (Drug),Traditional Medicine,144,Not Available,2020-08-30,http://www.chictr.org.cn/showproj.aspx?proj=51240,No Results,No Results,No Results,2020-03-30,2020-03-25,None
571,ChiCTR2000031176,ChiCTR,2020-03-23,2020-02-20,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,Study on home pharmaceutical care for chronic patients over the novel coronavirus pneumonia (COVID-19) epidemic,Other,No Intervention,100,Not Available,2021-03-11,http://www.chictr.org.cn/showproj.aspx?proj=51443,No Results,No Results,No Results,2020-03-30,2020-04-01,None
572,ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,204,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51317,No Results,No Results,No Results,2020-03-30,2020-03-25,None
573,ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,True,"The First People's Hospital of Jiangxia District, Wuhan",No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,50,Not Available,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50778,No Results,No Results,No Results,2020-03-30,2020-04-01,None
574,ChiCTR2000030962,ChiCTR,2020-03-20,2020-03-01,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study",Traditional Medicine (Other),Traditional Medicine,60,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51254,No Results,No Results,No Results,2020-03-30,2020-03-25,None
575,EUCTR2020-001162-12-FR,EU Clinical Trials Register,2020-03-20,2020-03-26,False,Sanofi,Authorised,Phase 2/Phase 3,Interventional,"Canada, Japan, Russian Federation, Italy, France, Spain, Germany, Israel",Sarilumab COVID-19,Drug,Sarilumab,460,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12,No Results,No Results,No Results,2020-03-30,2020-04-01,None
576,ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,False,West China Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,PD1,40,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49840,No Results,No Results,No Results,2020-03-30,2020-08-03,None
577,ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Unspecified),Traditional Medicine,204,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50202,No Results,No Results,No Results,2020-03-30,2020-08-03,None
578,ChiCTR2000030256,ChiCTR,2020-02-26,2020-02-01,True,"Daping Hospital,Army Medical University",Not Recruiting,Not Applicable,Epidemiological research,China,"Epidemiological and clinical characteristics of COVID-19: a large-scale investigation in epicenter Wuhan, China",Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50078,No Results,No Results,No Results,2020-03-30,2020-08-03,None
579,ChiCTR2000030938,ChiCTR,2020-03-18,2020-02-28,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical investigation and reseach on TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,160,Not Available,2021-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51239,No Results,No Results,No Results,2020-03-30,2020-03-25,None
580,NCT04319211,ClinicalTrials.gov,2020-03-20,2020-03-25,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",Other,Social Isolation,200,2020-05-15,2020-07-20,https://clinicaltrials.gov/show/NCT04319211,No Results,No Results,No Results,2020-04-06,2020-04-01,None
581,NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-06,False,Laval University,Not Recruiting,Not Applicable,Interventional,No Country Given,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During Pneumonia,Drug,Oxygen,216,2021-04-30,2021-10-31,https://clinicaltrials.gov/show/NCT04320056,No Results,No Results,No Results,2020-04-06,2020-04-01,None
582,ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,60,Not Available,2020-08-24,http://www.chictr.org.cn/showproj.aspx?proj=50066,No Results,No Results,No Results,2020-03-30,2020-08-03,None
583,EUCTR2020-001243-15-BE,EU Clinical Trials Register,2020-03-27,2020-03-26,True,UZLeuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Itraconazole,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,No Results,No Results,No Results,2020-03-30,2020-04-01,None
584,EUCTR2020-000919-69-NL,EU Clinical Trials Register,2020-03-17,2020-03-17,False,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-Gurin,ATMP,Vaccine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,No Results,No Results,No Results,2020-03-30,2020-04-01,None
585,NCT04320277,ClinicalTrials.gov,2020-03-20,2020-03-16,True,Hospital of Prato,Recruiting,Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug,Baricitinib,60,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04320277,No Results,No Results,No Results,2020-04-06,2020-04-01,None
586,NCT04321174,ClinicalTrials.gov,2020-03-18,2020-03-30,False,Darrell Tan,Not Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug,Lopinavir/ritonavir,1220,2021-03-31,2022-03-31,https://clinicaltrials.gov/show/NCT04321174,No Results,No Results,No Results,2020-04-06,2020-04-01,None
587,NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,False,INSERM,Recruiting,Phase 3,Interventional,France,Trial of Treatments for COVID-19 in Hospitalized Adults,Drug,Combination: remdesivir vs. lopinavir/ritonavir vs. lopinavir/ritonavir + interferon beta vs. hydroxychloroquine,3100,2023-03-01,2023-03-01,https://clinicaltrials.gov/show/NCT04315948,No Results,No Results,No Results,2020-04-06,2020-03-25,EUCTR2020-000936-23
588,NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug,Combination: Chloroquine + favipiravir vs. favipiravir,150,2020-04-30,2020-06-25,https://clinicaltrials.gov/show/NCT04319900,No Results,No Results,No Results,2020-04-06,2020-04-01,None
589,EUCTR2020-001224-33-DE,EU Clinical Trials Register,2020-03-24,2020-03-25,False,Universittsklinikum Tbingen,Authorised,Phase 2,Interventional,Germany,Systematic study of the medicine hydroxychloroquine against placebo for the treatment of adult patients with acute coronavirus disease 2019  COVID-19,Drug,Hydroxychloroquine,220,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001224-33,No Results,No Results,No Results,2020-03-30,2020-04-01,None
590,ChiCTR2000030817,ChiCTR,2020-03-15,2020-02-28,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Multicenter clinical study of evaluation of multi-organ function in patients with novel coronavirus pneumonia (COVID-19) by ultrasound,Clinical Presentation,No Intervention,800,Not Available,2022-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50631,No Results,No Results,No Results,2020-03-30,2020-03-18,None
591,EUCTR2020-001023-14-GB,EU Clinical Trials Register,2020-03-17,2020-03-17,False,Synairgen Research Limited,Authorised,Phase 2,Interventional,United Kingdom,a trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients with COVID-19,Drug,Interferon beta,400,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001023-14,No Results,No Results,No Results,2020-03-30,2020-03-25,None
592,ChiCTR2000029982,ChiCTR,2020-02-18,2020-03-26,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Prediction of prognosis and antiviral effect of patients with neocoronavirus infected pneumonia based on Peripheral blood exosomal metabolomics analysis and radiomics in CT of lung and its mechanism,Genomics,No Intervention,150,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49724,No Results,No Results,No Results,2020-03-30,2020-08-03,None
593,NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,True,Foundation IRCCS San Matteo Hospital,Not Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,ATMP,Plasma,49,2020-05-31,2020-05-31,https://clinicaltrials.gov/show/NCT04321421,No Results,No Results,No Results,2020-04-06,2020-04-01,None
594,NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,50,2020-03-01,2020-04-01,https://clinicaltrials.gov/show/NCT04323332,No Results,No Results,No Results,2020-04-06,2020-04-01,None
595,NCT04320017,ClinicalTrials.gov,2020-03-20,2020-03-20,False,Groupe Hospitalier Piti Salptrire,Recruiting,Not Applicable,Observational,France,Joint Use of Electrocardiogram and Transthoracic Echocardiography in an Observational Study to Monitor Cardio-vascular Events in Patients Diagnosed With COVID-19,Clinical Presentation,No Intervention,500,2020-05-20,2020-05-20,https://clinicaltrials.gov/show/NCT04320017,No Results,No Results,No Results,2020-04-06,2020-04-01,None
596,NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,True,University of Palermo,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,Drug,Vitamin C,500,2021-03-13,2021-03-13,https://clinicaltrials.gov/show/NCT04323514,No Results,No Results,No Results,2020-04-06,2020-04-01,None
597,NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,False,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug,Bevacizumab,140,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04305106,No Results,No Results,No Results,2020-04-06,2020-03-18,None
598,NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,False,University of Pecs,Not Recruiting,Not Applicable,Interventional,No Country Given,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Other,Health Education,7576,2021-04-21,2021-08-21,https://clinicaltrials.gov/show/NCT04321928,No Results,No Results,No Results,2020-04-06,2020-04-01,None
599,NCT04323345,ClinicalTrials.gov,2020-03-23,2020-03-25,False,Misr University for Science and Technology,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Traditional Medicine (Other),Traditional Medicine,1000,2020-12-15,2021-01-15,https://clinicaltrials.gov/show/NCT04323345,No Results,No Results,No Results,2020-04-06,2020-04-01,None
600,NCT04323592,ClinicalTrials.gov,2020-03-19,2020-03-23,False,University of Trieste,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Drug,Corticosteroids,104,2020-05-20,2020-05-30,https://clinicaltrials.gov/show/NCT04323592,No Results,No Results,No Results,2020-04-06,2020-04-01,None
601,NCT04323631,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Rambam Health Care Campus,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Drug,Hydroxychloroquine,1116,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04323631,No Results,No Results,No Results,2020-04-06,2020-04-01,None
602,NCT04325919,ClinicalTrials.gov,2020-03-24,2020-02-24,True,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,Clinical Presentation,No Intervention,170,2021-02-28,2021-06-17,https://clinicaltrials.gov/show/NCT04325919,No Results,No Results,No Results,2020-04-06,2020-04-07,None
603,NCT04288713,ClinicalTrials.gov,2020-02-27,2020-02-25,True,Hudson Medical,Not Recruiting,Phase 2,Expanded Access,No Country Given,Eculizumab (Soliris) in Covid-19 Infected Patients,Drug,Eculizumab,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04288713,No Results,No Results,No Results,2020-04-06,2020-08-03,None
604,NCT04322786,ClinicalTrials.gov,2020-03-23,1998-01-01,True,"University College, London",Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",Drug,ACE inhibitors,1302508,2016-05-31,2020-03-31,https://clinicaltrials.gov/show/NCT04322786,No Results,No Results,No Results,2020-04-06,2020-04-01,None
605,NCT04324996,ClinicalTrials.gov,2020-03-25,2020-03-21,True,Chongqing Public Health Medical Center,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,ATMP,Cells (NK),90,2020-05-31,2020-09-30,https://clinicaltrials.gov/show/NCT04324996,No Results,No Results,No Results,2020-04-06,2020-04-01,None
606,NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-01,False,Population Health Research Institute,Not Recruiting,Phase 3,Interventional,Canada,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug,Combination: Chloroquine + azithromycin,1500,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04324463,No Results,No Results,No Results,2020-04-06,2020-04-01,None
607,NCT04324866,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Universita di Verona,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Clinical Presentation (Epidemiology),No Intervention,300,2020-11-01,2020-12-01,https://clinicaltrials.gov/show/NCT04324866,No Results,No Results,No Results,2020-04-06,2020-04-01,None
608,NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Drug,Nitric oxide,Not Available,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04290871,No Results,No Results,No Results,2020-04-06,2020-03-18,None
609,NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-01,False,University of Oxford,Not Recruiting,Not Applicable,Interventional,No Country Given,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug,Chloroquine or Hydroxychloroquine,40000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04303507,No Results,No Results,No Results,2020-04-06,2020-03-18,None
610,NCT04325412,ClinicalTrials.gov,2020-03-25,2020-03-23,True,UMC Utrecht,Recruiting,Not Applicable,Observational,Netherlands,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Clinical Presentation,No Intervention,1000,2021-03-23,2021-06-23,https://clinicaltrials.gov/show/NCT04325412,No Results,No Results,No Results,2020-04-06,2020-04-01,None
611,NCT04326309,ClinicalTrials.gov,2020-03-26,2020-03-25,True,HealthMode Inc.,Recruiting,Not Applicable,Observational,United States,Audio Data Collection for Identification and Classification of Coughing,Diagnostics,Diagnostic Test or Assessment,1000,2022-09-25,2022-09-25,https://clinicaltrials.gov/show/NCT04326309,No Results,No Results,No Results,2020-04-06,2020-04-07,None
612,NCT04331860,ClinicalTrials.gov,2020-03-30,2020-03-30,False,RAD-AID International,Recruiting,Not Applicable,Observational,United States,COVID-19 Public Image Registry,Clinical Presentation,No Intervention,500000,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04331860,No Results,No Results,No Results,2020-04-06,2020-04-07,None
613,ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,Diagnostics,Diagnostic Test or Assessment,500,Not Available,2021-04-01,http://isrctn.com/ISRCTN14966673,No Results,No Results,No Results,2020-04-06,2020-03-25,None
614,NCT04327570,ClinicalTrials.gov,2020-03-26,2020-03-27,False,UZLeuven,Not Recruiting,Not Applicable,Observational,No Country Given,In-depth Immunological Investigation of COVID-19.,Clinical Presentation,No Intervention,100,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04327570,No Results,No Results,No Results,2020-04-06,2020-04-07,None
615,ChiCTR2000031539,ChiCTR,2020-04-03,2020-03-15,True,Wuhan Women and Children's Health Care Center,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Correlation between Angiotensin II Type 1 Receptor Blockers (ARBs) and  the Progression and Outcome of Novel Coronavirus Pneumonia (COVID-19),Drug,ARBs,180,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51893,No Results,No Results,No Results,2020-04-06,2020-04-07,None
616,ChiCTR2000031627,ChiCTR,2020-04-05,2020-04-20,False,Second People's Hospital of Fuyang City,Not Recruiting,Not Applicable,Basic Science,China,Study for the Mechanism of the Relationship between Infection of novel coronavirus pneumonia (COVID-19) and Host Innate Immune,Clinical Presentation,No Intervention,60,Not Available,2021-04-20,http://www.chictr.org.cn/showproj.aspx?proj=51865,No Results,No Results,No Results,2020-04-06,2020-04-07,None
617,NCT04316299,ClinicalTrials.gov,2020-03-17,2020-02-26,True,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Acute Kidney Injury in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,287,2020-02-28,2020-03-08,https://clinicaltrials.gov/show/NCT04316299,No Results,No Results,No Results,2020-04-06,2020-03-25,None
618,NCT04318314,ClinicalTrials.gov,2020-03-17,2020-03-18,False,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Clinical Presentation,No Intervention,400,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04318314,No Results,No Results,No Results,2020-04-06,2020-04-01,None
619,ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,True,Peking University Sixth Hospital,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,192,Not Available,2021-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51119,No Results,No Results,No Results,2020-04-06,2020-04-07,None
620,ChiCTR2000031533,ChiCTR,2020-04-03,2020-04-10,False,Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Health services research,China,Survey of psychological status and related factors of emergency medical staff in the country during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,7000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51835,No Results,No Results,No Results,2020-04-06,2020-04-07,None
621,ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),36,Not Available,2020-12-02,http://www.chictr.org.cn/showproj.aspx?proj=51904,No Results,No Results,No Results,2020-04-06,2020-04-07,None
622,ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,True,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),Other (device),Cardiopulmonary monitoring,100,Not Available,2022-10-31,http://www.chictr.org.cn/showproj.aspx?proj=51911,No Results,No Results,No Results,2020-04-06,2020-04-07,None
623,ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,True,Eastern Theater General Hospital,Not Recruiting,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",ATMP,Plasma,20,Not Available,2020-07-17,http://www.chictr.org.cn/showproj.aspx?proj=50254,No Results,No Results,No Results,2020-04-06,2020-04-07,None
624,ChiCTR2000031199,ChiCTR,2020-03-23,2020-02-04,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,A Medical Records Based Retrospective Study for Clinical Characteristics of severe Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,120,Not Available,2020-04-09,http://www.chictr.org.cn/showproj.aspx?proj=51478,No Results,No Results,No Results,2020-04-06,2020-04-01,None
625,NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-01,True,Columbia University,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,1600,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04318444,No Results,No Results,No Results,2020-04-06,2020-04-01,None
626,NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,False,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,Traditional Medicine (Drug),Traditional Medicine,120,2020-06-30,2020-08-30,https://clinicaltrials.gov/show/NCT04322344,No Results,No Results,No Results,2020-04-06,2020-04-01,None
627,ChiCTR2000031465,ChiCTR,2020-04-02,2020-03-25,True,"The First People's Hospital of Jiangxia District, Wuhan",Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus (2019-nCOV) IgG detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51538,No Results,No Results,No Results,2020-04-06,2020-04-07,None
628,ChiCTR2000031500,ChiCTR,2020-04-02,2020-03-05,True,Peking University First Hospital,Not Recruiting,Not Applicable,Health services research,China,Impact of measuring distance and cold outdoor environment on the screening of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,58,Not Available,2020-04-12,http://www.chictr.org.cn/showproj.aspx?proj=51897,No Results,No Results,No Results,2020-04-06,2020-04-07,None
629,NCT04323644,ClinicalTrials.gov,2020-03-25,2020-03-31,False,University of Birmingham,Not Recruiting,Not Applicable,Observational,No Country Given,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Other (surgery),No Intervention,1000,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04323644,No Results,No Results,No Results,2020-04-06,2020-04-01,None
630,ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Celecoxib,60,Not Available,2020-06-17,http://www.chictr.org.cn/showproj.aspx?proj=50474,No Results,No Results,No Results,2020-04-06,2020-04-07,None
631,ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),Drug,Combination: Rabeprazole + chloroquine vs. lopinavir + rabeprazole,56,Not Available,2021-07-31,http://www.chictr.org.cn/showproj.aspx?proj=51693,No Results,No Results,No Results,2020-04-06,2020-04-07,None
632,ChiCTR2000031432,ChiCTR,2020-03-31,2020-05-01,False,Nanjing University,Not Recruiting,Phase 1,Basic Science,China,A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults,ATMP,RNA Plasmid,15,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=51646,No Results,No Results,No Results,2020-04-06,2020-04-07,None
633,ChiCTR2000031439,ChiCTR,2020-04-01,2020-03-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,A medical records based study for novel coronavirus pneumonia (COVID-19) patients undergoing endotracheal intubation,Other (physical),Mechanical ventilation,Not Available,Not Available,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=51837,No Results,No Results,No Results,2020-04-06,2020-04-07,None
634,ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,ATMP,Cells (mesenchymal),200,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49254,No Results,No Results,No Results,2020-04-06,2020-04-07,None
635,ChiCTR2000031589,ChiCTR,2020-04-05,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,462,Not Available,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=51969,No Results,No Results,No Results,2020-04-06,2020-04-07,None
636,ChiCTR2000031428,ChiCTR,2020-03-31,2020-02-05,True,Wuhan Asia Heart Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,500,Not Available,2020-10-04,http://www.chictr.org.cn/showproj.aspx?proj=51813,No Results,No Results,No Results,2020-04-06,2020-04-07,None
637,ChiCTR2000031587,ChiCTR,2020-04-04,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"A paired clinical study for novel coronavirus pneumonia (COVID-19) patients with ordinary, severe, critical, and deceased patients in Tongji Hospital",Clinical Presentation,No Intervention,2000,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51952,No Results,No Results,No Results,2020-04-06,2020-04-07,None
638,ChiCTR2000031376,ChiCTR,2020-03-29,2020-03-28,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for safety and effectiveness analysis of data from novel coronavirus pneumonia (COVID-19) patients with conventional therapy,Drug,Unspecified Drug,600,Not Available,2020-05-29,http://www.chictr.org.cn/showproj.aspx?proj=51724,No Results,No Results,No Results,2020-04-06,2020-04-01,None
639,EUCTR2020-001386-37-IT,EU Clinical Trials Register,2020-04-02,2020-03-27,True,Azienda Unit Sanitaria Locale Reggio Emilia,Authorised,Phase 2,Interventional,Italy,Efficacy of Tocilizumab - COVID-19,Drug,Tocilizumab,Not Available,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001386-37,No Results,No Results,No Results,2020-04-06,2020-04-07,None
640,ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),Other,Rehabilitation,100,Not Available,2020-12-05,http://www.chictr.org.cn/showproj.aspx?proj=51684,No Results,No Results,No Results,2020-04-06,2020-04-07,None
641,ChiCTR2000031538,ChiCTR,2020-04-03,2020-04-03,False,"Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Health services research,China,Assessment of mental health status of first-line dental emergency medical personnel during novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,123,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=51938,No Results,No Results,No Results,2020-04-06,2020-04-07,None
642,EUCTR2020-001345-38-GR,EU Clinical Trials Register,2020-03-31,2020-04-02,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS,Drug,Chloroquine,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001345-38,No Results,No Results,No Results,2020-04-06,2020-04-07,None
643,ChiCTR2000031504,ChiCTR,2020-04-03,2019-12-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province,Clinical Presentation,No Intervention,2000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51781,No Results,No Results,No Results,2020-04-06,2020-04-07,None
644,ChiCTR2000031499,ChiCTR,2020-04-02,2020-02-10,True,Shanghai Oriental Hospital,Not Recruiting,Not Applicable,Observational,China,Sleep quality of patients with novel coronavirus pneumonia (COVID-19) treated in mobile cabin hospital: a retrospective study,Other,Sleep aids,55,Not Available,2020-02-25,http://www.chictr.org.cn/showproj.aspx?proj=51915,No Results,No Results,No Results,2020-04-06,2020-04-07,None
645,EUCTR2020-001271-33-FR,EU Clinical Trials Register,2020-03-24,2020-03-31,False,CHU Angers,Authorised,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19  risque daggravation secondaire : tude prospective multicentrique randomise en double aveugle,Drug,Hydroxychloroquine,1300,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,No Results,No Results,No Results,2020-04-06,2020-04-07,None
646,ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",Drug,Nintedanib,80,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=51859,No Results,No Results,No Results,2020-04-06,2020-04-07,None
647,ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-30,False,Australian Defence Force Malaria and Infectious Disease Institute,Not Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,Drug,Chloroquine,680,Not Available,2020-09-29,https://anzctr.org.au/ACTRN12620000417987.aspx,No Results,No Results,No Results,2020-04-06,2020-04-01,None
648,ChiCTR2000031438,ChiCTR,2020-04-01,2020-04-01,False,Affiliated Hospital of Southwest Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of changes in high risk factors of cervical spondylosis during novel coronavirus pneumonia (COVID-19) pandemic,Clinical Presentation,No Intervention,820,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51815,No Results,No Results,No Results,2020-04-06,2020-04-07,None
649,ChiCTR2000031429,ChiCTR,2020-03-31,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"The Effects of novel coronavirus pneumonia (COVID-19) Risk Factors on Dynamic Changes of  Immunological, biochemical, and Metabolic Parameters: a Retrospective Observational Study",Clinical Presentation,No Intervention,2000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51816,No Results,No Results,No Results,2020-04-06,2020-04-07,None
650,EUCTR2020-001281-11-FR,EU Clinical Trials Register,2020-03-26,2020-03-30,False,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit..,Drug,Hydroxychloroquine,50,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001281-11,No Results,No Results,No Results,2020-04-06,2020-04-07,None
651,ChiCTR2000031427,ChiCTR,2020-03-31,2020-03-25,True,"The First People's Hospital of Jiangxia District, Wuhan",Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus infection (COVID-19) IgM detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51809,No Results,No Results,No Results,2020-04-06,2020-04-07,None
652,EUCTR2020-001275-32-DK,EU Clinical Trials Register,2020-03-24,2020-04-03,False,The Parker Institute (Bispebjerg and Frederiksberg Hospital),Authorised,Phase 2,Interventional,Denmark,Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure,Drug,Tocilizumab vs. sarilumab,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001275-32,No Results,No Results,No Results,2020-04-06,2020-04-07,None
653,NCT04298060,ClinicalTrials.gov,2020-02-28,2020-04-01,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug,DAS181,280,2021-03-01,2022-09-01,https://clinicaltrials.gov/show/NCT04298060,No Results,No Results,No Results,2020-04-14,2020-04-07,None
654,NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,False,Qilu Hospital of Shandong University,Recruiting,Phase 2/Phase 3,Interventional,"Italy, China",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug,Bevacizumab,20,2020-04-01,2020-05-01,https://clinicaltrials.gov/show/NCT04275414,No Results,No Results,No Results,2020-04-14,2020-03-18,None
655,NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,False,Regeneron Pharmaceuticals,Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug,Sarilumab,400,2021-03-09,2021-04-01,https://clinicaltrials.gov/show/NCT04315298,No Results,No Results,No Results,2020-04-14,2020-03-25,None
656,EUCTR2020-001236-10-NL,EU Clinical Trials Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Authorised,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,Drug,Imatinib,304,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,No Results,No Results,No Results,2020-04-06,2020-04-07,None
657,NCT04318366,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Universita Vita-Salute San Raffaele,Recruiting,Not Applicable,Observational,Italy,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",Prognosis,No Intervention,1000,2022-03-19,2022-03-19,https://clinicaltrials.gov/show/NCT04318366,No Results,No Results,No Results,2020-04-14,2020-04-01,None
658,NCT04321811,ClinicalTrials.gov,2020-03-23,2020-03-21,True,xCures,Recruiting,Not Applicable,Observational,United States,"Behavior, Environment And Treatments for Covid-19",Clinical Presentation,No Intervention,100000,2021-03-20,2022-03-20,https://clinicaltrials.gov/show/NCT04321811,No Results,No Results,No Results,2020-04-14,2020-04-01,None
659,NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,True,Shanghai Jiaotong University,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug,Combination: Interferon Alpha vs. Interferon Alpha + Thymosin Alpha,2944,2020-05-01,2020-06-01,https://clinicaltrials.gov/show/NCT04320238,Pre-Print Article,2020-04-17,https://doi.org/10.1101/2020.04.11.20061473,2020-04-14,2020-04-01,None
660,NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Hospital Israelita Albert Einstein,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug,Combination: hydroxychloroquine + azithromycin vs. hydroxychloroquine,440,2020-08-30,2020-08-30,https://clinicaltrials.gov/show/NCT04321278,No Results,No Results,No Results,2020-04-14,2020-04-01,None
661,NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-02,False,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,NO Prevention of COVID-19 for Healthcare Providers,Drug,Nitric oxide,470,2021-03-20,2022-03-20,https://clinicaltrials.gov/show/NCT04312243,No Results,No Results,No Results,2020-04-14,2020-03-25,None
662,NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,False,"University Hospital, Akershus",Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,Drug,Hydroxychloroquine,202,2021-04-01,2025-03-03,https://clinicaltrials.gov/show/NCT04316377,No Results,No Results,No Results,2020-04-14,2020-03-25,None
663,EUCTR2020-001010-38-NO,EU Clinical Trials Register,2020-03-16,2020-03-23,False,Akershus University Hospital,Authorised,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,Drug,Hydroxychloroquine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,No Results,No Results,No Results,2020-04-06,2020-04-01,None
664,ACTRN12620000421932,ANZCTR,2020-03-30,2020-03-05,True,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Australia, Indonesia, Thailand, Japan, United Kingdom, Vietnam, United States, Singapore, China, Hong Kong, Italy, South Korea",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (COVID-19),Drug,Oxygen,400,Not Available,2020-07-31,https://anzctr.org.au/ACTRN12620000421932.aspx,No Results,No Results,No Results,2020-04-06,2020-04-01,None
665,NCT04322188,ClinicalTrials.gov,2020-03-24,2020-03-19,True,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Observational,Italy,An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection,Drug,Siltuximab,50,2020-05-19,2020-05-19,https://clinicaltrials.gov/show/NCT04322188,Pre-Print Article,2020-04-03,https://doi.org/10.1101/2020.04.01.20048561,2020-04-14,2020-04-01,None
666,NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,False,TMC HealthCare,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,Other (device),Bidirectional Oxygenation Valve,15,2020-05-01,2020-06-01,https://clinicaltrials.gov/show/NCT04326452,No Results,No Results,No Results,2020-04-14,2020-04-07,None
667,NCT04321096,ClinicalTrials.gov,2020-03-23,2020-03-31,False,Aarhus University,Recruiting,Phase 1/Phase 2,Interventional,Denmark,The Impact of Camostat Mesilate on COVID-19 Infection,Drug,Camostat Mesilate,180,2020-12-31,2021-05-01,https://clinicaltrials.gov/show/NCT04321096,No Results,No Results,No Results,2020-04-14,2020-04-01,None
668,NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,Drug,DAS181,4,2020-04-25,2020-04-30,https://clinicaltrials.gov/show/NCT04324489,No Results,No Results,No Results,2020-04-14,2020-04-01,None
669,NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,1000,2021-03-27,2021-12-31,https://clinicaltrials.gov/show/NCT04324047,No Results,No Results,No Results,2020-04-14,2020-04-01,EUCTR2020-001246-18
670,NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,1000,2021-03-27,2021-12-31,https://clinicaltrials.gov/show/NCT04324047,No Results,No Results,No Results,2020-04-14,2020-04-01,EUCTR2020-001456-18
671,NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,1000,2021-03-27,2021-12-31,https://clinicaltrials.gov/show/NCT04324047,No Results,No Results,No Results,2020-04-14,2020-04-01,EUCTR2020-001246-18
672,NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,1000,2021-03-27,2021-12-31,https://clinicaltrials.gov/show/NCT04324047,No Results,No Results,No Results,2020-04-14,2020-04-01,EUCTR2020-001456-18
673,NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,False,Professor Adrian Covic,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other,Other,200,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04325867,No Results,No Results,No Results,2020-04-14,2020-04-07,None
674,NCT04326075,ClinicalTrials.gov,2020-03-26,2020-04-06,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,No Country Given,Early CPAP in COVID Patients With Respiratory Failure.,Other (physical),Mechanical ventilation,900,2020-10-05,2020-11-09,https://clinicaltrials.gov/show/NCT04326075,No Results,No Results,No Results,2020-04-14,2020-04-07,None
675,NCT04326114,ClinicalTrials.gov,2020-03-26,2020-04-26,False,Universidad Complutense de Madrid,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Other (training),Other,240,2020-09-26,2020-10-12,https://clinicaltrials.gov/show/NCT04326114,No Results,No Results,No Results,2020-04-14,2020-04-07,None
676,NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Drug,Oxygen,30,2020-09-26,2020-11-26,https://clinicaltrials.gov/show/NCT04324528,No Results,No Results,No Results,2020-04-14,2020-04-01,None
677,NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,False,Umar Farooq,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,75,2020-05-28,2020-06-28,https://clinicaltrials.gov/show/NCT04328272,No Results,No Results,No Results,2020-04-14,2020-04-07,None
678,NCT04328480,ClinicalTrials.gov,2020-03-30,2020-03-01,True,Estudios Clnicos Latino Amrica,Not Recruiting,Phase 3,Interventional,No Country Given,The ECLA PHRI COLCOVID Trial,Drug,Colchicine,2500,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04328480,No Results,No Results,No Results,2020-04-14,2020-04-07,None
679,NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-01,False,University of Oxford,Not Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,Drug,Chloroquine,250,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04328493,No Results,No Results,No Results,2020-04-14,2020-04-07,None
680,NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Vanda Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,Drug,Tradipitant,300,2020-08-01,2020-08-31,https://clinicaltrials.gov/show/NCT04326426,No Results,No Results,No Results,2020-04-14,2020-04-07,None
681,NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,False,"University Hospital, Ghent",Recruiting,Phase 4,Interventional,"Italy, Belgium",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug,Sargramostim,80,2020-10-31,2020-12-31,https://clinicaltrials.gov/show/NCT04326920,No Results,No Results,No Results,2020-04-14,2020-04-07,None
682,NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,"Mexico, United States, Japan, United Kingdom, South Korea, Singapore, Germany, Denmark",Adaptive COVID-19 Treatment Trial (ACTT),Drug,Remdesivir,440,2023-04-01,2023-04-01,https://clinicaltrials.gov/show/NCT04280705,No Results,No Results,No Results,2020-04-14,2020-03-18,EUCTR2020-001052-18
683,NCT04313946,ClinicalTrials.gov,2020-03-17,2020-03-18,False,Professor Adrian Covic,Recruiting,Not Applicable,Observational,"Romania, Italy, United Kingdom",Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Diagnostics,Diagnostic Test or Assessment,200,2020-08-16,2020-08-18,https://clinicaltrials.gov/show/NCT04313946,No Results,No Results,No Results,2020-04-14,2020-03-25,None
684,NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-06,False,National and Kapodistrian University of Athens,Not Recruiting,Phase 2,Interventional,No Country Given,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Drug,Colchicine,180,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04326790,No Results,No Results,No Results,2020-04-14,2020-04-07,EUCTR2020-001455-40
685,NCT04327505,ClinicalTrials.gov,2020-03-25,2020-04-25,False,Karolinska University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug,Oxygen,200,2021-10-31,2022-12-31,https://clinicaltrials.gov/show/NCT04327505,No Results,No Results,No Results,2020-04-14,2020-04-07,None
686,NCT04327531,ClinicalTrials.gov,2020-03-27,2020-03-26,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",Other (psych),No Intervention,200,2020-04-26,2020-04-28,https://clinicaltrials.gov/show/NCT04327531,No Results,No Results,No Results,2020-04-14,2020-04-07,None
687,NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,True,UMC Utrecht,Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,ATMP,Vaccine,1500,2020-10-25,2020-12-25,https://clinicaltrials.gov/show/NCT04328441,No Results,No Results,No Results,2020-04-14,2020-04-07,None
688,NCT04320511,ClinicalTrials.gov,2020-03-23,2020-04-01,False,William Beaumont Hospitals,Not Recruiting,Not Applicable,Observational,United States,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Clinical Presentation,No Intervention,25,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04320511,No Results,No Results,No Results,2020-04-14,2020-04-01,None
689,NCT04320732,ClinicalTrials.gov,2020-03-23,2020-03-27,False,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Risk Factors for Community- and Workplace Transmission of COVID-19,Clinical Presentation,No Intervention,50000,2022-03-27,2030-03-20,https://clinicaltrials.gov/show/NCT04320732,No Results,No Results,No Results,2020-04-14,2020-04-01,None
690,NCT04329507,ClinicalTrials.gov,2020-03-26,2020-03-25,True,NHS Lothian,Not Recruiting,Not Applicable,Observational,No Country Given,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Diagnostics,Diagnostic Test or Assessment,200,2020-03-25,2020-03-25,https://clinicaltrials.gov/show/NCT04329507,No Results,No Results,No Results,2020-04-14,2020-04-07,None
691,NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,False,Gangnam Severance Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,2486,2021-03-30,2022-03-30,https://clinicaltrials.gov/show/NCT04330144,No Results,No Results,No Results,2020-04-14,2020-04-07,KCT0004907
692,NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-01,True,University of Washington,Not Recruiting,Phase 1,Interventional,United States,Hydroxychloroquine for COVID-19 PEP,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,2000,2020-09-30,2020-10-31,https://clinicaltrials.gov/show/NCT04328961,No Results,No Results,No Results,2020-04-14,2020-04-07,None
693,NCT04330261,ClinicalTrials.gov,2020-03-30,2020-03-18,True,University of Calgary,Recruiting,Not Applicable,Observational,Canada,Clinical Characteristics and Outcomes of Pediatric COVID-19,Clinical Presentation,No Intervention,12500,2021-03-17,2022-03-17,https://clinicaltrials.gov/show/NCT04330261,No Results,No Results,No Results,2020-04-14,2020-04-07,None
694,NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Korea University Guro Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,A Trial of Ciclesonide in Adults With Mild COVID-19,Drug,Ciclesonide + hydroxychloroquine vs. hydroxychloroquine,141,2020-06-30,2020-09-30,https://clinicaltrials.gov/show/NCT04330586,No Results,No Results,No Results,2020-04-14,2020-04-07,None
695,NCT04330599,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Queen Mary University of London,Not Recruiting,Not Applicable,Observational,No Country Given,Longitudinal Population-based Observational Study of Coronavirus Disease in the UK Population,Clinical Presentation,No Intervention,12000,2025-04-01,2025-04-01,https://clinicaltrials.gov/show/NCT04330599,No Results,No Results,No Results,2020-04-14,2020-04-07,None
696,NCT04323878,ClinicalTrials.gov,2020-03-25,2020-04-06,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Observational,No Country Given,Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,Other (physical),Mechanical ventilation,3000,2020-10-05,2020-11-09,https://clinicaltrials.gov/show/NCT04323878,No Results,No Results,No Results,2020-04-14,2020-04-01,None
697,NCT04325646,ClinicalTrials.gov,2020-03-26,2020-03-13,True,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples,Clinical Presentation (Epidemiology),No Intervention,1000,2021-02-28,2023-02-28,https://clinicaltrials.gov/show/NCT04325646,Pre-Print Article,2020-04-23,https://doi.org/10.1101/2020.04.18.20071134,2020-04-14,2020-04-01,None
698,NCT04330521,ClinicalTrials.gov,2020-03-30,2020-04-01,False,Stanford University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Clinical Presentation,No Intervention,50,2022-05-01,2022-05-01,https://clinicaltrials.gov/show/NCT04330521,No Results,No Results,No Results,2020-04-14,2020-04-07,None
699,NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,True,Chinese Academy of Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,ATMP,Cells (IMRC),9,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04331613,No Results,No Results,No Results,2020-04-14,2020-04-07,None
700,NCT04331574,ClinicalTrials.gov,2020-03-30,2020-03-10,True,Societ Italiana dell'Ipertensione Arteriosa-Lega Italiana,Recruiting,Not Applicable,Observational,Italy,Renin-Angiotensin System Inhibitors and COVID-19,Drug,ACE Inhibitors or ARBs,2000,2020-04-10,2020-04-30,https://clinicaltrials.gov/show/NCT04331574,No Results,No Results,No Results,2020-04-14,2020-04-07,None
701,NCT04332016,ClinicalTrials.gov,2020-03-30,2020-04-02,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,COVID-19 Biological Samples Collection,Clinical Presentation,No Intervention,2000,2023-03-01,2023-03-01,https://clinicaltrials.gov/show/NCT04332016,No Results,No Results,No Results,2020-04-14,2020-04-07,None
702,NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-06,False,Rush University Medical Center,Not Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Other (device),high flow nasal cannula (HFNC),346,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04325906,No Results,No Results,No Results,2020-04-14,2020-04-07,None
703,NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Healeon Medical Inc,Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,ATMP,Stromal Vascular Fraction,10,2021-11-01,2021-12-31,https://clinicaltrials.gov/show/NCT04326036,No Results,No Results,No Results,2020-04-14,2020-04-07,None
704,NCT04332835,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Universidad del Rosario,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study",ATMP (+ Drug),Combination: Plasma + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,80,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04332835,No Results,No Results,No Results,2020-04-14,2020-04-07,None
705,NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,False,Baylor Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,ATMP,Plasma,115,2022-12-31,2022-12-31,https://clinicaltrials.gov/show/NCT04333251,No Results,No Results,No Results,2020-04-14,2020-04-07,None
706,NCT04327180,ClinicalTrials.gov,2020-03-25,2020-03-30,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,Diagnostics,Diagnostic Test or Assessment,500,2021-09-01,2021-09-01,https://clinicaltrials.gov/show/NCT04327180,No Results,No Results,No Results,2020-04-14,2020-04-07,None
707,NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,False,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,ATMP,Plasma,30,2020-05-20,2020-09-30,https://clinicaltrials.gov/show/NCT04327349,No Results,No Results,No Results,2020-04-14,2020-04-07,None
708,NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-15,False,Stanford University,Not Recruiting,Phase 2,Interventional,No Country Given,Mild COVID-19 Peginterferon Lambda,Drug,Interferon lambda,120,2021-05-31,2022-05-31,https://clinicaltrials.gov/show/NCT04331899,No Results,No Results,No Results,2020-04-14,2020-04-07,None
709,NCT04333862,ClinicalTrials.gov,2020-04-01,2020-03-19,True,University Hospital of Bern,Recruiting,Not Applicable,Observational,Switzerland,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Health System,No Intervention,500,2020-06-30,2021-12-31,https://clinicaltrials.gov/show/NCT04333862,No Results,No Results,No Results,2020-04-14,2020-04-07,None
710,NCT04332666,ClinicalTrials.gov,2020-03-27,2020-03-31,False,Erasme University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug,Angiotensin (1-7),60,2020-05-30,2020-06-15,https://clinicaltrials.gov/show/NCT04332666,No Results,No Results,No Results,2020-04-14,2020-04-07,None
711,NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,Drug,Deferoxamine,50,2020-09-01,2021-03-01,https://clinicaltrials.gov/show/NCT04333550,No Results,No Results,No Results,2020-04-14,2020-04-07,None
712,NCT04327674,ClinicalTrials.gov,2020-03-27,2020-03-14,True,Aarhus University,Recruiting,Not Applicable,Observational,Denmark,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Diagnostics,Diagnostic Test or Assessment,375,2020-05-15,2020-05-15,https://clinicaltrials.gov/show/NCT04327674,No Results,No Results,No Results,2020-04-14,2020-04-07,None
713,NCT04328454,ClinicalTrials.gov,2020-03-27,2020-01-30,True,Shanghai 10th People's Hospital,Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,120,2020-04-02,2020-04-15,https://clinicaltrials.gov/show/NCT04328454,No Results,No Results,No Results,2020-04-14,2020-04-07,None
714,NCT04333693,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Spanish Society for Angiology and Vascular Surgery,Not Recruiting,Not Applicable,Observational,Spain,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Clinical Presentation,No Intervention,50,2020-10-01,2020-11-01,https://clinicaltrials.gov/show/NCT04333693,No Results,No Results,No Results,2020-04-14,2020-04-07,None
715,NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Providence Health & Services,Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Drug,Hydroxychloroquine vs. Vitamin C,1250,2021-09-30,2023-09-30,https://clinicaltrials.gov/show/NCT04334967,No Results,No Results,No Results,2020-04-14,2020-04-15,None
716,NCT04334629,ClinicalTrials.gov,2020-04-02,2020-04-06,False,King's College London,Not Recruiting,Phase 4,Interventional,No Country Given,LIBA Trial in COVID-19,Drug,Ibuprofen,230,2020-08-26,2020-11-26,https://clinicaltrials.gov/show/NCT04334629,No Results,No Results,No Results,2020-04-14,2020-04-15,None
717,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Clinical Presentation,Other (Procedure),194,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04334850,No Results,No Results,No Results,2020-04-14,2020-04-15,EUCTR2020-001324-33
718,ACTRN12620000438954,ANZCTR,2020-04-06,2020-04-20,False,Griffith University,Not Recruiting,Not Applicable,Observational,Australia,Utilizing lung ultrasound in COVID-19 patients in ICU  comparison of management strategies on survival and time on ventilation.,Diagnostics,Diagnostic Test or Assessment,60,Not Available,2020-10-31,https://anzctr.org.au/ACTRN12620000438954.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
719,NCT04329559,ClinicalTrials.gov,2020-03-29,2020-03-30,False,Hepatopancreatobiliary Surgery Institute of Gansu Province,Recruiting,Not Applicable,Observational,China,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Clinical Presentation,No Intervention,50,2020-06-29,2021-06-29,https://clinicaltrials.gov/show/NCT04329559,No Results,No Results,No Results,2020-04-14,2020-04-07,None
720,NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-06,False,Wroclaw Medical University,Not Recruiting,Phase 4,Interventional,No Country Given,ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020,Drug,Chloroquine,400,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04331600,No Results,No Results,No Results,2020-04-14,2020-04-07,None
721,ACTRN12620000449932,ANZCTR,2020-04-06,2020-04-10,False,University of Melbourne,Not Recruiting,Not Applicable,Observational,Australia,Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancy,Clinical Presentation,No Intervention,200,Not Available,2021-12-31,https://anzctr.org.au/ACTRN12620000449932.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
722,ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,False,Medical Research Institute of New Zealand,Not Recruiting,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,Drug,Hydroxychloroquine,70,Not Available,2021-01-29,https://anzctr.org.au/ACTRN12620000457943.aspx,No Results,No Results,No Results,2020-04-14,2020-04-15,None
723,NCT04335019,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Diagnostics,Diagnostic Test or Assessment,300,2020-04-01,2020-05-01,https://clinicaltrials.gov/show/NCT04335019,No Results,No Results,No Results,2020-04-14,2020-04-15,None
724,NCT04335084,ClinicalTrials.gov,2020-04-02,2020-04-01,True,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug,Combination: Hydroxychloroquine + vitamin C + vitamin D + zinc,600,2021-04-01,2021-07-01,https://clinicaltrials.gov/show/NCT04335084,No Results,No Results,No Results,2020-04-14,2020-04-15,None
725,NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Lady Davis Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other (psych),Psychological,162,2020-06-03,2020-06-03,https://clinicaltrials.gov/show/NCT04335279,No Results,No Results,No Results,2020-04-14,2020-04-15,None
726,ACTRN12620000443998,ANZCTR,2020-04-06,2020-05-01,False,Flinders Medical Centre,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,Telehealth,Rehabilitation,58,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000443998.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
727,ACTRN12620000454976,ANZCTR,2020-04-08,2020-04-09,False,Austin Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,Drug,Zinc,160,Not Available,2021-04-09,https://anzctr.org.au/ACTRN12620000454976.aspx,No Results,No Results,No Results,2020-04-14,2020-04-15,None
728,NCT04335201,ClinicalTrials.gov,2020-03-31,2020-04-06,False,IRCCS San Raffaele,Not Recruiting,Phase 2,Interventional,No Country Given,Defibrotide in COVID-19 Pneumonia,Drug,Defibrotide,50,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04335201,No Results,No Results,No Results,2020-04-14,2020-04-15,None
729,ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-01,False,Deakin University,Not Recruiting,Not Applicable,Interventional,Australia,Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,Other (psych),Psychological,154,Not Available,2021-03-01,https://anzctr.org.au/ACTRN12620000448943.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
730,NCT04332380,ClinicalTrials.gov,2020-03-30,2020-04-01,False,Universidad del Rosario,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,ATMP,Plasma,10,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04332380,No Results,No Results,No Results,2020-04-14,2020-04-07,None
731,NCT04333355,ClinicalTrials.gov,2020-03-31,2020-04-15,False,Hospital San Jose Tec de Monterrey,Not Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,ATMP,Plasma,20,2020-12-20,2021-04-30,https://clinicaltrials.gov/show/NCT04333355,No Results,No Results,No Results,2020-04-14,2020-04-07,None
732,ChiCTR2000031836,ChiCTR,2020-04-11,2020-01-23,True,The First Affiliated Hospital of Yangtze University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based study for the Clinical Characteristics Of Hospitalized Novel Coronavirus Pneumonia (COVID-19) Patients With Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,45,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52213,No Results,No Results,No Results,2020-04-13,2020-04-15,None
733,ChiCTR2000031794,ChiCTR,2020-04-10,2020-04-08,True,Huanggang Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for analysis clinical characteristics and risk factors of death in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,130,Not Available,2020-05-08,http://www.chictr.org.cn/showproj.aspx?proj=52193,No Results,No Results,No Results,2020-04-13,2020-04-15,None
734,ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,True,Fujian Provincial Maternity and Child Health Hospital,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),Other,Health Education,105,Not Available,2020-10-31,http://www.chictr.org.cn/showproj.aspx?proj=52165,No Results,No Results,No Results,2020-04-13,2020-04-15,None
735,NCT04333472,ClinicalTrials.gov,2020-04-01,2020-04-06,False,Can-Fite BioPharma,Not Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,Drug,Piclidenoson,40,2020-06-06,2020-07-06,https://clinicaltrials.gov/show/NCT04333472,No Results,No Results,No Results,2020-04-14,2020-04-07,None
736,ACTRN12620000444987,ANZCTR,2020-04-06,2020-04-07,False,South Metropolitan Health Service,Not Recruiting,Not Applicable,Observational,Australia,COVID-19 Research Response (ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections COVID-19 Research Response Trial),Clinical Presentation,No Intervention,100000,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000444987.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
737,ACTRN12620000447954,ANZCTR,2020-04-06,2020-03-31,True,Royal Brisbane & Women's Hospital,Recruiting,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,Drug,Hydroxychloroquine,150,Not Available,2020-08-31,https://anzctr.org.au/ACTRN12620000447954.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
738,ChiCTR2000031770,ChiCTR,2020-04-09,2020-01-22,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Experiences in nursing care for patients with suspected novel coronavirus pneumonia (COVID-19) in Shanghai,Clinical Presentation,No Intervention,119,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=52148,No Results,No Results,No Results,2020-04-13,2020-04-15,None
739,ChiCTR2000031782,ChiCTR,2020-04-10,2020-04-13,False,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,A questionnaire investigation of hydroxychloroquine for its potential protective effect against novel coronavirus infection (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,550,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51934,No Results,No Results,No Results,2020-04-13,2020-04-15,None
740,ChiCTR2000031783,ChiCTR,2020-04-10,2020-03-24,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Bolivia,Investigation for Prevention Awareness against COVID-19,Other,No Intervention,883,Not Available,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=51832,No Results,No Results,No Results,2020-04-13,2020-04-15,None
741,ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",ATMP,Vaccine,500,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=52006,No Results,No Results,No Results,2020-04-13,2020-04-15,None
742,ChiCTR2000031752,ChiCTR,2020-04-09,2020-01-01,True,the First Affiliated Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Observational,China,A medical records based observational study for myocardial injury and cardiac function in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,75,Not Available,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=52135,No Results,No Results,No Results,2020-04-13,2020-04-15,None
743,ChiCTR2000031860,ChiCTR,2020-04-12,2020-04-27,False,Beijing Sports University,Not Recruiting,Not Applicable,Observational,China,Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients,Other (exercise),Exercise,150,Not Available,2020-09-16,http://www.chictr.org.cn/showproj.aspx?proj=52198,No Results,No Results,No Results,2020-04-13,2020-04-15,None
744,ChiCTR2000031734,ChiCTR,2020-04-08,2020-03-19,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel Coronavirus Pneumonia (COVID-19): a randomized, open-label, controlled trial",Drug,Combination: Danorevir + ritonavir,40,Not Available,2020-05-29,http://www.chictr.org.cn/showproj.aspx?proj=52103,No Results,No Results,No Results,2020-04-13,2020-04-15,None
745,ChiCTR2000031751,ChiCTR,2020-04-08,2020-04-01,True,Wuhan Fourth Hospital,Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function,Prognosis,No Intervention,60,Not Available,2022-04-01,http://www.chictr.org.cn/showproj.aspx?proj=52130,No Results,No Results,No Results,2020-04-13,2020-04-15,None
746,ChiCTR2000031779,ChiCTR,2020-04-10,2020-01-01,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of novel coronavirus pneumonia (COVID-19) upon male reproductive system,Clinical Presentation,No Intervention,50,Not Available,2021-04-01,http://www.chictr.org.cn/showproj.aspx?proj=52051,No Results,No Results,No Results,2020-04-13,2020-04-15,None
747,ChiCTR2000031707,ChiCTR,2020-04-07,2020-03-01,True,Shanghai Oriental Hospital,Recruiting,Not Applicable,Observational,China,Study for sleep quality of medical teams members moved to Hubei for the fighting of novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,47,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52079,No Results,No Results,No Results,2020-04-13,2020-04-15,None
748,ChiCTR2000031705,ChiCTR,2020-04-07,2020-03-10,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for early biological warning signals in patients with acute renal injury caused by novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51793,No Results,No Results,No Results,2020-04-13,2020-04-15,None
749,ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,False,Jiangsu Province Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),Telehealth,Telehealth,120,Not Available,2020-10-20,http://www.chictr.org.cn/showproj.aspx?proj=52216,No Results,No Results,No Results,2020-04-13,2020-04-15,None
750,ChiCTR2000031700,ChiCTR,2020-04-07,2020-04-21,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Development and clinical application of novel coronavirus pneumonia (COVID-19) antigen reagent,Diagnostics,Diagnostic Test or Assessment,600,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=52052,No Results,No Results,No Results,2020-04-13,2020-04-15,None
751,ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,True,Huzhou Central Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (NK),20,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50613,No Results,No Results,No Results,2020-04-13,2020-04-15,None
752,ChiCTR2000031699,ChiCTR,2020-04-07,2020-02-01,True,Wenzhou Central Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Study for immune antibody and multi-group function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,33,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=51924,No Results,No Results,No Results,2020-04-13,2020-04-15,None
753,ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,150,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51940,No Results,No Results,No Results,2020-04-13,2020-04-15,None
754,ChiCTR2000031675,ChiCTR,2020-04-06,2020-04-06,False,Women's Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based retrospective analysis of maternal and infant outcomes in Cesarean delivery in Hangzhou non pneumonia Hospital during pandemic of Novel coronovirus pneumonia(COVID-19),Clinical Presentation,No Intervention,2000,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=52037,No Results,No Results,No Results,2020-04-13,2020-04-15,None
755,ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,True,Shenzhen Third People's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,ATMP,Vaccine,120,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50928,No Results,No Results,No Results,2020-04-13,2020-03-18,None
756,ChiCTR2000030494,ChiCTR,2020-03-05,2020-03-01,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Early risk stratification of the novel coronavirus infected diseases (COVID-19): a multicenter retrospective study  (ERS-COVID-19 study),Prognosis,No Intervention,600,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=50077,No Results,No Results,No Results,2020-04-13,2020-08-03,None
757,ChiCTR2000030331,ChiCTR,2020-02-28,2020-02-01,True,The First Affiliated Hospital Division of Life Sciences and Medicine University of Science and Technology of China,Recruiting,Not Applicable,Epidemiological research,China,Construction of a Bio information platform for novel coronavirus pneumonia (COVID-19) patients follow-up in Anhui,Clinical Presentation,No Intervention,498,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50271,No Results,No Results,No Results,2020-04-13,2020-08-03,None
758,EUCTR2020-001381-11-FR,EU Clinical Trials Register,2020-03-29,2020-04-08,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,Drug,ACE inhibitors or ARBs,554,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,No Results,No Results,No Results,2020-04-14,2020-04-15,None
759,EUCTR2020-001301-23-FR,EU Clinical Trials Register,2020-03-26,2020-04-10,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,Drug,Naproxen,584,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,No Results,No Results,No Results,2020-04-14,2020-04-15,None
760,EUCTR2020-001310-38-DE,EU Clinical Trials Register,2020-03-31,2020-04-06,False,DRK-Bluspendedienst Baden-Wrttemberg - Hessen gGmbH,Authorised,Phase 2,Interventional,Germany,Clinical Study to assess positive value of blood plasma from donors having built immunity against the new corona virus (SARS-CoV-2) transfused to patients suffering from SARS-CoV-2 infection,ATMP,Plasma,106,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001310-38,No Results,No Results,No Results,2020-04-14,2020-04-15,None
761,EUCTR2020-001335-28-NL,EU Clinical Trials Register,2020-03-27,2020-03-29,False,InflaRx GmbH,Authorised,Phase 2/Phase 3,Interventional,Netherlands,An open label phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,Drug,IFX-1,130,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28,No Results,No Results,No Results,2020-04-14,2020-04-15,None
762,EUCTR2020-001500-41-BE,EU Clinical Trials Register,2020-04-04,2020-04-03,True,University Hospital Ghent,Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,Drug,Anakinra or tocilizumab or siltuximab,342,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,No Results,No Results,No Results,2020-04-14,2020-04-07,None
763,EUCTR2020-001435-27-FR,EU Clinical Trials Register,2020-04-01,2020-04-10,False,CHU de Bordeaux,Authorised,Phase 3,Interventional,France,"Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety
of several experimental treatments to reduce the risk of hospitalization or death
(COVERAGE trial)",Drug,Hydroxychloroquine vs. imatinib vs. favipiravir vs. telmisartan,1057,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001435-27,No Results,No Results,No Results,2020-04-14,2020-04-15,None
764,EUCTR2020-001333-13-FR,EU Clinical Trials Register,2020-04-02,2020-04-09,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,Drug,Combination: Dexamethasone + hydroxychloroquine vs. hydroxychloroquine,122,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,No Results,No Results,No Results,2020-04-14,2020-04-15,None
765,EUCTR2020-001409-21-ES,EU Clinical Trials Register,2020-04-03,2020-04-01,True,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,Drug,Defibrotide,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,No Results,No Results,No Results,2020-04-14,2020-04-15,None
766,EUCTR2020-001457-43-FR,EU Clinical Trials Register,2020-04-02,2020-04-10,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia,Drug,Combination: Dexamethasone + Oxygen,550,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001457-43,No Results,No Results,No Results,2020-04-14,2020-04-15,None
767,EUCTR2020-001492-33-FR,EU Clinical Trials Register,2020-04-01,2020-04-10,False,L'Hpital Fondation Adolphe de Rothschild,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,Drug,Dornase alfa,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,No Results,No Results,No Results,2020-04-14,2020-04-15,None
768,EUCTR2020-001442-19-ES,EU Clinical Trials Register,2020-04-03,2020-04-02,True,Institut de Recerca Hospital de la Santa Creu i Sant Pau,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",Drug,Combination: Tocilizumab + hydroxychloroquine + azithromycin,276,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,No Results,No Results,No Results,2020-04-14,2020-04-15,None
769,EUCTR2020-001194-69-ES,EU Clinical Trials Register,2020-04-07,2020-03-30,True,Flix Gutirrez Rodero,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),Drug (Chemoprophylaxis),Mefloquine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,No Results,No Results,No Results,2020-04-14,2020-04-15,None
770,EUCTR2020-001385-11-ES,EU Clinical Trials Register,2020-04-03,2020-03-28,True,Plan Nacional sobre el Sida (PNS),Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,Drug (Chemoprophylaxis),Combination: Emtricitabine/tenofovir + hydroxychloroquine,4000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,No Results,No Results,No Results,2020-04-14,2020-04-15,None
771,EUCTR2020-001421-31-ES,EU Clinical Trials Register,2020-04-07,2020-04-06,True,Sociedad Espaola de Farmacia Hospitalaria,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,Drug (Chemoprophylaxis),Hydroxychloroquine,1530,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,No Results,No Results,No Results,2020-04-14,2020-04-15,None
772,EUCTR2020-001565-37-ES,EU Clinical Trials Register,2020-04-07,2020-04-03,True,ISGlobal,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,Drug,Hydroxychloroquine,440,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,No Results,No Results,No Results,2020-04-14,2020-04-15,None
773,EUCTR2020-001270-29-GB,EU Clinical Trials Register,2020-03-30,2020-04-02,False,Sanofi,Authorised,Phase 2/Phase 3,Interventional,"United Kingdom, Czech Republic, France, Germany, Denmark, Hungary",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,Drug,Hydroxychloroquine,350,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,No Results,No Results,No Results,2020-04-14,2020-04-07,None
774,EUCTR2020-001606-33-ES,EU Clinical Trials Register,2020-04-07,2020-04-07,False,Instituto Investigacin Sanitario Biocruces Bizkaia,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,Drug,Combination: Hydroxychloroquine + azithromycin vs. hydroxychloroquine,132,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,No Results,No Results,No Results,2020-04-14,2020-04-15,None
775,EUCTR2020-001307-16-ES,EU Clinical Trials Register,2020-04-08,2020-04-01,True,Fundacin para la Investigacion Biomedica Hospital Ramn y Cajal,Authorised,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,Drug,Corticosteroids,104,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,No Results,No Results,No Results,2020-04-14,2020-04-15,None
776,NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug,Corticosteroids,80,2020-04-13,2020-04-13,https://clinicaltrials.gov/show/NCT04244591,No Results,No Results,No Results,2020-04-20,2020-08-03,None
777,NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,False,Shanghai Public Health Clinical Center,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug,Combination: Darunavir + cobicistat,30,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04252274,No Results,No Results,No Results,2020-04-20,2020-08-03,None
778,NCT04274322,ClinicalTrials.gov,2020-02-16,2020-02-19,False,Peking University Third Hospital,Not Recruiting,Not Applicable,Observational,China,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Other (nutrition),Nutrition,117,2020-04-04,2020-07-01,https://clinicaltrials.gov/show/NCT04274322,No Results,No Results,No Results,2020-04-20,2020-03-18,None
779,NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,Drug,Remdesivir,308,2020-04-10,2020-04-27,https://clinicaltrials.gov/show/NCT04252664,No Results,No Results,No Results,2020-04-20,2020-08-03,None
780,NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug,Hydroxychloroquine,30,2020-02-25,2020-02-25,https://clinicaltrials.gov/show/NCT04261517,Journal Article,2020-03-06,https://doi.org/10.3785/j.issn.1008-9292.2020.03.03,2020-04-20,2020-08-03,None
781,NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,False,Beijing 302 Hospital,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,ATMP,Cells (mesenchymal),20,2020-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04252118,No Results,No Results,No Results,2020-04-20,2020-03-18,None
782,NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,True,"Beijing Chaoyang Hospital, Capital Medical University",Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,Drug,Corticosteroids,400,2020-05-01,2020-05-30,https://clinicaltrials.gov/show/NCT04273321,No Results,No Results,No Results,2020-04-20,2020-08-03,None
783,NCT04245631,ClinicalTrials.gov,2020-01-26,2020-01-01,True,Beijing Ditan Hospital,Recruiting,Not Applicable,Observational,China,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Diagnostics,Diagnostic Test or Assessment,50,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04245631,No Results,No Results,No Results,2020-04-20,2020-08-03,None
784,NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,True,The University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug,Combination: Lopinavir/ritonavir + ribavirin + interferon beta,127,2020-03-30,2020-03-31,https://clinicaltrials.gov/show/NCT04276688,No Results,No Results,No Results,2020-04-20,2020-03-18,None
785,NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,True,The Ninth Hospital of Nanchang,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Combination: Danoprevir + ritonavir (w/ or w/o Interferon),11,2020-03-19,2020-03-19,https://clinicaltrials.gov/show/NCT04291729,Pre-Print Article,2020-03-24,https://doi.org/10.1101/2020.03.22.20034041,2020-04-20,2020-03-18,None
786,NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,ATMP,Cells (mesenchymal),48,2020-06-30,2022-02-15,https://clinicaltrials.gov/show/NCT04273646,No Results,No Results,No Results,2020-04-20,2020-08-03,None
787,NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Clinical Presentation (Epidemiology),No Intervention,1000,2020-07-16,2020-10-16,https://clinicaltrials.gov/show/NCT04304690,No Results,No Results,No Results,2020-04-20,2020-04-15,None
788,NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,Drug,Remdesivir,237,2020-03-30,2020-04-10,https://clinicaltrials.gov/show/NCT04257656,No Results,No Results,No Results,2020-04-20,2020-08-03,None
789,NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,False,Xinxiang medical university,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,ATMP,Cells (NK),30,2020-09-30,2020-12-30,https://clinicaltrials.gov/show/NCT04280224,No Results,No Results,No Results,2020-04-20,2020-03-18,None
790,NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-03,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,45,2021-06-01,2021-06-01,https://clinicaltrials.gov/show/NCT04283461,No Results,No Results,No Results,2020-04-20,2020-08-03,None
791,NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,False,Beijing 302 Hospital,Recruiting,Phase 2,Interventional,China,Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19),ATMP,Cells (mesenchymal),90,2020-07-15,2020-07-31,https://clinicaltrials.gov/show/NCT04288102,No Results,No Results,No Results,2020-04-20,2020-08-03,None
792,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-05-10,False,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,ATMP,Cells (stem cells),20,2020-10-09,2020-11-10,https://clinicaltrials.gov/show/NCT04299152,No Results,No Results,No Results,2020-04-20,2020-04-22,None
793,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-04-15,False,Rajavithi Hospital,Not Recruiting,Phase 3,Interventional,Thailand,"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",320,2020-10-31,2020-11-30,https://clinicaltrials.gov/show/NCT04303299,No Results,No Results,No Results,2020-04-20,2020-03-18,None
794,NCT04312997,ClinicalTrials.gov,2020-03-16,2020-04-01,False,"Pulmotect, Inc.",Not Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug,"PUL-042, unspecified immunomodulatory drug",100,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04312997,No Results,No Results,No Results,2020-04-20,2020-03-25,None
795,NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,False,CanSino Biologics Inc.,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,ATMP,Adenovirus vector,108,2020-12-30,2022-12-20,https://clinicaltrials.gov/show/NCT04313127,No Results,No Results,No Results,2020-04-20,2020-03-25,None
796,NCT04290780,ClinicalTrials.gov,2020-02-27,2020-03-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Clinical Presentation,No Intervention,300,2020-10-10,2020-10-30,https://clinicaltrials.gov/show/NCT04290780,No Results,No Results,No Results,2020-04-20,2020-03-18,None
797,NCT04302766,ClinicalTrials.gov,2020-03-02,2020-04-01,False,U.S. Army Medical Research and Development Command,Not Recruiting,Phase 1,Expanded Access,No Country Given,Expanded Access Remdesivir (RDV; GS-5734),Drug,Remdesivir,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04302766,No Results,No Results,No Results,2020-04-20,2020-03-18,None
798,NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,False,Gilead Sciences,Recruiting,Phase 3,Interventional,"Switzerland, United States, Japan, United Kingdom, South Korea, Iran, France, Singapore, China, Hong Kong, Spain, Sweden, Italy, Germany, Taiwan, Netherlands",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug,Remdesivir,1600,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04292730,No Results,No Results,No Results,2020-04-20,2020-03-18,EUCTR2020-000842-32
799,NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,False,Gilead Sciences,Recruiting,Phase 3,Interventional,"Switzerland, United States, Japan, United Kingdom, South Korea, France, Singapore, Hong Kong, Spain, Sweden, Italy, Germany, Taiwan, Netherlands",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,6000,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04292899,No Results,No Results,No Results,2020-04-20,2020-03-18,EUCTR2020-000841-15
800,NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug,Nitric oxide,240,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04305457,No Results,No Results,No Results,2020-04-20,2020-03-18,None
801,NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug,Nitric oxide,200,2021-03-21,2022-03-21,https://clinicaltrials.gov/show/NCT04306393,No Results,No Results,No Results,2020-04-20,2020-03-18,EUCTR2020-001490-68
802,NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug,ARB (Losartan),580,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04311177,No Results,No Results,No Results,2020-04-20,2020-03-25,None
803,NCT04311697,ClinicalTrials.gov,2020-03-14,2020-04-01,False,"NeuroRx, Inc.",Not Recruiting,Phase 2,Interventional,"United States, Israel",Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress,Drug,Aviptadil,120,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04311697,No Results,No Results,No Results,2020-04-20,2020-03-25,None
804,NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,False,National Cancer Institute,Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug,Tocilizumab,400,2020-12-19,2022-12-19,https://clinicaltrials.gov/show/NCT04317092,No Results,No Results,No Results,2020-04-20,2020-03-25,EUCTR2020-001110-38
805,NCT04318301,ClinicalTrials.gov,2020-03-20,2020-03-21,False,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Hypertension in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,275,2020-03-28,2020-03-30,https://clinicaltrials.gov/show/NCT04318301,No Results,No Results,No Results,2020-04-20,2020-04-01,None
806,NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,False,University of Minnesota,Recruiting,Phase 3,Interventional,"Canada, United States",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,3000,2020-04-21,2020-05-12,https://clinicaltrials.gov/show/NCT04308668,No Results,No Results,No Results,2020-04-20,2020-04-01,None
807,NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,True,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug,Combination: Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,150,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04310228,No Results,No Results,No Results,2020-04-20,2020-03-25,None
808,NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,False,Fundacio Lluita Contra la SIDA,Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug (Chemoprophylaxis),Combination: Darunavir + cobicistat + hydroxychloroquine,3040,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04304053,No Results,No Results,No Results,2020-04-20,2020-03-18,EUCTR2020-001031-27
809,NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,Other,No Intervention,19491,2020-03-13,2020-04-03,https://clinicaltrials.gov/show/NCT04306055,No Results,No Results,No Results,2020-04-20,2020-03-18,None
810,NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug,ARB (Losartan),200,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04312009,No Results,No Results,No Results,2020-04-20,2020-03-25,None
811,NCT04313023,ClinicalTrials.gov,2020-03-16,2020-04-01,False,"Pulmotect, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug,"PUL-042, unspecified immunomodulatory drug",200,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04313023,No Results,No Results,No Results,2020-04-20,2020-03-25,None
812,NCT04315987,ClinicalTrials.gov,2020-03-18,2020-04-01,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,NestCell Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),66,2020-05-01,2020-06-01,https://clinicaltrials.gov/show/NCT04315987,No Results,No Results,No Results,2020-04-20,2020-03-25,None
813,NCT04319016,ClinicalTrials.gov,2020-03-20,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Clinical Presentation,No Intervention,20,2020-04-30,2020-05-01,https://clinicaltrials.gov/show/NCT04319016,No Results,No Results,No Results,2020-04-20,2020-04-01,None
814,NCT04320472,ClinicalTrials.gov,2020-03-22,2020-03-23,False,Ictal Group,Recruiting,Not Applicable,Observational,"France, Spain",Acute Encephalopathy in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,250,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04320472,No Results,No Results,No Results,2020-04-20,2020-04-01,None
815,NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Hospital do Corao,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus (COVID-19),Drug,Combination: hydroxychloroquine + azithromycin vs. hydroxychloroquine,630,2020-08-30,2020-08-30,https://clinicaltrials.gov/show/NCT04322123,No Results,No Results,No Results,2020-04-20,2020-04-01,None
816,NCT04319315,ClinicalTrials.gov,2020-03-16,2020-03-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Other,No Intervention,400,2020-04-01,2020-04-16,https://clinicaltrials.gov/show/NCT04319315,No Results,No Results,No Results,2020-04-20,2020-04-01,None
817,NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,Other (device),Non-contact Endoscopy,5,2020-03-26,2020-04-09,https://clinicaltrials.gov/show/NCT04320953,No Results,No Results,No Results,2020-04-20,2020-04-01,None
818,NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug,Tocilizumab,38,2020-04-09,2020-05-01,https://clinicaltrials.gov/show/NCT04315480,No Results,No Results,No Results,2020-04-20,2020-04-15,None
819,NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug,Hydroxychloroquine,500,2020-10-31,2021-03-22,https://clinicaltrials.gov/show/NCT04315896,No Results,No Results,No Results,2020-04-20,2020-03-25,None
820,NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,False,Wake Forest University,Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,Other (psych),Psychological,200,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04319445,No Results,No Results,No Results,2020-04-20,2020-04-01,None
821,NCT04321616,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Oslo University Hospital,Recruiting,Phase 2/Phase 3,Interventional,Norway,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Drug,Hydroxychloroquine vs. remdesivir,700,2020-08-01,2020-11-01,https://clinicaltrials.gov/show/NCT04321616,No Results,No Results,No Results,2020-04-20,2020-04-01,None
822,NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,False,"Chronic Obstructive Pulmonary Disease Trial Network, Denmark",Recruiting,Phase 2,Interventional,Denmark,Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19,Drug (Chemoprophylaxis),Combination: hydroxychloroquine + azithromycin,226,2020-10-31,2021-03-31,https://clinicaltrials.gov/show/NCT04322396,No Results,No Results,No Results,2020-04-20,2020-04-01,None
823,NCT04323761,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Gilead Sciences,Not Recruiting,Phase 3,Expanded Access,"Switzerland, United States, United Kingdom, Italy, France, Spain, Germany",Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),Drug,Remdesivir,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04323761,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001453-49
824,NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-08,False,"OncoImmune, Inc.",Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,ATMP,Gene-derived protein,230,2021-05-01,2022-05-01,https://clinicaltrials.gov/show/NCT04317040,No Results,No Results,No Results,2020-04-20,2020-03-25,None
825,NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,400,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04318015,No Results,No Results,No Results,2020-04-20,2020-04-01,None
826,NCT04323787,ClinicalTrials.gov,2020-03-24,2020-03-30,False,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Clinical Presentation,No Intervention,50000,2021-04-30,2021-04-30,https://clinicaltrials.gov/show/NCT04323787,No Results,No Results,No Results,2020-04-20,2020-04-01,None
827,NCT04323800,ClinicalTrials.gov,2020-03-24,2020-05-01,False,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19,ATMP,Plasma,150,2022-12-31,2023-01-01,https://clinicaltrials.gov/show/NCT04323800,No Results,No Results,No Results,2020-04-20,2020-04-01,None
828,NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,False,Roche,Recruiting,Phase 3,Interventional,"Canada, United States, United Kingdom, France, Spain, Italy, Germany, Denmark, Netherlands",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug,Tocilizumab,330,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04320615,No Results,No Results,No Results,2020-04-20,2020-04-01,EUCTR2020-001154-22
829,NCT04320862,ClinicalTrials.gov,2020-03-23,2020-04-03,False,Duke University,Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Response Network,Clinical Presentation (Epidemiology),No Intervention,200000,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04320862,No Results,No Results,No Results,2020-04-20,2020-04-01,None
830,NCT04322487,ClinicalTrials.gov,2020-03-23,2020-04-08,False,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Diagnostics,Diagnostic Test or Assessment,100,2020-12-31,2021-01-15,https://clinicaltrials.gov/show/NCT04322487,No Results,No Results,No Results,2020-04-20,2020-04-01,None
831,NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,False,AOU di Parma,Not Recruiting,Phase 2,Interventional,No Country Given,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug,Colchicine,310,2020-06-20,2020-07-20,https://clinicaltrials.gov/show/NCT04322565,No Results,No Results,No Results,2020-04-20,2020-04-01,None
832,NCT04321265,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Heinrich-Heine University,Recruiting,Not Applicable,Observational,"France, Germany, Denmark, Norway",Outcomes and Prognostic Factors in COVID-19,Prognosis,No Intervention,4000,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04321265,No Results,No Results,No Results,2020-04-20,2020-04-01,None
833,NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Montreal Heart Institute,Recruiting,Phase 3,Interventional,"Canada, United States",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug,Colchicine,6000,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04322682,No Results,No Results,No Results,2020-04-20,2020-04-01,None
834,NCT04323839,ClinicalTrials.gov,2020-03-24,2020-03-20,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),Clinical Presentation,No Intervention,1000,2024-03-31,2024-03-31,https://clinicaltrials.gov/show/NCT04323839,No Results,No Results,No Results,2020-04-20,2020-04-01,None
835,NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,False,Dr. Negrin University Hospital,Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Drug,Dexamethason,200,2020-10-30,2020-10-30,https://clinicaltrials.gov/show/NCT04325061,No Results,No Results,No Results,2020-04-20,2020-04-01,EUCTR2020-001278-31
836,NCT04321369,ClinicalTrials.gov,2020-03-23,2020-03-09,True,Dr. Deneen Vojta,Not Recruiting,Not Applicable,Observational,United States,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Diagnostics,Diagnostic Test or Assessment,533,2020-03-23,2020-03-23,https://clinicaltrials.gov/show/NCT04321369,Pre-Print Article,2020-04-06,https://doi.org/10.1101/2020.04.01.20050005,2020-04-20,2020-04-07,None
837,NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Lisa Barrett,Not Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. baricitinib vs. sarilumab,1000,2021-02-01,2021-07-01,https://clinicaltrials.gov/show/NCT04321993,No Results,No Results,No Results,2020-04-20,2020-04-01,None
838,NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug,Sarilumab,239,2021-03-27,2021-12-31,https://clinicaltrials.gov/show/NCT04324073,No Results,No Results,No Results,2020-04-20,2020-04-01,None
839,NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,False,Gunther Meinlschmidt,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,Other (psych),Psychological,600,2020-06-01,2021-12-01,https://clinicaltrials.gov/show/NCT04324190,No Results,No Results,No Results,2020-04-20,2020-04-01,None
840,NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,False,Marius Henriksen,Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Drug,Tocilizumab vs. sarilumab,200,2021-06-01,2021-06-01,https://clinicaltrials.gov/show/NCT04322773,No Results,No Results,No Results,2020-04-20,2020-04-01,None
841,NCT04323228,ClinicalTrials.gov,2020-03-23,2020-05-01,False,King Saud University,Not Recruiting,Phase 4,Interventional,No Country Given,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Supplement,Oral nutrition supplement,30,2020-10-01,2020-10-30,https://clinicaltrials.gov/show/NCT04323228,No Results,No Results,No Results,2020-04-20,2020-04-01,None
842,NCT04322513,ClinicalTrials.gov,2020-03-23,2020-03-24,False,University of Catanzaro,Recruiting,Not Applicable,Observational,Italy,Biomarkers for Identification of COVID-19 Infection,Diagnostics,Diagnostic Test or Assessment,110,2020-06-30,2020-08-30,https://clinicaltrials.gov/show/NCT04322513,No Results,No Results,No Results,2020-04-20,2020-04-01,None
843,NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,False,Swedish Orphan Biovitrum,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Drug,Combination: Emapalumab + Anakinra,54,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04324021,No Results,No Results,No Results,2020-04-20,2020-04-01,None
844,NCT04324736,ClinicalTrials.gov,2020-03-25,2020-03-10,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,"""COVID-19 and Diabetes Outcomes""",Clinical Presentation,No Intervention,1000,2020-04-10,2020-05-08,https://clinicaltrials.gov/show/NCT04324736,No Results,No Results,No Results,2020-04-20,2020-04-22,None
845,NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,ATMP,Plasma,Not Available,2022-12-31,2022-12-31,https://clinicaltrials.gov/show/NCT04325672,No Results,No Results,No Results,2020-04-20,2020-04-01,None
846,NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-29,False,Sanofi,Recruiting,Phase 2/Phase 3,Interventional,"Canada, Japan, France, Spain, Italy, Germany",Sarilumab COVID-19,Drug,Sarilumab,300,2020-07-01,2021-06-01,https://clinicaltrials.gov/show/NCT04327388,No Results,No Results,No Results,2020-04-20,2020-04-07,None
847,NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,False,"Luiz F. L. Reis, Ph.D.",Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Drug,Dexamethasone,290,2020-08-30,2020-08-30,https://clinicaltrials.gov/show/NCT04327401,No Results,No Results,No Results,2020-04-20,2020-04-07,None
848,NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-01,False,University of Oxford,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),ATMP,Vaccine,510,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04324606,No Results,No Results,No Results,2020-04-20,2020-04-01,None
849,NCT04324684,ClinicalTrials.gov,2020-03-25,2020-03-31,False,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,Prognostic Factors Keeping Track for Covid-19 Pneumonia,Prognosis,No Intervention,198,2020-05-05,2020-05-30,https://clinicaltrials.gov/show/NCT04324684,No Results,No Results,No Results,2020-04-20,2020-04-15,None
850,NCT04325048,ClinicalTrials.gov,2020-03-25,2020-04-01,False,Cordio Medical,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Other (software),eHealth,5000,2021-06-01,2021-09-01,https://clinicaltrials.gov/show/NCT04325048,No Results,No Results,No Results,2020-04-20,2020-04-22,None
851,NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Drug,Naproxen,584,2021-05-13,2021-07-13,https://clinicaltrials.gov/show/NCT04325633,No Results,No Results,No Results,2020-04-20,2020-04-01,None
852,NCT04326725,ClinicalTrials.gov,2020-03-26,2020-03-20,True,Istinye University,Recruiting,Not Applicable,Observational,Turkey,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,Drug (Chemoprophylaxis),Combination: Hydroxychloroquine + Zinc + Vitamin C,80,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04326725,No Results,No Results,No Results,2020-04-20,2020-04-07,None
853,NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,False,Murdoch Childrens Research Institute,Recruiting,Phase 3,Interventional,Australia,BCG Vaccination to Protect Healthcare Workers Against COVID-19,ATMP,Vaccine,4170,2020-10-30,2022-03-30,https://clinicaltrials.gov/show/NCT04327206,No Results,No Results,No Results,2020-04-20,2020-04-07,None
854,NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,False,"University Hospital, Angers",Recruiting,Phase 3,Interventional,"France, Monaco",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,Drug,Hydroxychloroquine,1300,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04325893,No Results,No Results,No Results,2020-04-20,2020-04-07,None
855,NCT04327804,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Dr. Deneen Vojta,Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Diagnostics,Diagnostic Test or Assessment,120,2020-04-03,2020-04-10,https://clinicaltrials.gov/show/NCT04327804,No Results,No Results,No Results,2020-04-20,2020-04-22,None
856,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,False,CHU de Saint Etienne,Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,1200,2020-11-30,2020-11-30,https://clinicaltrials.gov/show/NCT04328285,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001188-96
857,NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,False,University of Minnesota,Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,3500,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04328467,No Results,No Results,No Results,2020-04-20,2020-04-07,None
858,NCT04326387,ClinicalTrials.gov,2020-03-26,2020-04-06,False,Cambridge Clinical Trials Unit (CCTU),Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Novel Diagnostic Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,200,2021-04-07,2021-10-07,https://clinicaltrials.gov/show/NCT04326387,No Results,No Results,No Results,2020-04-20,2020-04-07,None
859,NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Institut Pasteur,Recruiting,Not Applicable,Interventional,French Guiana,Household Transmission Investigation Study for COVID-19 in French Guiana,Clinical Presentation (Epidemiology),No Intervention,450,2022-03-23,2022-03-23,https://clinicaltrials.gov/show/NCT04328129,No Results,No Results,No Results,2020-04-20,2020-04-07,None
860,NCT04327479,ClinicalTrials.gov,2020-03-26,2020-03-26,False,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Clinical Presentation,No Intervention,630,2026-03-25,2026-03-25,https://clinicaltrials.gov/show/NCT04327479,No Results,No Results,No Results,2020-04-20,2020-04-07,None
861,NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Bassett Healthcare,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. ARB (Losartan),4000,2021-01-01,2021-04-01,https://clinicaltrials.gov/show/NCT04328012,No Results,No Results,No Results,2020-04-20,2020-04-07,None
862,NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Drug,Combination: Hydroxychloroquine + Azithromycin,400,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04329572,No Results,No Results,No Results,2020-04-20,2020-04-07,None
863,NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,False,Judit Pich Martnez,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug,Siltuximab vs. Corticosteroids,200,2020-05-20,2020-05-20,https://clinicaltrials.gov/show/NCT04329650,No Results,No Results,No Results,2020-04-20,2020-04-07,None
864,NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-01,False,University of Arizona,Not Recruiting,Not Applicable,Interventional,No Country Given,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Other (psych),Psychological,150,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04329533,No Results,No Results,No Results,2020-04-20,2020-04-07,None
865,NCT04330300,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"National University of Ireland, Galway",Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,Drug,ACE inhibitors or ARBs vs. Calcium Channel Blockers or Thiazide/Thiazide-like diuretics,2414,2021-01-31,2021-03-01,https://clinicaltrials.gov/show/NCT04330300,No Results,No Results,No Results,2020-04-20,2020-04-07,None
866,NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"Intermountain Health Care, Inc.",Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug,Hydroxychloroquine vs. Azithromycin,300,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04329832,No Results,No Results,No Results,2020-04-20,2020-04-07,None
867,NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Assistance Publique  Hpitaux de Paris,Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug,Budesonide/formoterol,436,2020-07-13,2020-07-13,https://clinicaltrials.gov/show/NCT04331054,No Results,No Results,No Results,2020-04-20,2020-04-07,None
868,NCT04329546,ClinicalTrials.gov,2020-03-29,2020-03-27,True,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,Switzerland,Understanding COVID-19,Clinical Presentation,No Intervention,250,2022-01-31,2022-03-31,https://clinicaltrials.gov/show/NCT04329546,No Results,No Results,No Results,2020-04-20,2020-04-07,None
869,NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Dr. Michael Hill,Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Drug,Hydroxychloroquine,1660,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04329611,No Results,No Results,No Results,2020-04-20,2020-04-07,None
870,NCT04331106,ClinicalTrials.gov,2020-03-27,2020-03-27,False,Charit University,Recruiting,Not Applicable,Observational,Germany,Survey of the Anxiety Associated With the COVID-19 Pandemic,Other (psych),No Intervention,6000,2020-09-01,2021-09-01,https://clinicaltrials.gov/show/NCT04331106,No Results,No Results,No Results,2020-04-20,2020-04-15,None
871,NCT04331171,ClinicalTrials.gov,2020-03-30,2020-03-17,True,Weprom,Recruiting,Not Applicable,Observational,France,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Other (device),Other,3000000,2020-03-31,2020-07-31,https://clinicaltrials.gov/show/NCT04331171,No Results,No Results,No Results,2020-04-20,2020-04-07,None
872,NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,False,"Ravi Amaravadi, MD",Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Drug,Hydroxychloroquine,400,2021-04-01,2021-12-01,https://clinicaltrials.gov/show/NCT04329923,No Results,No Results,No Results,2020-04-20,2020-04-07,None
873,NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,False,Fasa University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug,Combination: Levamisole + budesonide/formoterol + lopinavir/ritonavir + hydroxychloroquine,30,2020-04-20,2020-05-20,https://clinicaltrials.gov/show/NCT04331470,No Results,No Results,No Results,2020-04-20,2020-04-07,None
874,NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,False,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,800,2020-11-06,2020-11-06,https://clinicaltrials.gov/show/NCT04330495,No Results,No Results,No Results,2020-04-20,2020-04-07,None
875,NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"University Hospital, Ghent",Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Drug,Combination: Anakinta + Siltuximab vs. Tocilizumab + Anakinra vs. Tocilizumab vs. Siltuximab vs. Anakinra,342,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04330638,No Results,No Results,No Results,2020-04-20,2020-04-07,None
876,NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Emory University,Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Other (device),Bidirectional Oxygenation Valve,5,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04331366,No Results,No Results,No Results,2020-04-20,2020-04-07,None
877,NCT04331509,ClinicalTrials.gov,2020-03-31,2020-03-23,True,King's College London,Recruiting,Not Applicable,Observational,"United States, United Kingdom",COVID-19 Symptom Tracker,Clinical Presentation,No Intervention,10000000,2022-03-23,2022-03-23,https://clinicaltrials.gov/show/NCT04331509,No Results,No Results,No Results,2020-04-20,2020-04-07,None
878,NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,440,2020-10-03,2020-10-30,https://clinicaltrials.gov/show/NCT04331834,No Results,No Results,No Results,2020-04-20,2020-04-07,None
879,NCT04331665,ClinicalTrials.gov,2020-04-01,2020-04-20,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug,Ruxolitinib,64,2020-10-30,2021-01-31,https://clinicaltrials.gov/show/NCT04331665,No Results,No Results,No Results,2020-04-20,2020-04-07,None
880,NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,False,University of Chicago,Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug,Tocilizumab,50,2020-07-01,2020-12-01,https://clinicaltrials.gov/show/NCT04331795,No Results,No Results,No Results,2020-04-20,2020-04-07,None
881,NCT04332107,ClinicalTrials.gov,2020-03-30,2020-04-01,False,"University of California, San Francisco",Not Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug,Azithromycin,2271,2020-08-30,2021-08-30,https://clinicaltrials.gov/show/NCT04332107,No Results,No Results,No Results,2020-04-20,2020-04-07,None
882,NCT04333420,ClinicalTrials.gov,2020-04-01,2020-03-31,True,InflaRx GmbH,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,"Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug,IFX-1,130,2020-10-31,2020-12-31,https://clinicaltrials.gov/show/NCT04333420,No Results,No Results,No Results,2020-04-20,2020-04-07,None
883,NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-31,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug,Tocilizumab,240,2021-03-31,2021-12-31,https://clinicaltrials.gov/show/NCT04331808,No Results,No Results,No Results,2020-04-20,2020-04-07,None
884,NCT04332913,ClinicalTrials.gov,2020-03-26,2020-04-01,False,University of L'Aquila,Recruiting,Not Applicable,Observational,Italy,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,Drug,Tocilizumab,30,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04332913,No Results,No Results,No Results,2020-04-20,2020-04-07,None
885,NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Fundaci Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Recruiting,Phase 2,Interventional,Spain,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",Drug,Combination: Hydroxychloroquine + Azithromycin + Tocilizumab,276,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04332094,No Results,No Results,No Results,2020-04-20,2020-04-07,None
886,NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Imperial College London,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug,Combination: Aspirin + clopidogrel + rivaroxaban + atorvastatin + omeprazole,3170,2021-03-30,2021-03-30,https://clinicaltrials.gov/show/NCT04333407,No Results,No Results,No Results,2020-04-20,2020-04-07,None
887,NCT04331886,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"Target PharmaSolutions, Inc.",Not Recruiting,Not Applicable,Observational,United States,An Observational Study of Patients With Coronavirus Disease 2019,Clinical Presentation,No Intervention,5000,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04331886,No Results,No Results,No Results,2020-04-20,2020-04-07,None
888,NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,False,NYU Langone Health,Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,Drug,Oxygen,40,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04332081,No Results,No Results,No Results,2020-04-20,2020-04-07,None
889,NCT04333732,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Washington University in St. Louis,Not Recruiting,Phase 3,Interventional,"Ireland, Zambia, Australia, Canada, United States, United Kingdom, South Africa",CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Drug (Chemoprophylaxis),Chloroquine/hydroxychloroquine,55000,2021-02-01,2021-02-01,https://clinicaltrials.gov/show/NCT04333732,No Results,No Results,No Results,2020-04-20,2020-04-07,None
890,NCT04333849,ClinicalTrials.gov,2020-04-01,2020-03-27,True,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Other,Other,100,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04333849,No Results,No Results,No Results,2020-04-20,2020-04-07,None
891,NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Not Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug,Favipiravir,210,2020-06-01,2020-09-15,https://clinicaltrials.gov/show/NCT04333589,No Results,No Results,No Results,2020-04-20,2020-04-07,None
892,NCT04333654,ClinicalTrials.gov,2020-04-01,2020-03-31,True,Sanofi,Recruiting,Phase 1,Interventional,"France, United States",Hydroxychloroquine in Outpatient Adults With COVID-19,Drug,Hydroxychloroquine,210,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04333654,No Results,No Results,No Results,2020-04-20,2020-04-07,None
893,NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Massachusetts General Hospital,Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug,Hydroxychloroquine,510,2021-04-01,2021-07-01,https://clinicaltrials.gov/show/NCT04332991,No Results,No Results,No Results,2020-04-20,2020-04-07,None
894,NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Baylor Research Institute,Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,360,2020-07-30,2020-07-30,https://clinicaltrials.gov/show/NCT04333225,No Results,No Results,No Results,2020-04-20,2020-04-07,None
895,NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Duke University,Not Recruiting,Phase 3,Interventional,No Country Given,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,15000,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04334148,No Results,No Results,No Results,2020-04-20,2020-04-15,None
896,NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-01,False,Blade Therapeutics,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug,BLD-2660,120,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04334460,No Results,No Results,No Results,2020-04-20,2020-04-15,None
897,NCT04334252,ClinicalTrials.gov,2020-04-02,2020-04-17,False,Jessa Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,Diagnostics,Diagnostic Test or Assessment,5000,2022-12-20,2023-12-20,https://clinicaltrials.gov/show/NCT04334252,No Results,No Results,No Results,2020-04-20,2020-04-15,None
898,NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Traditional Medicine (Drug),Traditional Medicine,750,2020-06-01,2020-12-01,https://clinicaltrials.gov/show/NCT04334265,No Results,No Results,No Results,2020-04-20,2020-04-15,None
899,NCT04333628,ClinicalTrials.gov,2020-04-01,2020-04-01,False,"HaEmek Medical Center, Israel",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Drug,Chloroquine,210,2021-04-01,2021-12-01,https://clinicaltrials.gov/show/NCT04333628,No Results,No Results,No Results,2020-04-20,2020-04-07,None
900,NCT04333953,ClinicalTrials.gov,2020-03-31,2020-04-01,False,University of Missouri-Columbia,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With HIV,Clinical Presentation,No Intervention,500,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04333953,No Results,No Results,No Results,2020-04-20,2020-04-07,None
901,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Centre Leon Berard,Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,273,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04333914,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001373-70
902,NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,False,Universidad de Granada,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,Drug,Vitamin D,200,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04334005,No Results,No Results,No Results,2020-04-20,2020-04-07,None
903,NCT04334291,ClinicalTrials.gov,2020-04-01,2020-03-23,True,Ivn J. Nez Gil,Recruiting,Not Applicable,Observational,Spain,"International COVID19 Clinical Evaluation Registry,",Clinical Presentation,No Intervention,2500,2020-05-01,2020-05-05,https://clinicaltrials.gov/show/NCT04334291,No Results,No Results,No Results,2020-04-20,2020-04-15,None
904,NCT04335162,ClinicalTrials.gov,2020-04-03,2020-02-28,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Cardiovascular Complications and COVID-19 (CovCardioVasc),Clinical Presentation,No Intervention,100,2020-08-28,2020-08-28,https://clinicaltrials.gov/show/NCT04335162,No Results,No Results,No Results,2020-04-20,2020-04-15,None
905,NCT04334044,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Grupo Cooperativo Hemopatas Malignas,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug,Ruxolitinib,20,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04334044,No Results,No Results,No Results,2020-04-20,2020-04-07,None
906,NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Intermountain Health Care, Inc.",Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug,Hydroxychloroquine vs. azithromycin,1550,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04334382,No Results,No Results,No Results,2020-04-20,2020-04-15,None
907,NCT04334512,ClinicalTrials.gov,2020-04-02,2020-04-01,True,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug,Combination: Hydroxychloroquine + azithromycin + vitamin C + vitamin D + zinc,600,2021-04-01,2021-07-01,https://clinicaltrials.gov/show/NCT04334512,No Results,No Results,No Results,2020-04-20,2020-04-15,None
908,NCT04334980,ClinicalTrials.gov,2020-03-31,2020-04-30,False,Symvivo Corporation,Not Recruiting,Phase 1,Interventional,Canada,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",ATMP,Vaccine,84,2021-08-31,2021-12-31,https://clinicaltrials.gov/show/NCT04334980,No Results,No Results,No Results,2020-04-20,2020-04-15,None
909,NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Plan Nacional sobre el Sida (PNS),Not Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug,Combination: Emtricitabine/tenofovir disoproxil + hydroxychloroquine vs. hydroxychloroquine vs. Emtricitabine/tenofovir disoproxil,4000,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04334928,No Results,No Results,No Results,2020-04-20,2020-04-15,None
910,NCT04335123,ClinicalTrials.gov,2020-03-31,2020-03-25,True,University of Kansas Medical Center,Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,Drug,ARB (Losartan),50,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04335123,No Results,No Results,No Results,2020-04-20,2020-04-15,None
911,NCT04335188,ClinicalTrials.gov,2020-03-31,2020-04-06,False,IHF GmbH - Institut for Herzinfarktforschung,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Rhineland-Palatinate (Germany),Clinical Presentation,No Intervention,4000,2021-07-31,2021-09-30,https://clinicaltrials.gov/show/NCT04335188,No Results,No Results,No Results,2020-04-20,2020-04-15,None
912,NCT04335305,ClinicalTrials.gov,2020-03-31,2020-04-14,False,MedSIR,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,Drug,Combination: Tocilizumab + Pembrolizumab,24,2020-05-15,2020-05-15,https://clinicaltrials.gov/show/NCT04335305,No Results,No Results,No Results,2020-04-20,2020-04-15,None
913,NCT04335032,ClinicalTrials.gov,2020-04-01,2020-04-13,False,S.L.A. Pharma AG,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug,Eicosapentaenoic acid,240,2020-07-13,2020-07-31,https://clinicaltrials.gov/show/NCT04335032,No Results,No Results,No Results,2020-04-20,2020-04-15,None
914,NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-01,True,University Hospital of Bern,Not Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Drug,Tocilizumab,100,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04335071,No Results,No Results,No Results,2020-04-20,2020-04-15,None
915,NCT04335630,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Memorial Hermann Health System,Recruiting,Not Applicable,Observational,United States,Cardiovascular Manifestations of COVID-19,Clinical Presentation,No Intervention,500,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04335630,No Results,No Results,No Results,2020-04-20,2020-04-15,None
916,NCT04335773,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Akershus",Recruiting,Not Applicable,Observational,Norway,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Clinical Presentation,No Intervention,350,2030-12-31,2030-12-31,https://clinicaltrials.gov/show/NCT04335773,No Results,No Results,No Results,2020-04-20,2020-04-15,None
917,NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,False,Biruni University,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,Other (exercise),Exercise,30,2020-05-13,2020-06-30,https://clinicaltrials.gov/show/NCT04335851,No Results,No Results,No Results,2020-04-20,2020-04-15,None
918,NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,True,Shanghai Asclepius Meditec Inc.,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Drug,Combination: Hydrogen + Oxygen vs Oxygen,100,2020-02-21,2020-08-01,https://clinicaltrials.gov/show/NCT04336462,No Results,No Results,No Results,2020-04-20,2020-04-15,None
919,NCT04335747,ClinicalTrials.gov,2020-04-03,2020-04-08,False,Salome Kristensen,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Clinical Presentation,No Intervention,333,2021-08-01,2021-09-01,https://clinicaltrials.gov/show/NCT04335747,No Results,No Results,No Results,2020-04-20,2020-04-15,None
920,NCT04336254,ClinicalTrials.gov,2020-03-28,2020-04-06,False,Renmin Hospital of Wuhan University,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,ATMP,Cells (mesenchymal),20,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04336254,No Results,No Results,No Results,2020-04-20,2020-04-15,None
921,NCT04334434,ClinicalTrials.gov,2020-04-02,2020-04-20,False,Kubra Koce,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Telehealth,Rehabilitation,30,2020-06-01,2020-07-31,https://clinicaltrials.gov/show/NCT04334434,No Results,No Results,No Results,2020-04-20,2020-04-15,None
922,NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-07,False,Lars Wik,Not Recruiting,Not Applicable,Interventional,No Country Given,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Other (device),Biosensors,214,2021-04-08,2025-12-20,https://clinicaltrials.gov/show/NCT04335097,No Results,No Results,No Results,2020-04-20,2020-04-15,None
923,NCT04336215,ClinicalTrials.gov,2020-04-02,2020-04-07,False,Rutgers University,Recruiting,Not Applicable,Observational,United States,Rutgers COVID-19 Cohort Study,Clinical Presentation,No Intervention,750,2020-09-01,2021-10-21,https://clinicaltrials.gov/show/NCT04336215,Pre-Print Article,2020-04-24,https://doi.org/10.1101/2020.04.20.20072470,2020-04-20,2020-04-15,None
924,NCT04336774,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Duke University,Not Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,Other (software),Other,500,2020-11-01,2020-11-09,https://clinicaltrials.gov/show/NCT04336774,No Results,No Results,No Results,2020-04-20,2020-04-15,None
925,NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Drug,Combination: Hydroxychloroquine + azithromycin vs. hydroxychloroquine,160,2021-04-30,2021-04-30,https://clinicaltrials.gov/show/NCT04336332,No Results,No Results,No Results,2020-04-20,2020-04-15,None
926,NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Renin Angiotesnin System - CoronaVirus,Clinical Presentation,No Intervention,50,2020-06-03,2020-07-31,https://clinicaltrials.gov/show/NCT04337008,No Results,No Results,No Results,2020-04-20,2020-04-15,None
927,NCT04336657,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,Clinical Presentation (Epidemiology),No Intervention,100,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04336657,No Results,No Results,No Results,2020-04-20,2020-04-15,None
928,NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,True,Giuliano Rizzardini,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug,Favipiravir,100,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04336904,No Results,No Results,No Results,2020-04-20,2020-04-15,None
929,NCT04336956,ClinicalTrials.gov,2020-03-30,2020-04-07,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Covid-19 Pediatric Observatory,Clinical Presentation,No Intervention,250,2021-06-30,2021-06-30,https://clinicaltrials.gov/show/NCT04336956,No Results,No Results,No Results,2020-04-20,2020-04-15,None
930,NCT04337216,ClinicalTrials.gov,2020-04-01,2020-05-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,10,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04337216,No Results,No Results,No Results,2020-04-20,2020-04-15,None
931,NCT04337151,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Royal National Orthopaedic Hospital NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Other,No Intervention,100,2021-01-01,2021-03-01,https://clinicaltrials.gov/show/NCT04337151,No Results,No Results,No Results,2020-04-20,2020-04-15,None
932,NCT04337190,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Drug,ARBs,100,2020-10-06,2020-12-06,https://clinicaltrials.gov/show/NCT04337190,No Results,No Results,No Results,2020-04-20,2020-04-15,None
933,NCT04337047,ClinicalTrials.gov,2020-04-03,2020-03-31,True,Wefight,Recruiting,Not Applicable,Observational,France,Assessment of Distress in Crisis Situations During COVID-19,Other (psych),No Intervention,2000,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04337047,No Results,No Results,No Results,2020-04-20,2020-04-15,None
934,NCT04337502,ClinicalTrials.gov,2020-04-06,2019-12-23,True,Maastricht University,Not Recruiting,Not Applicable,Observational,China,Clinical and Radiomic Model of COVID-19,Other (software),Other,300,2020-01-20,2020-03-03,https://clinicaltrials.gov/show/NCT04337502,No Results,No Results,No Results,2020-04-20,2020-04-15,None
935,NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Apeiron Biologics,Not Recruiting,Phase 2,Interventional,"Austria, Denmark, Germany",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,200,2020-09-01,2020-11-01,https://clinicaltrials.gov/show/NCT04335136,No Results,No Results,No Results,2020-04-20,2020-04-15,None
936,NCT04336345,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Not Recruiting,Not Applicable,Observational,Mexico,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Clinical Presentation,No Intervention,150,2020-04-30,2020-05-30,https://clinicaltrials.gov/show/NCT04336345,No Results,No Results,No Results,2020-04-20,2020-04-15,None
937,NCT04337359,ClinicalTrials.gov,2020-04-03,2020-04-05,False,Novartis Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,Drug,Ruxolitinib,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04337359,No Results,No Results,No Results,2020-04-20,2020-04-15,None
938,NCT04337996,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostics,Diagnostic Test or Assessment,176,2020-07-01,2020-10-01,https://clinicaltrials.gov/show/NCT04337996,No Results,No Results,No Results,2020-04-20,2020-04-15,None
939,NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other (device),Masks,6000,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04337541,No Results,No Results,No Results,2020-04-20,2020-04-15,None
940,NCT04337762,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Beat COVID LLC,Recruiting,Not Applicable,Observational,United States,Beat COVID-19 - Observational Trial,Clinical Presentation,No Intervention,100000,2020-12-01,2021-07-01,https://clinicaltrials.gov/show/NCT04337762,No Results,No Results,No Results,2020-04-20,2020-04-15,None
941,NCT04336384,ClinicalTrials.gov,2020-03-30,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Impact of Covid-19 in Congenital Heart Disease,Clinical Presentation,No Intervention,5000,2020-12-01,2020-12-30,https://clinicaltrials.gov/show/NCT04336384,No Results,No Results,No Results,2020-04-20,2020-04-15,None
942,NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Inovio Pharmaceuticals,Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug,INO-4800,40,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04336410,No Results,No Results,No Results,2020-04-20,2020-04-15,None
943,NCT04338074,ClinicalTrials.gov,2020-04-06,2020-04-15,False,University of Alabama at Birmingham,Not Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,Drug,Tranexamic acid,100,2020-10-15,2020-10-30,https://clinicaltrials.gov/show/NCT04338074,No Results,No Results,No Results,2020-04-20,2020-04-15,None
944,NCT04338100,ClinicalTrials.gov,2020-03-31,2020-04-06,False,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,No Country Given,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Prognosis,No Intervention,300,2020-12-29,2021-01-29,https://clinicaltrials.gov/show/NCT04338100,No Results,No Results,No Results,2020-04-20,2020-04-15,None
945,NCT04337983,ClinicalTrials.gov,2020-03-30,2020-04-15,False,Bicetre Hospital,Not Recruiting,Not Applicable,Observational,France,Hemodynamic Characteristics of Patients With SARS-CoV-2,Clinical Presentation,No Intervention,200,2020-10-01,2021-04-01,https://clinicaltrials.gov/show/NCT04337983,No Results,No Results,No Results,2020-04-20,2020-04-15,None
946,NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-01,True,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug,Nitric oxide,260,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04338828,No Results,No Results,No Results,2020-04-20,2020-04-15,None
947,NCT04336761,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Clinical Presentation (Epidemiology),No Intervention,914,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04336761,No Results,No Results,No Results,2020-04-20,2020-04-15,None
948,NCT04336787,ClinicalTrials.gov,2020-04-03,2020-04-12,False,Istanbul Koltor University,Not Recruiting,Not Applicable,Observational,Turkey,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",Other (psych),No Intervention,100,2020-05-10,2020-06-10,https://clinicaltrials.gov/show/NCT04336787,No Results,No Results,No Results,2020-04-20,2020-04-15,None
949,NCT04338347,ClinicalTrials.gov,2020-03-31,2019-01-10,True,Capricor Inc.,Not Recruiting,Not Applicable,Expanded Access,United States,CAP-1002 in Severe COVID-19 Disease,ATMP,Cells (allogeneic cardiosphere-derived),Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04338347,No Results,No Results,No Results,2020-04-20,2020-04-15,None
950,NCT04338672,ClinicalTrials.gov,2020-04-04,2020-04-05,False,Sheba Medical Center,Not Recruiting,Not Applicable,Observational,Israel,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,Health system,No Intervention,1000000,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04338672,No Results,No Results,No Results,2020-04-20,2020-04-15,None
951,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug,Anakinra or Tocilizumab,20,2022-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04339712,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001039-29
952,NCT04340349,ClinicalTrials.gov,2020-04-02,2020-04-10,False,Instituto Nacional de Rehabilitacion,Not Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,Drug (Chemoprophylaxis),Combination: Hydroxychloroquine + bromhexine vs. bromhexine,100,2020-06-09,2020-07-10,https://clinicaltrials.gov/show/NCT04340349,No Results,No Results,No Results,2020-04-20,2020-04-15,None
953,NCT04338932,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Jessa Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Deep Venous Thrombosis,Clinical Presentation,No Intervention,12,2020-09-30,2020-12-30,https://clinicaltrials.gov/show/NCT04338932,No Results,No Results,No Results,2020-04-20,2020-04-15,None
954,NCT04338945,ClinicalTrials.gov,2020-04-07,2020-03-15,True,Ospedale Policlinico San Martino,Recruiting,Not Applicable,Observational,Italy,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,Other,No Intervention,1200,2020-04-15,2020-05-01,https://clinicaltrials.gov/show/NCT04338945,No Results,No Results,No Results,2020-04-20,2020-04-15,None
955,NCT04338958,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Andreas Hochhaus,Not Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug,Ruxolitinib,200,2021-01-31,2021-08-31,https://clinicaltrials.gov/show/NCT04338958,No Results,No Results,No Results,2020-04-20,2020-04-15,None
956,NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-07,False,Shehnoor Azhar,Not Recruiting,Phase 3,Interventional,No Country Given,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug,"Monotherapy and all Combinations of: Hydroxychloroquine, oseltamivir, and azithromycin",500,2020-09-01,2020-11-30,https://clinicaltrials.gov/show/NCT04338698,No Results,No Results,No Results,2020-04-20,2020-04-15,None
957,NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,False,Heinrich-Heine University,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,Drug,Combination: Camostat Mesilate + hydroxychloroquine vs. hydroxychloroquine,334,2021-06-01,2021-12-31,https://clinicaltrials.gov/show/NCT04338906,No Results,No Results,No Results,2020-04-20,2020-04-15,None
958,NCT04337346,ClinicalTrials.gov,2020-04-05,2020-04-05,False,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Covid 19 Anxiety in Endometriosis Patients,Other (psych),No Intervention,80,2020-04-20,2020-04-25,https://clinicaltrials.gov/show/NCT04337346,No Results,No Results,No Results,2020-04-20,2020-04-15,None
959,NCT04337489,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Imperial College London,Not Recruiting,Not Applicable,Observational,No Country Given,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Other (device),Wearable,200,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04337489,No Results,No Results,No Results,2020-04-20,2020-04-15,None
960,NCT04337788,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University Hospital, Limoges",Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Telehealth,Telehealth,200,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04337788,No Results,No Results,No Results,2020-04-20,2020-04-15,None
961,NCT04341012,ClinicalTrials.gov,2020-04-07,2019-09-10,True,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Diagnostics,Diagnostic Test or Assessment,120,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04341012,No Results,No Results,No Results,2020-04-20,2020-04-15,None
962,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug,Combination: Tacrolimus + Corticosteroids,84,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04341038,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001445-39
963,NCT04337918,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Sanotize Research and Development corp.,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug,Nitric oxide,200,2020-07-31,2020-09-30,https://clinicaltrials.gov/show/NCT04337918,No Results,No Results,No Results,2020-04-20,2020-04-15,None
964,NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,True,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,No Country Given,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Drug,ACE inhibitors or ARBs,152,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04338009,No Results,No Results,No Results,2020-04-20,2020-04-15,None
965,NCT04339387,ClinicalTrials.gov,2020-04-06,2020-03-01,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,COVID-19 Risk Stratification,Prognosis,No Intervention,1500,2020-04-15,2020-04-15,https://clinicaltrials.gov/show/NCT04339387,No Results,No Results,No Results,2020-04-20,2020-04-15,None
966,NCT04339608,ClinicalTrials.gov,2020-04-07,2020-04-02,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Max COVID19- Study,Clinical Presentation,No Intervention,10000,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04339608,No Results,No Results,No Results,2020-04-20,2020-04-15,None
967,NCT04339322,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,Clinical Presentation,No Intervention,200,2020-07-30,2020-07-30,https://clinicaltrials.gov/show/NCT04339322,No Results,No Results,No Results,2020-04-20,2020-04-15,None
968,NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,True,Puren Hospital Affiliated to Wuhan University of Science and Technology,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),30,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04339660,No Results,No Results,No Results,2020-04-20,2020-04-15,None
969,NCT04338360,ClinicalTrials.gov,2020-04-03,2019-01-10,True,Mayo Clinic,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04338360,No Results,No Results,No Results,2020-04-20,2020-04-15,None
970,NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-13,False,Hasselt University,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostics,Diagnostic Test or Assessment,50,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04338568,No Results,No Results,No Results,2020-04-20,2020-04-15,None
971,NCT04339634,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,Clinical Presentation,No Intervention,12123,2020-07-07,2021-04-06,https://clinicaltrials.gov/show/NCT04339634,No Results,No Results,No Results,2020-04-20,2020-04-15,None
972,NCT04339816,ClinicalTrials.gov,2020-04-06,2020-04-20,False,Frantisek Duska,Not Recruiting,Phase 3,Interventional,No Country Given,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,Drug,Combination: Hydroxychloroquine + azithromycin vs. hydroxychloroquine,240,2021-12-31,2022-06-30,https://clinicaltrials.gov/show/NCT04339816,No Results,No Results,No Results,2020-04-20,2020-04-15,None
973,NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Henry Ford Health System,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,Drug,Hydroxychloroquine,3000,2020-06-30,2021-04-30,https://clinicaltrials.gov/show/NCT04341441,No Results,No Results,No Results,2020-04-20,2020-04-15,None
974,NCT04341480,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Tongji Hospital,Not Recruiting,Not Applicable,Observational,China,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,Clinical Presentation,No Intervention,207,2020-07-10,2020-07-10,https://clinicaltrials.gov/show/NCT04341480,No Results,No Results,No Results,2020-04-20,2020-04-22,None
975,NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Huilan Zhang,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug,Nintedanib,96,2020-05-04,2020-08-01,https://clinicaltrials.gov/show/NCT04338802,No Results,No Results,No Results,2020-04-20,2020-04-15,None
976,NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-01,True,HonorHealth Research Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug,Combination: Atovaquone + azithromycin,25,2020-10-01,2021-04-01,https://clinicaltrials.gov/show/NCT04339426,No Results,No Results,No Results,2020-04-20,2020-04-15,None
977,NCT04340219,ClinicalTrials.gov,2020-03-31,2020-03-30,True,"University Hospital, Ghent",Recruiting,Not Applicable,Observational,Belgium,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",Other (psych),No Intervention,180,2020-04-01,2020-09-01,https://clinicaltrials.gov/show/NCT04340219,No Results,No Results,No Results,2020-04-20,2020-04-15,None
978,NCT04340544,ClinicalTrials.gov,2020-04-03,2020-04-10,False,Universittsklinikum Tbingen,Not Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,Drug,Hydroxychloroquine,2700,2021-11-30,2022-09-30,https://clinicaltrials.gov/show/NCT04340544,No Results,No Results,No Results,2020-04-20,2020-04-15,None
979,NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,False,University of Chicago,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,ATMP,Plasma,10,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04340050,No Results,No Results,No Results,2020-04-20,2020-04-15,None
980,NCT04340466,ClinicalTrials.gov,2020-04-07,2020-04-03,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Clinical Presentation,No Intervention,220,2020-06-30,2021-04-30,https://clinicaltrials.gov/show/NCT04340466,No Results,No Results,No Results,2020-04-20,2020-04-15,None
981,NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-15,False,University of Cincinnati,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug,Sirolimus,30,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04341675,No Results,No Results,No Results,2020-04-20,2020-04-15,None
982,NCT04341688,ClinicalTrials.gov,2020-04-06,2020-07-01,False,Aga Khan University,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug,Mouthwash,40,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04341688,No Results,No Results,No Results,2020-04-20,2020-04-15,None
983,NCT04339790,ClinicalTrials.gov,2020-04-08,2020-04-20,False,National Institute of Mental Health (NIMH),Recruiting,Not Applicable,Observational,United States,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Other (psych),No Intervention,5000,2022-03-01,2022-04-01,https://clinicaltrials.gov/show/NCT04339790,No Results,No Results,No Results,2020-04-20,2020-04-15,None
984,NCT04339998,ClinicalTrials.gov,2020-04-06,2020-04-15,False,University of Minnesota,Not Recruiting,Not Applicable,Observational,United States,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Diagnostics,Diagnostic Test or Assessment,500,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04339998,No Results,No Results,No Results,2020-04-20,2020-04-15,None
985,NCT04340479,ClinicalTrials.gov,2020-04-06,2020-05-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Diagnostics,Diagnostic Test or Assessment,20,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04340479,No Results,No Results,No Results,2020-04-20,2020-04-15,None
986,NCT04340921,ClinicalTrials.gov,2020-04-03,2020-04-10,False,Barts & The London NHS Trust,Not Recruiting,Not Applicable,Observational,No Country Given,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Clinical Presentation,No Intervention,140,2020-04-10,2020-06-10,https://clinicaltrials.gov/show/NCT04340921,No Results,No Results,No Results,2020-04-20,2020-04-15,None
987,NCT04341103,ClinicalTrials.gov,2020-03-16,2020-04-01,False,CareDx,Not Recruiting,Not Applicable,Observational,No Country Given,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Clinical Presentation,No Intervention,500,2020-12-01,2021-03-01,https://clinicaltrials.gov/show/NCT04341103,No Results,No Results,No Results,2020-04-20,2020-04-15,None
988,NCT04341168,ClinicalTrials.gov,2020-04-03,2020-04-01,True,University Hospital of Cologne,Not Recruiting,Not Applicable,Observational,Germany,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Clinical Presentation,No Intervention,160,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04341168,No Results,No Results,No Results,2020-04-20,2020-04-15,None
989,NCT04340232,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,Drug,Baricitinib,80,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04340232,No Results,No Results,No Results,2020-04-20,2020-04-15,None
990,NCT04340414,ClinicalTrials.gov,2020-03-03,2020-03-03,False,Peking Union Medical College Hospital,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Drug,Oxygen,10,2020-08-15,2020-10-15,https://clinicaltrials.gov/show/NCT04340414,No Results,No Results,No Results,2020-04-20,2020-04-15,None
991,NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,False,Assistance Publique  Hpitaux de Paris,Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Drug,Combination: Sarilumab + Azithromycin + Hydroxychloroquine vs Sarilumab,60,2020-05-01,2020-07-01,https://clinicaltrials.gov/show/NCT04341870,No Results,No Results,No Results,2020-04-20,2020-04-15,None
992,NCT04342104,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Hospital General Universitario Morales Meseguer,Recruiting,Not Applicable,Observational,Spain,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Clinical Presentation,No Intervention,100,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342104,No Results,No Results,No Results,2020-04-20,2020-04-15,None
993,NCT04341285,ClinicalTrials.gov,2020-03-30,2020-06-01,False,Universittsklinikum Tbingen,Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Drug,Oxygen,200,2024-06-01,2025-12-01,https://clinicaltrials.gov/show/NCT04341285,No Results,No Results,No Results,2020-04-20,2020-04-15,None
994,NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Hugo Mendieta Zeron,Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Drug,Hydroxychloroquine vs. Nitazoxanide,86,2020-08-30,2020-12-30,https://clinicaltrials.gov/show/NCT04341493,No Results,No Results,No Results,2020-04-20,2020-04-15,None
995,NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,False,I-Mab Biopharma Co. Ltd.,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug,TJ003234,144,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04341116,No Results,No Results,No Results,2020-04-20,2020-04-15,None
996,NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,No Country Given,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostics,Diagnostic Test or Assessment,400,2020-09-09,2020-09-09,https://clinicaltrials.gov/show/NCT04341142,No Results,No Results,No Results,2020-04-20,2020-04-15,None
997,NCT04341519,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Other (psych),No Intervention,1464,2020-11-30,2021-12-31,https://clinicaltrials.gov/show/NCT04341519,No Results,No Results,No Results,2020-04-20,2020-04-15,None
998,NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,ATMP,Cells (mesenchymal),40,2021-01-30,2021-04-30,https://clinicaltrials.gov/show/NCT04341610,No Results,No Results,No Results,2020-04-20,2020-04-15,None
999,NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug,Anakinra,240,2020-05-01,2020-12-31,https://clinicaltrials.gov/show/NCT04341584,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1000,NCT04341766,ClinicalTrials.gov,2020-04-01,2020-03-31,True,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Clinical Presentation,No Intervention,200,2020-05-01,2020-09-30,https://clinicaltrials.gov/show/NCT04341766,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1001,NCT04343001,ClinicalTrials.gov,2020-04-08,2020-04-01,True,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Nigeria, Pakistan",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Drug,"Monotherapy and all Combinations of: ARB (Losartan), simvastatin, and aspirin",10000,2021-04-01,2021-08-01,https://clinicaltrials.gov/show/NCT04343001,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1002,NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Ochsner Health System,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Drug,Oxygen,48,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04343183,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1003,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,True,Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,1000,2022-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04341207,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001250-21
1004,NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),ATMP,Vaccine,500,2021-01-31,2021-01-31,https://clinicaltrials.gov/show/NCT04341389,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1005,NCT04341935,ClinicalTrials.gov,2020-04-06,2020-04-30,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,Drug,Linagliptin,20,2020-06-30,2020-09-30,https://clinicaltrials.gov/show/NCT04341935,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1006,NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-14,False,University of Utah,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,Drug,Hydroxychloroquine,400,2022-04-01,2023-04-01,https://clinicaltrials.gov/show/NCT04342169,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1007,NCT04341792,ClinicalTrials.gov,2020-04-07,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Clinical Presentation,No Intervention,1000,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04341792,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1008,NCT04342195,ClinicalTrials.gov,2020-04-08,2020-03-25,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Acquiring Convalescent Specimens for COVID-19 Antibodies,Clinical Presentation,No Intervention,12,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04342195,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1009,NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Procedure,Auricular neuromodulation,60,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04341415,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1010,NCT04341506,ClinicalTrials.gov,2020-04-07,2020-04-15,False,Northwestern Medicine,Not Recruiting,Not Applicable,Observational,No Country Given,Non-contact ECG Sensor System for COVID19,Clinical Presentation,No Intervention,100,2020-07-15,2020-09-15,https://clinicaltrials.gov/show/NCT04341506,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1011,NCT04342208,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,Other,Other,500,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342208,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1012,NCT04342221,ClinicalTrials.gov,2020-04-08,2020-03-29,True,Universittsklinikum Tbingen,Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for COVID-19,Drug,Hydroxychloroquine,220,2021-03-01,2022-02-01,https://clinicaltrials.gov/show/NCT04342221,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1013,NCT04341714,ClinicalTrials.gov,2020-04-08,2020-03-16,True,Pierre and Marie Curie University,Recruiting,Not Applicable,Observational,France,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,400,2020-05-30,2020-06-15,https://clinicaltrials.gov/show/NCT04341714,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1014,NCT04341922,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Karolinska Institutet,Not Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Other (psych),Psychological,670,2021-06-10,2021-06-10,https://clinicaltrials.gov/show/NCT04341922,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1015,NCT04343404,ClinicalTrials.gov,2020-04-08,2020-04-01,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2,Drug,Oxygen,100,2020-04-15,2020-04-15,https://clinicaltrials.gov/show/NCT04343404,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1016,NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug,Leronlimab,75,2020-12-04,2021-04-04,https://clinicaltrials.gov/show/NCT04343651,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1017,NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Tan Tock Seng Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine As COVID-19 Prophylaxis For At-Risk Population (SHARP): A Cluster Randomized Controlled Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,3000,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04342156,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1018,NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Erasmus Medical Center,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ATMP,Plasma,426,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342182,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1019,NCT04342702,ClinicalTrials.gov,2020-04-04,2020-03-16,True,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,A Study on the Prospective Cohort Library of COVID-19 in Southeran,Clinical Presentation,No Intervention,504,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04342702,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1020,NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Drug,Combination: Zinc + Vitamin C vs Zinc vs. Vitamin C,520,2020-09-30,2021-04-30,https://clinicaltrials.gov/show/NCT04342728,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1021,NCT04342637,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Al-Azhar University,Not Recruiting,Not Applicable,Observational,"Iran, United States, Egypt",COVID-19 Endoscopy Survey,Other,Other,40,2020-10-10,2020-12-10,https://clinicaltrials.gov/show/NCT04342637,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1022,NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,False,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug,Chloroquine,210,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04342650,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1023,NCT04342689,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Yale University,Not Recruiting,Not Applicable,Interventional,No Country Given,The Role of Resistant Potato Starch in COVID-19 Infection,Supplement,Resistant Potato Starch,1300,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04342689,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1024,NCT04342806,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Duke University,Recruiting,Not Applicable,Observational,United States,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",Clinical Presentation,No Intervention,100000,2099-12-31,2099-12-31,https://clinicaltrials.gov/show/NCT04342806,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1025,NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug,Nivolumab,92,2020-07-31,2020-09-30,https://clinicaltrials.gov/show/NCT04343144,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1026,NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Saint Francis Care,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,ATMP,Plasma,15,2020-12-01,2021-04-01,https://clinicaltrials.gov/show/NCT04343261,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1027,NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Universittsklinikum Hamburg-Eppendorf,Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Other (device),CytoSorb Adsorber,24,2020-12-01,2021-02-01,https://clinicaltrials.gov/show/NCT04344080,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1028,NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug,"Dexamethasone, Oxygen",550,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04344730,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1029,NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Washington University in St. Louis,Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug,Fluvoxamine,152,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342663,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1030,NCT04342884,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Wake Forest University,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Community Research Partnership,Clinical Presentation,No Intervention,150000,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04342884,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1031,NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-18,False,Eli Lilly and Company,Not Recruiting,Phase 2,Interventional,No Country Given,A Study of LY3127804 in Participants With COVID-19,Drug,LY3127804,200,2020-07-10,2020-07-10,https://clinicaltrials.gov/show/NCT04342897,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1032,NCT04343248,ClinicalTrials.gov,2020-04-08,2020-04-30,False,Romark Laboratories L.C.,Not Recruiting,Phase 3,Interventional,No Country Given,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug (Chemoprophylaxis),Nitazoxanide,600,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04343248,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1033,NCT04343677,ClinicalTrials.gov,2020-04-09,2020-04-01,True,United States Department of Defense,Not Recruiting,Phase 2,Interventional,United States,Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study,Drug (Chemoprophylaxis),Hydroxychloroquine,1450,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04343677,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1034,NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug,Combination: Hydroxychloroquine + lopinavir/ritonavir + interferon beta 1a vs. hydroxychloroquine + lopinavir/ritonavir + interferon beta 1b vs. hydroxychloroquine + lopinavir/ritonavir ,60,2020-04-19,2020-04-19,https://clinicaltrials.gov/show/NCT04343768,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1035,NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-08,False,University of Baghdad,Not Recruiting,Phase 1,Interventional,No Country Given,Ivermectin Adjuvant to Hydroxychloroquin in COVID19 Patients,Drug,Combination: Ivermectin + hydroxychloroquine vs. hydroxychloroquine,50,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04343092,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1036,NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Not Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug,Corticosteroids,420,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04343729,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1037,NCT04344925,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Lawson Health Research Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,Other (device),Mask,50,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04344925,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1038,NCT04344938,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,Other,No Intervention,874,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04344938,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1039,NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug,Chloroquine,60,2021-04-01,2021-04-30,https://clinicaltrials.gov/show/NCT04344951,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1040,NCT04343742,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Genesis Foundation,Recruiting,Not Applicable,Observational,Colombia,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Drug,Chlorine dioxide,20,2020-04-07,2020-06-01,https://clinicaltrials.gov/show/NCT04343742,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1041,NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,ATMP,Plasma,55,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04343755,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1042,NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,False,The University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Using Biovitals Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Other (device),Biosensors,200,2021-12-31,2022-01-31,https://clinicaltrials.gov/show/NCT04343794,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1043,NCT04344002,ClinicalTrials.gov,2020-04-09,2020-05-15,False,Spanish Lung Cancer Group,Not Recruiting,Not Applicable,Observational,Spain,LunG canceR pAtients coVId19 Disease (GRAVID),Clinical Presentation,No Intervention,200,2021-05-15,2022-05-15,https://clinicaltrials.gov/show/NCT04344002,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1044,NCT04343339,ClinicalTrials.gov,2020-04-08,2020-04-08,False,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,Other (psych),No Intervention,100,2020-07-30,2020-09-30,https://clinicaltrials.gov/show/NCT04343339,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1045,NCT04343664,ClinicalTrials.gov,2020-04-09,2020-04-12,False,Tjhin Wiguna,Not Recruiting,Not Applicable,Observational,Indonesia,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Other (psych),No Intervention,10000,2020-06-30,2020-12-31,https://clinicaltrials.gov/show/NCT04343664,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1046,NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug,Pyridostigmine,436,2020-09-30,2021-04-30,https://clinicaltrials.gov/show/NCT04343963,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1047,NCT04343976,ClinicalTrials.gov,2020-04-09,2020-05-01,False,Raymond Chung,Not Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,Drug,Interferon lambda,40,2020-10-01,2021-12-31,https://clinicaltrials.gov/show/NCT04343976,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1048,NCT04345159,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Observational,France,Prevalence of COVID-19 Symptoms History in Patients With Autoimmune Diseases,Clinical Presentation,No Intervention,1500,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04345159,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1049,NCT04345601,ClinicalTrials.gov,2020-04-10,2020-05-01,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),ATMP,Cells (mesenchymal),30,2022-02-01,2022-02-01,https://clinicaltrials.gov/show/NCT04345601,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1050,NCT04343690,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),Other (psych),Psychological,100,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04343690,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1051,NCT04343781,ClinicalTrials.gov,2020-04-09,2020-03-22,True,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Clinical Presentation,No Intervention,353,2020-04-05,2020-04-05,https://clinicaltrials.gov/show/NCT04343781,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1052,NCT04344171,ClinicalTrials.gov,2020-04-10,2020-03-30,True,ClarData,Recruiting,Not Applicable,Observational,"Romania, Germany",CovidDB: The Covid-19 Inpatient Database,Clinical Presentation,No Intervention,5000,2022-12-31,2023-06-30,https://clinicaltrials.gov/show/NCT04344171,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1053,NCT04344184,ClinicalTrials.gov,2020-04-09,2020-04-22,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI),Drug,Vitamin C,200,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04344184,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1054,NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,True,Francis Corazza,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Clinical Presentation,No Intervention,200,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346017,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1055,NCT04346043,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,No Country Given,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Genomics,No Intervention,100,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346043,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1056,NCT04344119,ClinicalTrials.gov,2020-04-09,2020-04-09,False,CHU de Nice,Recruiting,Not Applicable,Observational,France,Assessment of Chilbains Occuring During Covid-19 Infection,Clinical Presentation,No Intervention,30,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04344119,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1057,NCT04344145,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Universit Libre de Bruxelles,Not Recruiting,Not Applicable,Observational,No Country Given,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,Other (psych),No Intervention,200,2020-06-15,2020-07-15,https://clinicaltrials.gov/show/NCT04344145,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1058,NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Telehealth,Telehealth,149,2020-08-20,2020-08-30,https://clinicaltrials.gov/show/NCT04344210,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1059,NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,False,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Other,Povidone/Iodine rinse,48,2020-05-01,2020-05-09,https://clinicaltrials.gov/show/NCT04344236,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1060,NCT04343898,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,2000,2020-04-15,2022-06-01,https://clinicaltrials.gov/show/NCT04343898,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1061,NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,30,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04343989,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1062,NCT04344197,ClinicalTrials.gov,2020-04-09,2020-04-02,True,University of Rome Tor Vergata,Recruiting,Not Applicable,Observational,Italy,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Clinical Presentation,No Intervention,1200,2020-04-08,2020-04-15,https://clinicaltrials.gov/show/NCT04344197,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1063,NCT04344587,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Boston University,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 smArtphone-based Trial of Non-ICU Admission Prone Positioning,Procedure,Other,380,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04344587,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1064,NCT04346212,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Hospital de Matar,Not Recruiting,Not Applicable,Observational,Spain,Oropharyngeal Dysphagia in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,100,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04346212,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1065,NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-14,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,ATMP,Plasma,20,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04346446,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1066,NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Thomas Jefferson University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,ATMP,Plasma,2000,2021-04-12,2021-04-12,https://clinicaltrials.gov/show/NCT04344015,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1067,NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,True,ELHARRAR Xavier,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure,Other,25,2020-04-15,2020-05-01,https://clinicaltrials.gov/show/NCT04344106,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1068,NCT04344327,ClinicalTrials.gov,2020-04-09,2020-04-10,False,French Cardiology Society,Recruiting,Not Applicable,Observational,France,COVID-19 in Cardiology Unit in France : Risk Factors for Mortality (CCF),Clinical Presentation,No Intervention,500,2020-04-19,2020-07-09,https://clinicaltrials.gov/show/NCT04344327,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1069,NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-10,False,LCMC Health,Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,600,2021-04-10,2021-12-10,https://clinicaltrials.gov/show/NCT04344444,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1070,NCT04344834,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Covid-19 on Egyptian Health Care Workers and General Population Mental Health,Other (psych),No Intervention,300,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04344834,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1071,NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,True,Huo-Shen-Shan Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Combination: Danoprevir + Ritonavir,40,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04345276,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1072,NCT04344249,ClinicalTrials.gov,2020-04-08,2020-04-15,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,Clinical Presentation,No Intervention,850,2020-09-30,2021-09-01,https://clinicaltrials.gov/show/NCT04344249,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1073,NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Direction Centrale du Service de Sant des Armes,Not Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Drug,Oxygen,100,2021-04-01,2021-05-01,https://clinicaltrials.gov/show/NCT04344431,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1074,NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Stony Brook University,Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,ATMP,Plasma,500,2021-04-30,2021-08-31,https://clinicaltrials.gov/show/NCT04344535,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1075,NCT04344561,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Procedure,Other,70,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04344561,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1076,NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Not Recruiting,Phase 4,Interventional,No Country Given,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,400,2020-04-28,2021-05-28,https://clinicaltrials.gov/show/NCT04346667,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1077,NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Drug,Combination: Dalargin + Hydroxychloroquine + azithromycin + / - tocilizumab vs. Hydroxychloroquine + azithromycin + / - tocilizumab,320,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346693,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1078,NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,False,Orthosera Kft.,Not Recruiting,Phase 1,Interventional,No Country Given,Anti COVID-19 Convalescent Plasma Therapy,ATMP,Plasma,20,2020-06-01,2021-04-01,https://clinicaltrials.gov/show/NCT04345679,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1079,NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,True,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Drug,Hydroxychloroquine,350,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04345692,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1080,NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,False,"Perseverance Research Center, LLC",Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug,Combination: Hydroxychloroquine + Indomethacin + Azithromycin,80,2020-06-20,2020-09-30,https://clinicaltrials.gov/show/NCT04344457,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1081,NCT04344548,ClinicalTrials.gov,2020-04-10,2020-04-13,False,Universidad Nacional de Colombia,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,ATMP,Cells (NK),10,2020-06-10,2020-11-10,https://clinicaltrials.gov/show/NCT04344548,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1082,NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Istanbul University-Cerrahpasa,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,Drug,Spironolactone,60,2020-07-21,2020-10-21,https://clinicaltrials.gov/show/NCT04345887,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1083,NCT04346121,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,Other,No Intervention,1000,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04346121,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1084,NCT04344977,ClinicalTrials.gov,2020-04-13,2020-04-15,False,National Institutes of Health Clinical Center (CC),Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Plasma Collection,ATMP,Plasma,2800,2024-07-01,2025-04-01,https://clinicaltrials.gov/show/NCT04344977,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1085,NCT04345419,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,A Real-life Experience on Treatment of Patients With COVID 19,Drug,Chloroquine vs. Favipiravir vs. Nitazoxanide vs. Ivermectin vs. Niclosamide,100,2029-12-01,2029-12-01,https://clinicaltrials.gov/show/NCT04345419,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1086,NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,False,University of Malaya,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug,Tocilizumab vs. Corticosteroids,310,2020-10-31,2020-10-31,https://clinicaltrials.gov/show/NCT04345445,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1087,NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Tinzaparin or Heparin,808,2020-07-31,2020-09-30,https://clinicaltrials.gov/show/NCT04344756,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1088,NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin/Zeribev) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Bevacizumab,130,2020-09-30,2020-11-30,https://clinicaltrials.gov/show/NCT04344782,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1089,NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Vanderbilt University,Not Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Procedure,Saline Nasal Irrigation,90,2021-06-01,2022-06-01,https://clinicaltrials.gov/show/NCT04347538,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1090,NCT04347954,ClinicalTrials.gov,2020-04-13,2020-05-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug,Povidone-iodine,45,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04347954,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1091,NCT04344964,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Austin Health,Not Recruiting,Not Applicable,Observational,No Country Given,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,Telehealth,Telehealth,150,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04344964,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1092,NCT04345315,ClinicalTrials.gov,2020-04-10,2020-03-27,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Not Applicable,Observational,Italy,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Clinical Presentation (Epidemiology),No Intervention,500,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04345315,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1093,NCT04345510,ClinicalTrials.gov,2020-04-12,2020-04-20,False,German Cancer Research Center,Not Recruiting,Not Applicable,Observational,No Country Given,Testing for COVID-19 Infection in Asymptomatic Persons,Clinical Presentation (Epidemiology),No Intervention,500,2020-05-31,2020-12-31,https://clinicaltrials.gov/show/NCT04345510,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1094,NCT04345536,ClinicalTrials.gov,2020-04-05,2020-03-15,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Clinical Presentation,No Intervention,400,2021-01-01,2021-05-01,https://clinicaltrials.gov/show/NCT04345536,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1095,NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,45,2021-04-08,2022-04-08,https://clinicaltrials.gov/show/NCT04345653,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1096,NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Centre Chirurgical Marie Lannelongue,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug,Combination: Dexamethasone + Hydroxychloroquine vs. Hydroxychloroquine,122,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04347980,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1097,NCT04347993,ClinicalTrials.gov,2020-04-13,2020-03-27,True,Hackensack Meridian Health,Recruiting,Not Applicable,Observational,United States,"A Prospective ""Universal"" Observational Database for COVID-19",Clinical Presentation,No Intervention,5000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04347993,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1098,NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Tanta University,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug,Ace inhibitors,60,2029-12-01,2029-12-01,https://clinicaltrials.gov/show/NCT04345406,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1099,NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,False,Cristina Avendao Sol,Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,ATMP,Plasma,278,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04345523,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1100,NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-10,False,"University Hospital, Montpellier",Not Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,150,2020-09-06,2021-04-06,https://clinicaltrials.gov/show/NCT04345861,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1101,NCT04346160,ClinicalTrials.gov,2020-04-10,2020-04-14,False,D'Annunzio University of ChietiPescara,Not Recruiting,Not Applicable,Observational,Italy,"A Study to Assess the Virus, RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Diagnostics,Diagnostic Test or Assessment,25,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04346160,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1102,NCT04346147,ClinicalTrials.gov,2020-04-07,2020-04-13,False,Hospital Universitario de Fuenlabrada,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug,"Lopinavir/ritonavir vs. Imatinib vs. Baricitinib

All in comibination with Hydroxychloroquine ",165,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04346147,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1103,NCT04346329,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Universidad Nacional de Colombia,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,86,2020-06-01,2020-10-01,https://clinicaltrials.gov/show/NCT04346329,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1104,NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Traditional Medicine (Other),Traditional Medicine,18,2020-03-30,2020-03-30,https://clinicaltrials.gov/show/NCT04345549,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1105,NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,False,"CalciMedica, Inc.",Recruiting,Phase 2,Interventional,United States,A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia,Drug,CM4620-Injectable Emulsion,120,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04345614,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1106,NCT04346186,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"Copenhagen University Hospital, Herlev Hospital",Not Recruiting,Not Applicable,Observational,Denmark,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Diagnostics,Diagnostic Test or Assessment,30000,2020-10-01,2021-08-01,https://clinicaltrials.gov/show/NCT04346186,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1107,NCT04346277,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Implicit Bioscience,Not Recruiting,Phase 2,Expanded Access,Italy,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04346277,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1108,NCT04348214,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,No Country Given,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Clinical Presentation,No Intervention,3000,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04348214,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1109,NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug,Defibrotide,120,2020-07-08,2020-08-08,https://clinicaltrials.gov/show/NCT04348383,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1110,NCT04346342,ClinicalTrials.gov,2020-04-09,2020-03-06,True,UMC Amsterdam,Recruiting,Not Applicable,Observational,Netherlands,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Other (physical),Mechanical ventilation,1000,2020-05-01,2020-08-01,https://clinicaltrials.gov/show/NCT04346342,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1111,NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,True,Azienda Unit Sanitaria Locale Reggio Emilia,Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Drug,Tocilizumab,398,2020-05-30,2020-05-30,https://clinicaltrials.gov/show/NCT04346355,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1112,NCT04345640,ClinicalTrials.gov,2020-04-10,2020-04-14,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Not Applicable,Observational,India,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Clinical Presentation,No Intervention,100,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04345640,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1113,NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-14,False,"University Hospital, Geneva",Not Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug,Enoxaparin,200,2020-11-30,2020-11-30,https://clinicaltrials.gov/show/NCT04345848,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1114,NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Cliniques universitaires Saint-Luc- Universit Catholique de Louvain,Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other (device),Mask,15,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04346420,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1115,NCT04346628,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild COVID-19,Drug,Favipiravir,120,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04346628,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1116,NCT04345991,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",ATMP,Plasma,120,2020-05-15,2020-06-01,https://clinicaltrials.gov/show/NCT04345991,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1117,NCT04346056,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,No Country Given,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Clinical Presentation,No Intervention,500,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346056,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1118,NCT04348396,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Istituto Nazionale di Ricovero e Cura per Anziani,Not Recruiting,Not Applicable,Observational,Italy,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,Clinical Presentation,No Intervention,300,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04348396,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1119,NCT04348409,ClinicalTrials.gov,2020-04-03,2020-04-12,False,Azidus Brasil,Not Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug,Nitazoxanide,50,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04348409,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1120,NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),20,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346368,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1121,NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-01,True,A.O. Ospedale Papa Giovanni XXIII,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,ATMP,Plasma,10,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04346589,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1122,NCT04346810,ClinicalTrials.gov,2020-04-08,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,Other (psych),No Intervention,100,2020-08-15,2020-09-01,https://clinicaltrials.gov/show/NCT04346810,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1123,NCT04346927,ClinicalTrials.gov,2020-04-13,2020-04-10,True,Yasemin Airak,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation for Patients Diagnosed With Coronavirus,Telehealth,Rehabilitation,30,2020-06-10,2020-07-31,https://clinicaltrials.gov/show/NCT04346927,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1124,NCT04348422,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluating the Immune Response for COVID-19,Clinical Presentation,No Intervention,1000,2020-12-01,2020-12-31,https://clinicaltrials.gov/show/NCT04348422,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1125,NCT04348435,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,Study of Allogeneic HB-adMSCs to Provide Immune Support Against COVID-19,ATMP,Cells (mesenchymal),100,2020-12-31,2021-04-30,https://clinicaltrials.gov/show/NCT04348435,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1126,NCT04346082,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Other (psych),Psychological,30,2021-04-30,2021-04-30,https://clinicaltrials.gov/show/NCT04346082,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1127,NCT04346199,ClinicalTrials.gov,2020-04-09,2020-04-24,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,Spain,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. CALAVI (Calquence Against the Virus),Drug,Acalabrutinib,428,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04346199,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1128,NCT04346953,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Other (exercise),Exercise,128,2020-06-01,2020-07-31,https://clinicaltrials.gov/show/NCT04346953,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1129,NCT04347070,ClinicalTrials.gov,2020-04-10,2017-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Implementation of Physiotherapy on COVID-19 Patients in ICU,Other (physio),Physio,150,2020-09-01,2022-12-01,https://clinicaltrials.gov/show/NCT04347070,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1130,NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug,Eculizumab,120,2020-05-01,2020-08-01,https://clinicaltrials.gov/show/NCT04346797,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1131,NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Matthew Dallos,Not Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Cancer Patients With COVID-19,Drug,Anti-Interleukin-8,138,2021-09-01,2022-09-01,https://clinicaltrials.gov/show/NCT04347226,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1132,NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-01,True,Neuroganics LLC,Recruiting,Not Applicable,Interventional,United States,COVID-19 Antibody Self-testing Using Virtual Point-of-care,Diagnostics,Diagnostic Test or Assessment,100,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04348864,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1133,NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Saint Luke's Health System,Recruiting,Phase 3,Interventional,United States,Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug,Dapagliflozin,900,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04350593,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1134,NCT04346264,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Ludwig Boltzmann Institute for Lung Health,Recruiting,Not Applicable,Observational,Austria,CoVid-19 - Infection and Antibody Formation in the Viennese Population,Clinical Presentation (Epidemiology),No Intervention,5500,2020-06-01,2020-09-30,https://clinicaltrials.gov/show/NCT04346264,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1135,NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-01,True,"Biohaven Pharmaceuticals, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug,Vazegepant,120,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04346615,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1136,NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug,Leronlimab,390,2020-12-31,2021-04-01,https://clinicaltrials.gov/show/NCT04347239,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1137,NCT04347408,ClinicalTrials.gov,2020-04-07,2020-04-13,False,"Queen's University, Belfast",Not Recruiting,Not Applicable,Observational,United Kingdom,"Rapid Diagnostics, Antibody Testing and Host Response in Children With COVID-19",Diagnostics,Diagnostic Test or Assessment,150,2020-10-13,2020-10-13,https://clinicaltrials.gov/show/NCT04347408,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1138,NCT04347278,ClinicalTrials.gov,2020-04-03,2020-04-15,False,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Not Applicable,Observational,No Country Given,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,Drug,Unspecified,100,2020-10-15,2021-01-01,https://clinicaltrials.gov/show/NCT04347278,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1139,NCT04347369,ClinicalTrials.gov,2020-03-18,2020-01-17,True,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,Clinical Presentation,No Intervention,1000,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04347369,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1140,NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-20,False,Cadila Pharnmaceuticals,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,40,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04347174,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1141,NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Sheikh Zayed Federal Postgraduate Medical Institute,Recruiting,Phase 3,Interventional,Pakistan,Efficacy of Nigella Sativa and Natural Honey Against COVID-19: an RCT,Traditional Medicine (Drug),Traditional Medicine,30,2020-05-25,2020-05-30,https://clinicaltrials.gov/show/NCT04347382,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1142,NCT04351646,ClinicalTrials.gov,2020-04-07,2020-04-15,False,"St George's, University of London",Not Recruiting,Not Applicable,Observational,United Kingdom,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),Diagnostics,Diagnostic Test or Assessment,500,2022-04-15,2022-04-15,https://clinicaltrials.gov/show/NCT04351646,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1143,NCT04351659,ClinicalTrials.gov,2020-04-16,2020-04-01,True,KK Women's and Children's Hospital,Recruiting,Not Applicable,Observational,Singapore,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,ATMP,Plasma,8,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04351659,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1144,NCT04347850,ClinicalTrials.gov,2020-04-09,2020-02-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,500,2022-12-01,2022-12-30,https://clinicaltrials.gov/show/NCT04347850,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1145,NCT04347876,ClinicalTrials.gov,2020-04-14,2020-04-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,Diagnostics,Diagnostic Test or Assessment,100,2020-06-16,2020-06-30,https://clinicaltrials.gov/show/NCT04347876,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1146,NCT04347460,ClinicalTrials.gov,2020-04-08,2020-03-27,True,Technische Universitt Mnchen,Recruiting,Not Applicable,Observational,Germany,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,Clinical Presentation,No Intervention,20,2020-07-01,2020-08-31,https://clinicaltrials.gov/show/NCT04347460,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1147,NCT04347694,ClinicalTrials.gov,2020-04-12,2020-04-11,True,Medical University of Vienna,Not Recruiting,Not Applicable,Observational,No Country Given,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months,Clinical Presentation,No Intervention,400,2021-04-11,2021-04-11,https://clinicaltrials.gov/show/NCT04347694,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1148,NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-12,False,King Fahad Specialist Hospital,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,ATMP,Plasma,40,2020-12-31,2021-04-11,https://clinicaltrials.gov/show/NCT04347681,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1149,NCT04347798,ClinicalTrials.gov,2020-04-13,2020-04-15,False,University of Alberta,Recruiting,Not Applicable,Observational,Canada,IMPACT: IMPact of Antimalarials on Covid Infections in RAPPORT,Drug,Hydroxychloroquine or Chloroquine,500,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04347798,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1150,NCT04347928,ClinicalTrials.gov,2020-04-08,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,Clinical Presentation,No Intervention,15,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04347928,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1151,NCT04348227,ClinicalTrials.gov,2020-04-10,2019-01-01,True,Hpital Universitaire Fattouma Bourguiba,Not Recruiting,Not Applicable,Observational,Tunisia,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Clinical Presentation,No Intervention,120,2020-01-01,2021-02-04,https://clinicaltrials.gov/show/NCT04348227,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1152,NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Stony Brook University,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,1212,2020-12-30,2020-12-30,https://clinicaltrials.gov/show/NCT04347889,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1153,NCT04348071,ClinicalTrials.gov,2020-04-13,2020-04-01,True,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,Drug,Ruxolitinib,80,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04348071,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1154,NCT04347824,ClinicalTrials.gov,2020-04-09,2020-04-13,False,University Hospital Gttingen,Not Recruiting,Not Applicable,Observational,Germany,Predict Adverse Events by Covid-19 Nephritis,Clinical Presentation,No Intervention,100,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04347824,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1155,NCT04347915,ClinicalTrials.gov,2020-04-14,2020-04-24,False,Bukwang Pharmaceutical,Not Recruiting,Phase 2,Interventional,No Country Given,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug,Clevudine vs. Hydroxychloroquine,60,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04347915,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1156,NCT04351906,ClinicalTrials.gov,2020-04-09,2020-04-01,True,University of Giessen,Not Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Other (device),ECCO2R,20,2020-04-01,2020-05-01,https://clinicaltrials.gov/show/NCT04351906,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1157,ACTRN12620000468921,ANZCTR,2020-04-14,2020-04-20,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,Other (psych),Psychological,140,Not Available,2020-11-09,https://anzctr.org.au/ACTRN12620000468921.aspx,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1158,NCT04348461,ClinicalTrials.gov,2020-04-10,2020-04-06,True,Instituto de Investigacin Sanitaria Fundacin Jimnez Daz,Not Recruiting,Phase 2,Interventional,No Country Given,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,ATMP,Cells (mesenchymal),100,2020-09-15,2020-09-30,https://clinicaltrials.gov/show/NCT04348461,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1159,NCT04348552,ClinicalTrials.gov,2020-04-13,2020-04-15,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,Other,No Intervention,1000,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04348552,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1160,NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Scandinavian Critical Care Trials Group,Not Recruiting,Phase 3,Interventional,No Country Given,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug,Hydrocortisone,1000,2021-03-30,2021-12-30,https://clinicaltrials.gov/show/NCT04348305,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1161,NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-21,False,Cedars-Sinai Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug,Clazakizumab,60,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04348500,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1162,NCT04347941,ClinicalTrials.gov,2020-04-08,2020-04-11,False,University College Hospital Galway,Not Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure,Other,200,2021-03-11,2021-05-11,https://clinicaltrials.gov/show/NCT04347941,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1163,NCT04348240,ClinicalTrials.gov,2020-04-15,2020-04-22,False,National Institute of Dental and Craniofacial Research (NIDCR),Recruiting,Not Applicable,Observational,United States,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,Clinical Presentation,No Intervention,30,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04348240,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1164,ACTRN12620000480987,ANZCTR,2020-04-16,2020-06-01,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),Supplement,Probiotics,507,Not Available,2020-10-18,https://anzctr.org.au/ACTRN12620000480987.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1165,NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,True,Fundacin de Investigacin HM Hospitales,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug,Combination: Ruxolitinib + Simvastatin,94,2020-05-13,2020-05-13,https://clinicaltrials.gov/show/NCT04348695,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001405-23
1166,NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Interventional,No Country Given,Plasma Rich Antibodies From Recovered Patients From COVID19,ATMP,Plasma,20,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04348877,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1167,NCT04348448,ClinicalTrials.gov,2020-04-13,2020-04-01,True,AUSL Romagna Rimini,Not Recruiting,Not Applicable,Observational,No Country Given,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",Drug,Canakinumab,100,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04348448,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1168,NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Combination: Hydroxychloroquine + Azithromycin ,200,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04348474,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1169,ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,True,Juan Pedro Fuentes Garca,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",Other (exercise),Exercise,34,Not Available,2020-04-26,https://anzctr.org.au/ACTRN12620000482965.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1170,NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-02,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Not Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug,Triiodothyronine,60,2021-05-02,2021-05-31,https://clinicaltrials.gov/show/NCT04348513,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1171,NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,False,CHU de Nancy,Not Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,Clinical Presentation,No Intervention,600,2021-08-16,2021-11-01,https://clinicaltrials.gov/show/NCT04348929,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1172,ACTRN12620000493943,ANZCTR,2020-04-20,2020-04-07,True,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Front-line health care workers serial blood COVID-19 antibody results in relation to symptom presentation,Clinical Presentation,No Intervention,50,Not Available,2021-04-07,https://anzctr.org.au/ACTRN12620000493943.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1173,NCT04348656,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Hamilton Health Sciences Corporation,Not Recruiting,Phase 3,Interventional,Canada,CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),ATMP,Plasma,1200,2020-10-31,2020-12-31,https://clinicaltrials.gov/show/NCT04348656,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1174,NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-30,False,Karyopharm Therapeutics Inc,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug,Selinexor,230,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04349098,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001411-25
1175,NCT04348942,ClinicalTrials.gov,2020-04-13,2020-04-20,False,ObvioHealth,Not Recruiting,Not Applicable,Observational,No Country Given,"A COVID-19 Symptom, Exposure and Immune Response Registry",Clinical Presentation,No Intervention,10000,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04348942,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1176,NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,Drug (Chemoprophylaxis),Chloroquine,350,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04349371,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1177,NCT04349202,ClinicalTrials.gov,2020-04-13,2020-04-01,True,William Beaumont Hospitals,Recruiting,Not Applicable,Observational,United States,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Clinical Presentation,No Intervention,50000,2021-06-01,2021-06-01,https://clinicaltrials.gov/show/NCT04349202,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1178,NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,False,"University Hospital, Limoges",Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Drug,Dexmedetomidine,10,2020-11-20,2020-11-20,https://clinicaltrials.gov/show/NCT04350086,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1179,ISRCTN18348009,ISRCTN,2020-04-15,2020-04-16,False,University of Valladolid,Recruiting,Not Applicable,Observational,Spain,Occupational health and safety among health care personnel in a COVID-19 pandemic,Clinical Presentation,No Intervention,80,Not Available,2020-04-22,http://isrctn.com/ISRCTN18348009,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1180,NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug,Favipiravir,100,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04349241,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1181,NCT04349982,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,ICU Trial in Critical Ill COVID-19 Patients,Clinical Presentation,No Intervention,50,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04349982,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1182,NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,False,The Camelot Foundation,Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Drug (+ ATMP),Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Doxycycline vs. Hydroxychloroquine + Clindamycin vs. Hydroxychloroquine  + Clindamycin + Primaquine vs. Remdesivir vs. Tocilizumab vs. Corticosteroids vs. Interferon alpha vs. Losartan vs. Plasma,500,2020-10-11,2020-11-11,https://clinicaltrials.gov/show/NCT04349410,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1183,NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other (physical),Mechanical ventilation,200,2021-07-14,2022-04-14,https://clinicaltrials.gov/show/NCT04349618,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1184,ISRCTN10077335,ISRCTN,2020-04-07,2020-03-19,True,Klinikum der Universitt Mnchen,Recruiting,Not Applicable,Observational,Germany,Comparison of lung water in COVID-19 patients and other patients with acute respiratory failure,Clinical Presentation,No Intervention,25,Not Available,2020-04-30,http://isrctn.com/ISRCTN10077335,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1185,NCT04350073,ClinicalTrials.gov,2020-04-14,2020-04-17,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Clinical Presentation,No Intervention,120,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04350073,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1186,NCT04350099,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,Emotional Burden of Healthcare Professionals and Covid Infection 19,Other (psych),No Intervention,200,2020-12-15,2021-06-15,https://clinicaltrials.gov/show/NCT04350099,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1187,NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-20,False,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Not Recruiting,Phase 3,Interventional,No Country Given,Randomized Open-blind Controlled Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug,Colchicine,102,2020-10-20,2020-11-20,https://clinicaltrials.gov/show/NCT04350320,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1188,NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Theravance Biopharma,Not Recruiting,Phase 1,Interventional,United Kingdom,"First in Human Study SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug,TD-0903,54,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04350736,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1189,NCT04349631,ClinicalTrials.gov,2020-04-06,2020-04-16,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,ATMP,Cells (mesenchymal),56,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04349631,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1190,NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,True,The University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug,Combination: Interferon beta + Hydroxychloroquine vs. Hydroxychloroquine,80,2022-03-31,2022-07-31,https://clinicaltrials.gov/show/NCT04350281,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1191,NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Montefiore Medical Center,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Drug,Hydroxychloroquine,100,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04350450,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1192,NCT04350476,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Vivek Reddy,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,Clinical Presentation,No Intervention,1000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04350476,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1193,NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Not Recruiting,Phase 4,Interventional,No Country Given,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,400,2020-04-30,2020-05-30,https://clinicaltrials.gov/show/NCT04351191,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1194,NCT04351399,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,Other (psych),No Intervention,100,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04351399,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1195,NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-17,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,Drug,Favipiravir,40,2030-12-01,2030-12-01,https://clinicaltrials.gov/show/NCT04351295,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1196,NCT04351529,ClinicalTrials.gov,2020-04-16,2020-04-01,True,AGMT,Recruiting,Not Applicable,Observational,Austria,Austrian COVID-19 Registry,Clinical Presentation,No Intervention,1000,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04351529,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1197,ISRCTN40092247,ISRCTN,2020-04-01,2020-03-20,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,UKOSS: Pandemic COVID-19 in pregnancy,Clinical Presentation,No Intervention,500,Not Available,2022-12-31,http://isrctn.com/ISRCTN40092247,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1198,NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,True,University of Chicago,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine,20,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04351620,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1199,NCT04351711,ClinicalTrials.gov,2020-04-10,2020-04-01,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Clinical Presentation,No Intervention,60,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04351711,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1200,NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,"Interferon Beta 1a in COVID-19: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial",Drug,Combination:  Interferon beta + Lopinavir/Ritonavir + Hydroxychlroquine vs. Lopinavir/Ritonavir + Hydroxychloroquine,40,2020-04-20,2020-04-24,https://clinicaltrials.gov/show/NCT04350671,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1201,NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,"Umifenovir in COVID-19: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial",Drug,Combination: Umifenovir + Interferon beta + Lopinavir/Ritonavir + Hydroxychloroquine vs. Interferon beta + Lopinavir/Ritonavir + Hydroxycholroquine,40,2020-04-22,2020-04-24,https://clinicaltrials.gov/show/NCT04350684,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1202,ACTRN12620000486921,ANZCTR,2020-04-17,2020-04-20,False,Royal North Shore Hospital,Not Recruiting,Not Applicable,Observational,Australia,"AUSTRALIAN CARDIOVASCULAR COVID-19 REGISTRY (AUS-COVID) 
",Clinical Presentation,No Intervention,865,Not Available,2020-09-19,https://anzctr.org.au/ACTRN12620000486921.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1203,ACTRN12620000473965,ANZCTR,2020-04-15,2020-06-01,False,The University of Queensland,Not Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,Drug (chemoprophylaxis),OM85,1000,Not Available,2021-04-30,https://anzctr.org.au/ACTRN12620000473965.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1204,ACTRN12620000474954,ANZCTR,2020-04-15,2020-04-27,False,Sir Charles Gairdner Hospital,Not Recruiting,Not Applicable,Observational,Australia,Airway Pressure Release Ventilation for mechanically ventilated patients with COVID-19 in Western Australian Intensive Care Units: an observational study,Other (physical),Mechanical ventilation,100,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000474954.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1205,NCT04351633,ClinicalTrials.gov,2020-04-15,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Other (psych),No Intervention,50,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04351633,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1206,NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,False,Medical University of Vienna,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial,Drug,"Chloroquine or Hydroxychloroquine vs. lopinavir/ritonavir

Substudies: Rovaroxaban, Clazakizumab, Candesartan",500,2020-12-01,2020-12-31,https://clinicaltrials.gov/show/NCT04351724,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1207,NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,No Country Given,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,ATMP,Vaccine,900,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04350931,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1208,NCT04351139,ClinicalTrials.gov,2020-04-15,2020-04-01,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic in Gynecological Oncology,Clinical Presentation,No Intervention,200,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04351139,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1209,ACTRN12620000445976,ANZCTR,2020-04-06,2020-04-10,False,University of Melbourne,Not Recruiting,Phase 3,Interventional,"New Zealand, Australia","To compare the effectiveness of two drugs (hydroxychloroquine and lopinavir/ritonavir alone or combined in treating hospitalized patients with confirmed COVID-19 compared to standard of care

",Drug,Combination: Lopinavir/ritonavir + hydroxychloroquine vs. lopinavir/ritonavir vs. hydroxychloroquine,2500,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000445976.aspx,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1210,ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,False,World Health Organization,Recruiting,Phase 3,Interventional,"Argentina, Switzerland, Qatar, Indonesia, Canada, Thailand, South Africa, Norway, Spain, Germany, Brazil, Peru, Iran",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,Drug,Remdesivir vs. chloroquine/hydroxychloroquine vs. lopinavir/ritonavir vs. interferon beta,10000,Not Available,2021-03-25,http://isrctn.com/ISRCTN83971151,No Results,No Results,No Results,2020-04-20,2020-04-01,EUCTR2020-001366-11; NCT04330690; PER-010-20
1211,ACTRN12620000492954,ANZCTR,2020-04-20,2020-05-01,False,University of New South Wales,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,Other (exercise),Exercise,20,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000492954.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1212,ISRCTN51255782,ISRCTN,2020-04-14,2020-04-14,False,Labormedizinisches Zentrum Dr. Risch,Recruiting,Not Applicable,Observational,Liechtenstein,Can the Ava fertility tracker device detect early signs of COVID-19?,Diagnostics,Diagnostic Test or Assessment,2170,Not Available,2021-12-31,http://isrctn.com/ISRCTN51255782,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1213,ACTRN12620000478910,ANZCTR,2020-04-16,2020-06-01,False,Monash Health,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,ATMP,Cells (stem cells),24,Not Available,2021-04-30,https://anzctr.org.au/ACTRN12620000478910.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1214,ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,False,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,A trial evaluating treatments for suspected coronavirus infection in people aged 50 years and above with pre-existing conditions and those aged 65 years and above,Drug,Hydroxychloroquine,3000,Not Available,2021-03-24,http://isrctn.com/ISRCTN86534580,No Results,No Results,No Results,2020-04-20,2020-03-25,EUCTR2020-001209-22
1215,ISRCTN50189673,ISRCTN,2020-04-02,2020-03-19,True,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus),Drug,lopinavir/ritonavir vs. interferon beta vs. dexamethasone vs. hydroxychloroquine,5000,Not Available,2021-06-30,http://isrctn.com/ISRCTN50189673,No Results,No Results,No Results,2020-04-20,2020-04-07,EUCTR2020-001113-21
1216,ISRCTN14326006,ISRCTN,2020-04-14,2020-04-13,True,"University Health Network, Toronto",Recruiting,Phase 3,Interventional,Canada,Does taking hydroxychloroquine before and during exposure to patients protect frontline healthcare workers from coronavirus?,Drug (chemoprophylaxis),Hydroxychloroquine,988,Not Available,2022-01-30,http://isrctn.com/ISRCTN14326006,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1217,ISRCTN13694948,ISRCTN,2020-04-01,2020-04-02,False,University Hospital of Bern,Recruiting,Not Applicable,Observational,"Ireland, French Southern Territories, Lebanon, Czech Republic, Sweden, Slovenia, Italy, Germany, Luxembourg, United States, Israel, Turkey, Cyprus, Croatia, Belgium, Malta, France, Portugal, Liechtenstein, Greece, Brazil, Netherlands, Bulgaria, Lithuania, United Kingdom, South Africa, New Zealand, Spain, Switzerland, Australia, Slovakia, Norway, Austria, Finland, Isle of Man, Denmark",Distress and resilience of healthcare professionals during the COVID-19 (coronavirus) pandemic,Other (psych),No Intervention,400,Not Available,2021-01-01,http://isrctn.com/ISRCTN13694948,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1218,ChiCTR2000032009,ChiCTR,2020-04-17,2020-02-08,True,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19) patients with chronic liver disease,Clinical Presentation,No Intervention,30,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52490,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1219,ISRCTN15281137,ISRCTN,2020-04-06,2020-03-26,True,University of Oxford,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,"A phase I/II study to determine efficacy, safety and immunogenicity of the candidate coronavirus disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers",ATMP,Vaccine,510,Not Available,2020-12-31,http://isrctn.com/ISRCTN15281137,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1220,NCT04351152,ClinicalTrials.gov,2020-04-15,2020-05-01,False,"Humanigen, Inc.",Not Recruiting,Phase 3,Interventional,No Country Given,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia,Drug,Lenzilumab,238,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04351152,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1221,NCT04351347,ClinicalTrials.gov,2020-04-15,2020-04-17,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Drug,Combination: Chloroquine + Nitazoxanide vs. Chloroquine + Ivermectin vs. Chloroquine ,60,2030-12-01,2030-12-01,https://clinicaltrials.gov/show/NCT04351347,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1222,NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,32,2020-04-06,2020-04-12,https://clinicaltrials.gov/show/NCT04351542,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1223,NCT04351581,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"Copenhagen University Hospital, Gentofte",Not Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Drug,ACE inhibitors or ARBs,215,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04351581,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1224,ISRCTN16912075,ISRCTN,2020-04-06,2020-04-06,False,University of Warwick,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19  CPAP, high-flow nasal oxygen, and standard care",Drug,Oxygen,4002,Not Available,2021-05-05,http://isrctn.com/ISRCTN16912075,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1225,ChiCTR2000031982,ChiCTR,2020-04-16,2020-04-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people,Traditional Medicine (drug),Traditional Medicine,240,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=52341,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1226,ChiCTR2000031896,ChiCTR,2020-04-14,2020-02-05,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the influence of novel coronavirus pneumonia (COVID-19) on mental health of Chinese public hospital stuffs,Other (psych),No Intervention,923,Not Available,2020-02-10,http://www.chictr.org.cn/showproj.aspx?proj=52332,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1227,NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Nicolaus Copernicus University,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug,Amiodarone or Verapamil,804,2021-03-02,2021-04-10,https://clinicaltrials.gov/show/NCT04351763,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1228,NCT04351789,ClinicalTrials.gov,2020-04-11,2020-04-01,True,"Copenhagen University Hospital, Hvidovre",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other (psych),Psychological,66,2023-04-01,2023-04-01,https://clinicaltrials.gov/show/NCT04351789,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1229,ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (drug),Traditional Medicine,300,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=52477,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1230,NCT04351802,ClinicalTrials.gov,2020-04-16,2020-04-20,False,University Hospital Plymouth NHS Trust,Not Recruiting,Not Applicable,Observational,No Country Given,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Diagnostics,Diagnostic Test or Assessment,180,2021-01-20,2021-01-20,https://clinicaltrials.gov/show/NCT04351802,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1231,ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-20,False,Dr. Michael Soares,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,Other (physical),Mechanical ventilation,1,Not Available,2020-04-20,https://anzctr.org.au/ACTRN12620000477921.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1232,ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,False,Dr. Simon Joosten,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group Easybreathe snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,Other (device),Mask,100,Not Available,2020-10-27,https://anzctr.org.au/ACTRN12620000472976.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1233,ACTRN12620000487910,ANZCTR,2020-04-20,2020-04-07,True,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Coronavirus (COVID-19) nasal/oral swab results compared to blood antibody results in COVID-19 clinic patients.,Diagnostics,Diagnostic Test or Assessment,500,Not Available,2021-04-07,https://anzctr.org.au/ACTRN12620000487910.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1234,ACTRN12620000479909,ANZCTR,2020-04-16,2020-05-01,False,The George Institute for Global Health,Not Recruiting,Not Applicable,Observational,"Australia, Italy, China, Spain, United States, Germany",Mental health and wellbeing on general population during the COVID-19 outbreak,Other (psych),No Intervention,3000,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000479909.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1235,ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,False,Firebrick Pharma Pty Ltd,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of Nasodine Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,Drug,Povidone-iodine,20,Not Available,2020-06-30,https://anzctr.org.au/ACTRN12620000470998.aspx,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1236,ChiCTR2000032095,ChiCTR,2020-04-19,2020-03-18,True,The Third Affiliated Hospital of Sun Yat-sen University,Recruiting,Not Applicable,Observational,China,"Study for Healthy Behavior, Psychological Analysis and Psychological Reconstruction Strategies of Students Population Keeping in Home Under the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",Other (psych),No Intervention,130,Not Available,2021-03-18,http://www.chictr.org.cn/showproj.aspx?proj=52565,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1237,ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,True,Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,Clinical Presentation (Epidemiology),No Intervention,3808,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52364,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1238,ISRCTN80453162,ISRCTN,2020-04-14,2020-04-09,True,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Not Applicable,Observational,"Palestinian Territory, Saint Martin (French part), Lesotho, Tunisia, Egypt, Virgin Islands, U.S., Congo, Democratic Republic, Luxembourg, Nigeria, Gibraltar, Equatorial Guinea, Israel, Antigua and Barbuda, Comoros, Norfolk Island, Peru, Turkey, Mongolia, Laos, Christmas Island, Nicaragua, Burundi, Croatia, Azerbaijan, Congo, France, Saint Lucia, Uganda, Senegal, Macedonia, Guatemala, Martinique, Monaco, Netherlands, New Caledonia, Sri Lanka, Svalbard and Jan Mayen, Saint Barthelemy, Aruba, Ukraine, El Salvador, Mozambique, Thailand, Kiribati, Tuvalu, China, Mauritius, French Polynesia, Papua New Guinea, Solomon Islands, Spain, Swaziland, Bahamas, Switzerland, Mauritania, Botswana, Slovakia, United Arab Emirates, Macao, Bouvet Island, Liberia, San Marino, Colombia, Finland, Yemen, Denmark, Grenada, Northern Mariana Islands, Kuwait, French Guiana, British Indian Ocean Territory, Cambodia, Guernsey, Oman, Uzbekistan, Jersey, Bonaire Saint Eustatius and Saba, Kenya, Sweden, Tonga, Cote d'Ivoire, Malawi, Mayotte, Somalia, Turks and Caicos Islands, Cyprus, Puerto Rico, Brunei, Greenland, Jamaica, Malta, Marshall Islands, Myanmar, Philippines, Vanuatu, Timor-Leste, Vietnam, Andorra, Libya, India, Reunion, Bulgaria, United Kingdom, Dominican Republic, Montenegro, Sao Tome and Principe, Falkland Islands, South Sudan, Algeria, Bermuda, Hungary, Zambia, Australia, Eritrea, Tanzania, Bangladesh, Georgia, Saint Pierre and Miquelon, Cocos (Keeling) Islands, Korea, North, Saint Kitts and Nevis, Niger, Uruguay, Taiwan, Ireland, Montserrat, Nauru, Virgin Islands, British, Mexico, Chad, Cayman Islands, French Southern Territories, Kyrgyzstan, Czech Republic, Lebanon, Nepal, Antarctica, Poland, South Georgia and the South Sandwich Is, Argentina, Saudi Arabia, Angola, Syria, Anguilla, Wallis and Futuna, Armenia, Hong Kong, Burkina Faso, Chile, Brazil, Fiji, Greece, Suriname, Pitcairn, Afghanistan, Malaysia, Belarus, Canada, Russian Federation, Gabon, Western Sahara, Singapore, Morocco, Saint Vincent and the Grenadines, Sudan, Guam, Saint Helena, Palau, Haiti, Bhutan, Faroe Islands, Indonesia, Curacao, Panama, Gambia, Maldives, Micronesia, Federated States of, Latvia, American Samoa, Austria, Netherlands Antilles, Isle of Man, Barbados, Central African Republic, Ethiopia, Ecuador, Qatar, Cameroon, Sierra Leone, Turkmenistan, Paraguay, Kazakhstan, Bosnia and Herzegovina, Japan, Kosovo, Bolivia, Guinea-Bissau, Madagascar, Seychelles, Sint Maarten (Dutch part), Trinidad and Tobago, Tokelau, Benin, Germany, Italy, Togo, United States, Iran, Belize, Rwanda, Costa Rica, Heard Island and Mcdonald Islands, United States Minor Outlying Islands, Djibouti, Honduras, Belgium, Guyana, Portugal, Iraq, Liechtenstein, Namibia, Cuba, Holy See (Vatican City State), Serbia, Bahrain, Cook Islands, Ghana, Jordan, Romania, Korea, South, Lithuania, South Africa, New Zealand, Samoa, Guadeloupe, Dominica, Iceland, Zimbabwe, Norway, Cape Verde, Guinea, Niue, Venezuela, Estonia, Albania, Slovenia, Tajikistan, Mali, Moldova, Pakistan","The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery (COVER study)",Clinical Presentation,No Intervention,200,Not Available,2022-04-01,http://isrctn.com/ISRCTN80453162,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1239,ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (other),Traditional Medicine,2000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52414,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1240,ChiCTR2000031928,ChiCTR,2020-04-14,2020-06-01,False,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,"Delineate the prevalence, risk factors, temporal distribution and epidemiological characteristics of hidden novel coronavirus (2019-nCoV) infection in the community",Clinical Presentation (Epidemiology),No Intervention,3000,Not Available,2021-04-14,http://www.chictr.org.cn/showproj.aspx?proj=52353,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1241,ChiCTR2000031954,ChiCTR,2020-04-16,2020-04-15,True,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Recruiting,Not Applicable,Observational,China,Medical Records Based Study for Maternal and Perinatal Outcomes of Women with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52365,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1242,NL8498,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients,Clinical Presentation,No Intervention,20,Not Available,2020-05-31,https://trialregister.nl/trial/8498,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1243,ISRCTN43900695,ISRCTN,2020-04-08,2020-04-06,True,Northumbria University,Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,Other,Sleep aids,75,Not Available,2022-04-06,http://isrctn.com/ISRCTN43900695,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1244,ISRCTN77353041,ISRCTN,2020-04-07,2020-04-08,False,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,Cohort study for predicting severe disease courses in patients presenting for coronavirus testing to the University of Zurich COVID-19 Testing Center,Clinical Presentation,No Intervention,2000,Not Available,2020-12-31,http://isrctn.com/ISRCTN77353041,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1245,ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,160,Not Available,2022-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49631,No Results,No Results,No Results,2020-04-20,2020-03-18,None
1246,ChiCTR2000032040,ChiCTR,2020-04-18,2020-04-01,True,Affiliated Hospital of Guangdong Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the curative effect of combined traditional Chinese and western medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,30,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=52529,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1247,ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,True,The Fourth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,8,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=52483,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1248,NL8512,Netherlands Trial Register,2020-04-02,2020-03-18,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,"The use of ACE2 receptor increasing medication at hospital admission and
mortality rates in COVID-19 patints 
",Drug,ACE inhibitors,400,Not Available,2020-09-18,https://trialregister.nl/trial/8512,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1249,ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,45,Not Available,2020-05-17,http://www.chictr.org.cn/showproj.aspx?proj=52142,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1250,ChiCTR2000032010,ChiCTR,2020-04-17,2020-05-01,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus pneumonia (COVID-19) Intelligent Assistant Analysis System:A Multi-center Clinical Research,Clinical Presentation,No Intervention,3000,Not Available,2022-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52479,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1251,ChiCTR2000031930,ChiCTR,2020-04-15,2020-01-31,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics and therapeutic effect of 9 cases of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,9,Not Available,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51602,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1252,ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (drug),Traditional Medicine,300,Not Available,2020-11-30,http://www.chictr.org.cn/showproj.aspx?proj=52106,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1253,EUCTR2020-001257-51-DK,EU Clinical Trials Register,2020-03-26,2020-04-15,False,"Rigshospitalet, Denmark",Authorised,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,Drug (chemoprophylaxis),Hydroxychloroquine,568,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1254,NL8513,Netherlands Trial Register,2020-04-07,2020-04-13,False,Reade Research BV,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in rheumatic patients: a prospective cohort study,Clinical Presentation,No Intervention,8000,Not Available,2021-04-13,https://trialregister.nl/trial/8513,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1255,NL8473,Netherlands Trial Register,2020-03-23,2020-03-23,False,National Institute for Public Health and the Environment (RIVM),Not Recruiting,Not Applicable,Observational,Netherlands,Immunity against SARS-CoV-2 in Dutch population,Clinical Presentation,No Intervention,4000,Not Available,2021-09-23,https://trialregister.nl/trial/8473,No Results,No Results,No Results,2020-04-20,2020-04-01,None
1256,NL8485,Netherlands Trial Register,2020-03-27,2020-03-27,False,Mxima MC,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 during pregnancy: a prospective observational cohort,Clinical Presentation,No Intervention,20,Not Available,2020-12-31,https://trialregister.nl/trial/8485,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1257,ChiCTR2000031712,ChiCTR,2020-04-07,2020-04-01,True,The Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,No Country Given,Study for investigation of contamination by novel coronavirus pneumonia (COVID-19) in the clinical environment,Other,Other,60,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51650,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1258,NL8490,Netherlands Trial Register,2020-03-31,2020-04-12,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",Drug,Chloroquine vs. hydroxychloroquine,950,Not Available,2021-04-12,https://trialregister.nl/trial/8490,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1259,ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,240,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48889,No Results,No Results,No Results,2020-04-20,2020-03-18,None
1260,ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,240,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48898,No Results,No Results,No Results,2020-04-20,2020-08-03,None
1261,EUCTR2020-001420-34-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Aarhus University,Authorised,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,Drug,Senicapoc,46,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1262,NL8501,Netherlands Trial Register,2020-04-01,2020-03-23,True,Interactive Studios,Recruiting,Not Applicable,Observational,Netherlands,"Using eHealth to support COVID-19 education, self-assessment and symptom tracking.",Other (software),eHealth,2000,Not Available,2020-06-30,https://trialregister.nl/trial/8501,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1263,NL8521,Netherlands Trial Register,2020-04-13,2020-04-18,False,UMC Amsterdam,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,Drug,Oxygen,13,Not Available,2020-07-18,https://trialregister.nl/trial/8521,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1264,EUCTR2020-001290-74-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Consorci Parc de Salut Mar (PSMAR),Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,Drug,Sarilumab vs. Hydroxychloroquine + Azithromycin,216,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1265,NL8460,Netherlands Trial Register,2020-03-16,2020-03-16,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Biomarkers for prognosis in critically ill COVID-19 patients : a prospective cohort study,Prognosis,No Intervention,100,Not Available,2020-08-16,https://trialregister.nl/trial/8460,No Results,No Results,No Results,2020-04-20,2020-03-25,None
1266,NL8483,Netherlands Trial Register,2020-03-26,2020-03-16,True,Fred Foundation; Noaber Foundation,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,Other,Other,17000,Not Available,2020-03-29,https://trialregister.nl/trial/8483,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1267,EUCTR2020-001262-11-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Instituto de Investigacin Sanitaria Fundacin Jimnez Daz,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,Drug,cyclosporine A vs. lopinavir/ritonavir + interferon beta + darunavir + spironolactone + tocilizumab + chloroquine,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1268,NL8497,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound vs CT scan in COVID-19 disease,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-06-30,https://trialregister.nl/trial/8497,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1269,EUCTR2020-001406-27-FR,EU Clinical Trials Register,2020-04-03,2020-04-07,False,University Hospital of Montpellier,Authorised,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,Drug,Combination: Hydroxychloroquine vs. Azithromycin vs. Hydroxychloroquine,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1270,NL8491,Netherlands Trial Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Recruiting,Not Applicable,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection (CounterCovid) study,Drug,Imatinib,386,Not Available,2020-06-30,https://trialregister.nl/trial/8491,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1271,NL8504,Netherlands Trial Register,2020-04-03,2020-04-06,False,University Medical Center Groningen; Roche,Recruiting,Not Applicable,Interventional,Netherlands,"Pre-emptive tocilizumab in hypoxic COVID-19 patients, a prospective randomized trial",Drug,Tocilizumab,354,Not Available,2020-12-31,https://trialregister.nl/trial/8504,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1272,EUCTR2020-001156-18-ES,EU Clinical Trials Register,2020-04-03,2020-03-27,True,Fundacin para la investigacin Biomedica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,Drug,"Dolquine, Azithromycin, Lopinavir/ritonavir",1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1273,EUCTR2020-001530-35-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Fundacin para la investigacin Biomedica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,Drug,Melatonin,450,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1274,EUCTR2020-001437-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",Drug,"Cyclosporine, Tocilizumab",290,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1275,EUCTR2020-001160-28-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Medica Scientia Innovation Research S.L. (MEDSIR),Authorised,Phase 2,Interventional,Spain,Tocilizumab plus Pembrolizumab in COVID-19,Drug,Combinatino: Tocilizumab + Pembrolizumab,24,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001160-28,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1276,EUCTR2020-001587-29-ES,EU Clinical Trials Register,2020-04-13,2020-04-08,True,Barcelona Institute for Global Health,Authorised,Phase 4,Interventional,Spain,Preventing SARS-CoV-2 virus infection and severity of COVID-19 diseases during pregnancy with hydroxychloroquine,Drug (chemoprophylaxis),Hydroxychloroquine,714,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001587-29,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1277,EUCTR2020-001321-31-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Hospital Universitario de Fuenlabrada,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,Drug,Combination: Hydroxychloroquine + baricitinib or imatinib or lopinavir/ritonavir,165,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1278,EUCTR2020-001682-36-ES,EU Clinical Trials Register,2020-04-14,2020-04-13,True,CITOSPIN S.L.,Authorised,Phase 2,Interventional,Spain,Treatment of COVID-19 with allogeneic mesenchymal cells (MSV).,ATMP,Cells (mesenchymal),24,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001682-36,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1279,EUCTR2020-001172-15-DK,EU Clinical Trials Register,2020-03-23,2020-04-03,False,Apeiron Biologics,Authorised,Phase 2,Interventional,"Austria, Denmark",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,Drug,ACE enzyme,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1280,EUCTR2020-001331-26-GB,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Cambridge University Hospitals NHS Foundation Trust,Authorised,Phase 3,Interventional,United Kingdom,Preventative Drug Treatment for COVID-19 Infectious Disease,Drug (chemoprophylaxis),Hydroxychloroquine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001331-26,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1281,EUCTR2020-001634-36-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Rosario Garca de Vicua,Authorised,Phase 2,Interventional,Spain,Randomized open pilot study to evaluate the efficacy of subcutaneous sarilumab in patients with moderate-severe COVID-19 infection.,Drug,Sarilumab,30,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001634-36,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1282,EUCTR2020-001413-20-ES,EU Clinical Trials Register,2020-04-13,2020-04-07,True,Fundaci Clnic per a la Recerca Biomdica,Authorised,Phase 2,Interventional,Spain,Efficacy and safety of siltuximab vs. corticosteroids in hospitalized patients with COVID-19 pneumonia,Drug,Siltuximab vs. Corticosteroids,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001413-20,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1283,EUCTR2020-001266-11-ES,EU Clinical Trials Register,2020-04-16,2020-04-16,False,Fundacin Instituto de Investigacin Sanitaria Fundacin Jimenez Diaz,Authorised,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,ATMP,Cells (mesenchymal),100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1284,EUCTR2020-001689-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Montreal Heart Institute,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),Drug,Colchicine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1285,EUCTR2020-001765-37-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,nstitut Catal d'Oncologia,Authorised,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,Drug,Hydroxychloroquine,103,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1286,EUCTR2020-001448-24-GB,EU Clinical Trials Register,2020-04-17,2020-04-15,True,University of Birmingham,Authorised,Phase 3,Interventional,"Ghana, India, United Kingdom, South Africa, Nigeria",Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug (chemoprophylaxis),"Hydroxychloroquine, Lopinavir/Ritonavir",6400,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1287,EUCTR2020-000982-18-NO,EU Clinical Trials Register,2020-03-24,2020-03-26,False,Oslo University Hospital,Authorised,Phase 3,Interventional,Norway,A clinical study to evaluate the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19).,Drug,Hydroxychloroquine,1218,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000982-18,No Results,No Results,No Results,2020-04-20,2020-04-01,None
1288,EUCTR2020-001511-25-ES,EU Clinical Trials Register,2020-04-15,2020-04-14,True,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,Drug,Colchicine,102,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1289,EUCTR2020-001466-11-GR,EU Clinical Trials Register,2020-04-14,2020-04-15,False,Hellenic Institute for the Study of Sepsis,Authorised,Phase 2,Interventional,Greece,Prevention of severe respiratory failure in Covid-19,Drug,Anakinra,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001466-11,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1290,EUCTR2020-001379-34-ES,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Instituto de Investigacin Sanitaria INCLIVA,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,Drug,Sevoflurane vs. Propofol,50,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1291,EUCTR2020-001254-22-BE,EU Clinical Trials Register,2020-03-24,2020-03-24,False,University Hospital Ghent,Authorised,Phase 4,Interventional,Belgium,Sargramostim in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Sargramostin,80,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001254-22,No Results,No Results,No Results,2020-04-20,2020-04-01,None
1292,DRKS00021214,German Clinical Trials Register,2020-04-01,2020-04-06,False,Universittsklinikum Schleswig-Holstein,Not Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,Drug,Vitamin B3,1300,Not Available,Not Available,http://www.drks.de/DRKS00021214,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1293,DRKS00021225,German Clinical Trials Register,2020-04-01,2020-04-02,False,Klinikum der Universitt Mnchen,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry of the LMU Hospital Munich,Clinical Presentation,No Intervention,1500,Not Available,Not Available,http://www.drks.de/DRKS00021225,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1294,DRKS00021220,German Clinical Trials Register,2020-04-01,2020-04-05,False,Universittsklinikum Heidelberg,Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the performance of novel rapid diagnostics for COVID-19 at point-of-care,Diagnostics,Diagnostic Test or Assessment,2000,Not Available,Not Available,http://www.drks.de/DRKS00021220,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1295,DRKS00021395,German Clinical Trials Register,2020-04-17,2020-04-20,False,Universittsklinikum Freiburg,Not Recruiting,Not Applicable,Observational,Germany,The effects of the COVID-19 pandemic on mental health,Other (psych),No Intervention,60,Not Available,Not Available,http://www.drks.de/DRKS00021395,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1296,DRKS00021420,German Clinical Trials Register,2020-04-16,2020-04-01,True,Technische Universitt Mnchen,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,30,Not Available,Not Available,http://www.drks.de/DRKS00021420,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1297,DRKS00021166,German Clinical Trials Register,2020-03-27,2020-03-30,False,University Hospital Leipzig,Not Recruiting,Not Applicable,Observational,Germany,Development of a test to measure the immune response in patients with Covid-19,Clinical Presentation,No Intervention,15,Not Available,Not Available,http://www.drks.de/DRKS00021166,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1298,DRKS00021231,German Clinical Trials Register,2020-04-02,2020-04-03,False,Paracelsus Medical University ,Not Recruiting,Not Applicable,Observational,"Germany, Austria",Accompanying monitoring of primary care in GP practices during the COVID-19 pandemic,Health System,No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021231,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1299,DRKS00021254,German Clinical Trials Register,2020-04-03,2020-04-05,False,Universittsklinikum Schleswig-Holstein,Recruiting,Not Applicable,Observational,Germany,"Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy",Other (psych),No Intervention,50,Not Available,Not Available,http://www.drks.de/DRKS00021254,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1300,DRKS00021206,German Clinical Trials Register,2020-03-30,2020-03-26,True,Universitts-Herzzentrum Freiburg Bad Krozingen,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Freiburg,Clinical Presentation,No Intervention,400,Not Available,Not Available,http://www.drks.de/DRKS00021206,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1301,DRKS00021161,German Clinical Trials Register,2020-04-07,2020-02-15,True,Abteilung fr Krankenhaushygiene,Recruiting,Not Applicable,Observational,Germany,Demographic and epidemiological characteristics of Covid-19 disease in Helios-Hospital and determinants of clinical course,Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021161,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1302,DRKS00021208,German Clinical Trials Register,2020-03-31,2020-04-01,False,Vorstand der Deutschen Gesellschaft for Perinatale Medizin (DGPM),Not Recruiting,Not Applicable,Observational,Germany,COVID-19 related obstetric and neonatal outcome study (CRONOS),Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021208,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1303,DRKS00021164,German Clinical Trials Register,2020-03-27,2020-03-16,True,Universitt Duisburg-Essen,Recruiting,Not Applicable,Observational,Germany,Psychological distress of the COVID-19 pandemic: A comparison between cancer patients and healthy controls,Other (psych),No Intervention,220,Not Available,Not Available,http://www.drks.de/DRKS00021164,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1304,DRKS00021306,German Clinical Trials Register,2020-04-14,2020-03-31,True,University Hospital Bonn,Recruiting,Not Applicable,Observational,Germany,Covid-19 Case-Cluster-Study,Clinical Presentation (Epidemiology),No Intervention,1400,Not Available,Not Available,http://www.drks.de/DRKS00021306,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1305,DRKS00021153,German Clinical Trials Register,2020-04-06,2020-04-07,False,Leuphana Universitt Lneburg,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on  tackling worries and finding strength for the crisis (COVID-19) in 10 steps,Other (psych),Psychological,352,Not Available,Not Available,http://www.drks.de/DRKS00021153,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1306,DRKS00021186,German Clinical Trials Register,2020-03-26,2020-03-26,False,KKH Bergstrae Abteilung,Recruiting,Not Applicable,Observational,Germany,"prospective observational study to evaluate transpulmonary pressure, end expiratory lung volume and intraabdominal pressure in mechanical ventilated patients with Covid-19",Clinical Presentation,No Intervention,45,Not Available,Not Available,http://www.drks.de/DRKS00021186,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1307,DRKS00021145,German Clinical Trials Register,2020-04-08,2020-03-16,True,Deutsches Zentrum fr Infektionsforschung (DZIF) e. V.,Recruiting,Not Applicable,Observational,"Ireland, Switzerland, United Kingdom, Belgium, France, Portugal, Austria, Spain, Italy, Germany, Iceland","Lean European Open Survey on 
SARS-CoV-2 (COVID-19)",Clinical Presentation,No Intervention,20000,Not Available,Not Available,http://www.drks.de/DRKS00021145,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1308,CTRI/2020/04/024442,CTRI,2020-04-01,2020-04-08,False,Max Super Speciality Hospital,Not Recruiting,Not Applicable,Observational,India,Screening for symptoms of COVID-19,Clinical Presentation,No Intervention,5000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42687,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1309,DRKS00021300,German Clinical Trials Register,2020-04-08,2020-03-29,True,Universittsklinikum Freiburg,Recruiting,Phase 2/Phase 3,Interventional,Germany,Cytokine adsorption in severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation,Drug,Oxygen,30,Not Available,Not Available,http://www.drks.de/DRKS00021300,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1310,DRKS00021152,German Clinical Trials Register,2020-04-07,2020-04-05,True,Medizinische Hochschule Hannover,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact,Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021152,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1311,IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,Drug,Vitamin A,30,Not Available,Not Available,http://en.irct.ir/trial/46564,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1312,DRKS00021289,German Clinical Trials Register,2020-04-14,2020-03-31,True,Performa Nord,Recruiting,Not Applicable,Observational,Germany,Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector,Clinical Presentation (Epidemiology),No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021289,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1313,DRKS00021301,German Clinical Trials Register,2020-04-16,2020-04-23,False,Universitt Duisburg-Essen,Not Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,Other (psych),Psychological,90,Not Available,Not Available,http://www.drks.de/DRKS00021301,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1314,IRCT20200310046736N1,IRCT,2020-04-01,No Date Available,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,ATMP,Plasma,45,Not Available,Not Available,http://en.irct.ir/trial/46424,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1315,IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,Drug,Combination: sofosbuvir + ledipasvir vs. hydroxychloroquine + oseltamivir + lopinavir/ritonavir,50,Not Available,2020-05-17,http://en.irct.ir/trial/46567,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1316,DRKS00021268,German Clinical Trials Register,2020-04-09,2020-04-20,False,Universittsklinikum Erlangen,Not Recruiting,Not Applicable,Observational,Germany,VOICE: Online-Survey on distress and mental resources of medical health care workers during Covid-19-pandemic,Other (psych),No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021268,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1317,DRKS00021270,German Clinical Trials Register,2020-04-15,2020-04-14,True,Krankenhaus Reinbek St. Adolf-Stift,Not Recruiting,Not Applicable,Observational,Germany,Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany,Clinical Presentation,No Intervention,800,Not Available,Not Available,http://www.drks.de/DRKS00021270,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1318,IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,False,Tehran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with corona virus disease-2019 (COVID-19) referring to Sina Hospital in 2020,Drug,RAAS inhibitors,60,Not Available,Not Available,http://en.irct.ir/trial/46531,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1319,DRKS00021276,German Clinical Trials Register,2020-04-06,2020-04-12,False,Universittsmedizin Rostock,Not Recruiting,Not Applicable,Observational,Germany,Dynamics of regional lung aeration non-invasive determined by electrical impedance tomography in patients with COVID 19,Clinical Presentation,No Intervention,24,Not Available,Not Available,http://www.drks.de/DRKS00021276,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1320,IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,True,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,Other (psych),Psychological,62,Not Available,Not Available,http://en.irct.ir/trial/46609,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1321,IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,Drug,Combination: Hydroxychloroquine +  Oseltamivir + lopinavir/ritonavir or atazanavir/ritonavir ,50,Not Available,2020-05-14,http://en.irct.ir/trial/46536,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1322,CTRI/2020/04/024413,CTRI,2020-04-01,2020-04-09,False,K M Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, attitude and fear of COVID-19 in Bangladesh",Other (psych),No Intervention,1000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42718,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1323,IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,Drug,TNF-alpha inhibitor,80,Not Available,Not Available,http://en.irct.ir/trial/46551,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1324,IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,True,Iran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,150,Not Available,Not Available,http://en.irct.ir/trial/46554,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1325,DRKS00021134,German Clinical Trials Register,2020-03-19,2020-03-20,False,University Hospital Leipzig,Not Recruiting,Not Applicable,Observational,Germany,Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19),Genomics,No Intervention,60,Not Available,Not Available,http://www.drks.de/DRKS00021134,No Results,No Results,No Results,2020-04-20,2020-03-25,None
1326,CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,False,Command Hospital Airforce,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Chloroquine in addition to standard therapy in COVID-19 patients,Drug,Chloroquine,32,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1327,IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,False,Kerman University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,ATMP,Cells (mesenchymal),10,Not Available,Not Available,http://en.irct.ir/trial/46668,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1328,CTRI/2020/03/024402,CTRI,2020-03-31,2020-04-08,False,Dr. Remesh Bhasi,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",Drug,Hydroxychloroquine,500,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1329,CTRI/2020/04/024636,CTRI,2020-04-15,2020-05-01,False,DACH Jaipur,Not Recruiting,Not Applicable,Observational,India,Assessment of Objective clinical scoring system to rule out COVID-19 with high sensitivity,Diagnostics,Diagnostic Test or Assessment,1000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42961,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1330,IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,True,Artesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,Traditional Medicine (drug),Traditional Medicine,374,Not Available,Not Available,http://en.irct.ir/trial/46678,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1331,CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,False,SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,Traditional Medicine (drug),Traditional Medicine,30,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1332,IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,Drug,Camostat Mesilate,40,Not Available,Not Available,http://en.irct.ir/trial/46573,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1333,IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,Drug (chemoprophylaxis),Hydroxychloroquine,310,Not Available,Not Available,http://en.irct.ir/trial/46603,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1334,CTRI/2020/04/024473,CTRI,2020-04-03,2020-04-15,False,Discovery the Critical Care Research Network,Not Recruiting,Not Applicable,Observational,"Italy, United Kingdom, India, United States",Viral Infection and Respiratory illness Universal Study,Clinical Presentation,No Intervention,50000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42684,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1335,IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,30,Not Available,2020-04-13,http://en.irct.ir/trial/46538,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1336,IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon  in treatment  of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,30,Not Available,2020-05-14,http://en.irct.ir/trial/46545,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1337,IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,True,Aryogen Pharmed,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in COVID-19,Drug,Tocilizumab,500,Not Available,Not Available,http://en.irct.ir/trial/46550,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1338,IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,True,MOM Research and Innovation Center,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,ATMP,Cells (mesenchymal),10,Not Available,Not Available,http://en.irct.ir/trial/46623,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1339,IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,Drug,Combination: Acetaminophen + Febuxostat vs.  Acetaminophen + Hydroxychloroquine,60,Not Available,2020-04-09,http://en.irct.ir/trial/46629,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1340,IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,False,Digestive Disease Research Institute,Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Drug,Combination: sofosbuvir + daclatasvir,70,Not Available,Not Available,http://en.irct.ir/trial/46463,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1341,IRCT20200324046850N3,IRCT,2020-03-30,2020-03-28,True,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,Drug,"Investigational: Naproxen

All Arms: Hydroxychloroquine + Lopinavir/Ritonavir",40,Not Available,Not Available,http://en.irct.ir/trial/46718,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1342,IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,Drug,"Interventional: Pirfenidine


Both Arms: Lopinavir/ritonavir + chloroquine + osiltamivir",40,Not Available,Not Available,http://en.irct.ir/trial/46533,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1343,IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,Drug,Septimeb,30,Not Available,Not Available,http://en.irct.ir/trial/46720,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1344,IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46637,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1345,IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,Drug,Interferon beta,40,Not Available,Not Available,http://en.irct.ir/trial/46665,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1346,IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),Drug,Combination: Interferon beta + hydroxychloroquine + osletamivir + lopinavir/ritonavir,20,Not Available,Not Available,http://en.irct.ir/trial/46561,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1347,IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,Traditional Medicine (drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/46721,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1348,IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,Drug,Atorvastatin,100,Not Available,Not Available,http://en.irct.ir/trial/46639,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1349,IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,Drug,Noscapine,125,Not Available,Not Available,http://en.irct.ir/trial/46576,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1350,IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,Drug,Metformin,200,Not Available,Not Available,http://en.irct.ir/trial/46693,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1351,IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,True,RNA Biotechnology,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,Drug,Unspecified,30,Not Available,Not Available,http://en.irct.ir/trial/46624,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1352,IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46697,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1353,IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,True,Darmanara Co.,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,ATMP,Plasma,200,Not Available,Not Available,http://en.irct.ir/trial/46759,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1354,IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,True,Abadan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,Drug,Daclatasvir/sofosbuvir vs. Ribavirin,60,Not Available,Not Available,http://en.irct.ir/trial/46713,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1355,IRCT20200324046852N1,IRCT,2020-04-05,2020-04-01,True,Fasa University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of efficacy of oral Levamisole and  Formoterol+Budesonide inhaler with standard treatment of Corona infection.,Drug,Combination: Levamisole + Formoterol + Budesonide + hydroxychloroquine + Lopinavir/ritonavir vs. hydroxychloroquine + Lopinavir/ritonavir,30,Not Available,Not Available,http://en.irct.ir/trial/46706,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1356,IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,Drug,Remdesivir + hydroxychloroquine or chloroquine + lopinavir/ritonavir or atazanavir,120,Not Available,Not Available,http://en.irct.ir/trial/46660,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1357,IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,Drug,Tocilizumab + hydroxychloroquine + oseltamivir + lopinavir/ritonavir,40,Not Available,Not Available,http://en.irct.ir/trial/46681,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1358,IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46736,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1359,IRCT20200324046850N1,IRCT,2020-03-29,2020-03-29,False,Abadan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,Drug,Combination: Vitamin D vs. N-acetylcysteine vs. Vitamin D + N-acetylcysteine,100,Not Available,Not Available,http://en.irct.ir/trial/46732,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1360,IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,Other (psych),Psychological,60,Not Available,Not Available,http://en.irct.ir/trial/46803,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1361,IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,Drug,Metformin,200,Not Available,Not Available,http://en.irct.ir/trial/46690,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1362,IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,Drug,"Interventional: Interferon beta

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",70,Not Available,Not Available,http://en.irct.ir/trial/46741,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1363,IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,False,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46715,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1364,IRCT20200324046850N5,IRCT,2020-04-04,2020-04-19,False,Abadan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Study of the effect of vitamin C in patients with Covid-19,Drug,"Investigational: Vitamin C

All Arms: Hydroxychloroquine or Chloroquine + Lopinavir/Ritonavir",40,Not Available,Not Available,http://en.irct.ir/trial/46751,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1365,IRCT20200204046369N1,IRCT,2020-04-08,2020-04-14,False,Shiraz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,Drug,Corticosteroids,48,Not Available,Not Available,http://en.irct.ir/trial/46776,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1366,IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,Drug,Vitamin C,60,Not Available,Not Available,http://en.irct.ir/trial/46804,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1367,IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,Traditional Medicine (drug),Traditional Medicine,68,Not Available,Not Available,http://en.irct.ir/trial/46782,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1368,IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,True,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,Drug,Medium-chain triglycerides,120,Not Available,Not Available,http://en.irct.ir/trial/46762,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1369,IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,False,Gorgan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",Drug (+ ATMP),"Intreventional: Dexamethason + Immunoglobulin vs. Dexamethason + Immunoglobulin + interferon beta

All Arms: Hydroxychloroquine + antiviral ",105,Not Available,Not Available,http://en.irct.ir/trial/46810,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1370,IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,Drug,Fingolimod,40,Not Available,Not Available,http://en.irct.ir/trial/46786,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1371,IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,Drug,Combination: Favipiravir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine,324,Not Available,Not Available,http://en.irct.ir/trial/46783,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1372,IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,ATMP,Plasma,50,Not Available,Not Available,http://en.irct.ir/trial/46811,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1373,IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,True,Semnan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris, Lepidium sativum supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46828,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1374,IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,ATMP,Cells (mesenchymal),5,Not Available,2020-04-29,http://en.irct.ir/trial/46789,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1375,IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,Traditional Medicine (drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/46728,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1376,IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,True,Babol University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,Other (device),Hemoperfusion,10,Not Available,Not Available,http://en.irct.ir/trial/46837,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1377,IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,Drug,Daclatasvir/sofosbuvir,48,Not Available,2020-05-04,http://en.irct.ir/trial/46885,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1378,IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,Traditional Medicine (drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46868,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1379,IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,Drug,Combination: Vitamin A + Vitamin D + Vitamin C + Vitamin B,60,Not Available,Not Available,http://en.irct.ir/trial/46838,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1380,IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,True,Center for Progress and Development of Iran,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,Drug,"Investigational: Umifenovir

All Arms: Hydroxychloroquine + Atazanavir/Ritonavir",100,Not Available,Not Available,http://en.irct.ir/trial/46731,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1381,IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,Drug (chemoprophylaxis),Hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/46849,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1382,IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,Traditional Medicine (drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46893,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1383,IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,True,Qom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),Traditional Medicine (drug),Traditional Medicine,130,Not Available,Not Available,http://en.irct.ir/trial/46913,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1384,IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,Traditional Medicine (drug),Traditional Medicine,64,Not Available,2020-03-24,http://en.irct.ir/trial/46733,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1385,IRCT20200401046909N1,IRCT,2020-04-09,2020-04-15,False,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the  efficacy of oral 25-hydroxyvitamin D3 on COVID-19,Drug,Calcifediol,260,Not Available,Not Available,http://en.irct.ir/trial/46875,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1386,IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,Traditional Medicine (other),Traditional Medicine,80,Not Available,Not Available,http://en.irct.ir/trial/46775,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1387,IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",Traditional Medicine (drug),Traditional Medicine,110,Not Available,Not Available,http://en.irct.ir/trial/46879,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1388,IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,Drug (chemoprophylaxis),Hydroxychloroquine,500,Not Available,Not Available,http://en.irct.ir/trial/46932,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1389,IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (drug),Traditional Medicine,15,Not Available,Not Available,http://en.irct.ir/trial/46961,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1390,IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir to standard of caretherapeutic regimen in patients with COVID-19,Drug,"Interventional: Sofosbuvir/Velpatasvir

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",80,Not Available,Not Available,http://en.irct.ir/trial/46790,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1391,IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,True,Torbate-Heidaria University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",Other (psych),Psychological,30,Not Available,Not Available,http://en.irct.ir/trial/46933,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1392,IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",Traditional Medicine (drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46940,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1393,IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46903,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1394,IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,Drug,Combination: Prednisolone + naproxen + azithromycin + hydroxychloroquine vs. naproxen + azithromycin + hydroxychloroquine vs. hydroxychloroquine + Lopinavit/ritonavir,906,Not Available,Not Available,http://en.irct.ir/trial/46968,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1395,IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,True,HomaPharmed  Company,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46907,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1396,IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,Drug,Favipiravir vs. Lopinavir/ritonavir,84,Not Available,Not Available,http://en.irct.ir/trial/46942,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1397,IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,Drug,Bromhexine,60,Not Available,Not Available,http://en.irct.ir/trial/46969,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1398,IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,False,Ardabil University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,Drug,Favipravir + hydroxychloroquine vs. lopinavir/ritonavir + hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/47022,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1399,IRCT20200405046953N1,IRCT,2020-04-06,2020-04-08,False,Iranian Ministry of Health and Medical Education,Recruiting,Phase 3,Interventional,Iran,Comparison of therapies for COVID-19,Drug,Combination: Remdesivir vs. Chloroquine or Hydroxychloroquine vs. Lopinavir/ritonavir vs. Lopinavir/ritonavir + interferon,3000,Not Available,Not Available,http://en.irct.ir/trial/46930,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1400,IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,Drug,"Interventional: Teicoplanin

Both Arms: Hydroxychloroquine + lopinavir/ritonavir or atazanavir",40,Not Available,Not Available,http://en.irct.ir/trial/46814,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1401,IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,Drug,Losartan vs. amlodipine,100,Not Available,Not Available,http://en.irct.ir/trial/46824,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1402,IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,Drug,Hydroxychloroquine,60,Not Available,Not Available,http://en.irct.ir/trial/46946,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1403,IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,True,Iranian Academic Center for Education Culture and Research,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),6,Not Available,2020-04-25,http://en.irct.ir/trial/47030,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1404,IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,False,Ghoum University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46850,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1405,IRCT20200401046909N2,IRCT,2020-04-11,2020-04-14,False,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19,Drug,Calcifediol,540,Not Available,Not Available,http://en.irct.ir/trial/47010,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1406,IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,False,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,Drug,Umifenovir + Hydroxychloroquine vs. Lopinavir/ritonavir vs. Hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/46897,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1407,IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,True,The University of Baqiyatallah,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,Other (physical),Mechanical ventilation,30,Not Available,2020-04-13,http://en.irct.ir/trial/47013,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1408,IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,Drug,Vitamin A,140,Not Available,Not Available,http://en.irct.ir/trial/46974,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1409,IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,ATMP,"Interventional: Immunoglobulin

Both Arms: hydroxychloroquine + ribavirin + lopinavir/ritonavir",100,Not Available,Not Available,http://en.irct.ir/trial/47014,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1410,IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47139,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1411,IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,Drug,Corticosteroids,40,Not Available,Not Available,http://en.irct.ir/trial/46904,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1412,IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,Traditional Medicine (drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46978,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1413,IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,Drug,Combination: Daclatasvir/sofosbuvir + hydroxychloroquine vs. hydroxychloroquine,60,Not Available,Not Available,http://en.irct.ir/trial/46926,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1414,IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47061,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1415,IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,ATMP,Plasma,12,Not Available,Not Available,http://en.irct.ir/trial/46931,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1416,IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,Other (device),Hemoperfusion,10,Not Available,Not Available,http://en.irct.ir/trial/47015,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1417,IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,Traditional Medicine (drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46958,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1418,IRCT20200217046526N2,IRCT,2020-04-13,2020-04-05,True,Iranian Academic Center for Education Culture and Research,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),60,Not Available,Not Available,http://en.irct.ir/trial/47073,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1419,IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,ATMP,Plasma,60,Not Available,Not Available,http://en.irct.ir/trial/46973,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1420,IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,Procedure,Foot bath,60,Not Available,Not Available,http://en.irct.ir/trial/47018,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1421,IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,Drug,Minocycline,40,Not Available,Not Available,http://en.irct.ir/trial/46977,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1422,IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,Drug,Combination: Vitamin C + Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Atazanavir/ritonavir,110,Not Available,Not Available,http://en.irct.ir/trial/47078,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1423,LBCTR2020043459,LBCTR,2020-04-16,2020-04-14,True,Htel-Dieu de France Hospital,Not Recruiting,Not Applicable,Observational,Lebanon,The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey,Other (psych),No Intervention,500,Not Available,2020-05-18,http://lbctr.emro.who.int/Trials/Details/3459,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1424,IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,True,Center for Progress and Development of Iran,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,Drug,Umifenovir,200,Not Available,Not Available,http://en.irct.ir/trial/47087,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1425,IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,True,Saveh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,Traditional Medicine (drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/47234,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1426,IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,Drug,Combination: Trifluoprazine + hydroxychloroquine vs. hydroxychloroquine,70,Not Available,Not Available,http://en.irct.ir/trial/47006,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1427,IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,False,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,Drug,Combination: Azithromycin +  oseltamivir + lopinavir/ritonavir or atazanavir + hydroxychloroquine vs. Oseltamivir + lopinavir/ritonavir or atazanavir + hydroxychloroquine,110,Not Available,Not Available,http://en.irct.ir/trial/47244,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1428,IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,Traditional Medicine (drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47016,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1429,IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,False,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,Drug,Ozone,80,Not Available,Not Available,http://en.irct.ir/trial/47149,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1430,IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,Drug,Tocilizumab,10,Not Available,Not Available,http://en.irct.ir/trial/47021,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1431,IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,ATMP,Plasma,32,Not Available,Not Available,http://en.irct.ir/trial/47058,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1432,IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,Drug (chemophrophylaxis),Hydroxychloroquine,1000,Not Available,Not Available,http://en.irct.ir/trial/47090,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1433,PACTR202004693933092,PACTR,2020-04-12,2020-04-15,False,Misr University for Science and Technology,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),ATMP,Vaccine,200,Not Available,2020-06-30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1434,JPRN-jRCT2031190264,JPRN,2020-03-24,2020-03-26,False,Ohmagari Norio,Recruiting,Phase 3,Interventional,"South Korea, Japan, United States","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",Drug,Remdesivir,100,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCT2031190264,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1435,JPRN-JapicCTI-205238,JPRN,2020-03-27,2020-03-31,False,"FUJIFILM Toyama Chemical Co., Ltd.",Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,Drug,Favipiravir,96,Not Available,Not Available,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1436,IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,Drug,Combination: Melatonin + Hydroxychloroquine + azithormycin vs. Hydroxychloroquine + azithormycin,82,Not Available,Not Available,http://en.irct.ir/trial/47099,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1437,IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,ATMP,Plasma vs. Immunoglobulin,15,Not Available,Not Available,http://en.irct.ir/trial/47212,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1438,PACTR202004761408382,PACTR,2020-04-13,2020-05-01,False,Neimeth International Pharmaceuticals Plc.,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot placebo-controlled randomized trial",Traditional Medicine (Drug),Traditional Medicine,72,Not Available,2020-08-31,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1439,JPRN-jRCTs031190269,JPRN,2020-03-27,2020-03-27,False,Sugiyama Haruhito,Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled trial to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",Drug,Ciclesonide,100,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1440,JPRN-jRCTs031190226,JPRN,2020-02-27,2020-03-14,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,Drug,Favipiravir,50,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,No Results,No Results,No Results,2020-04-20,2020-03-25,None
1441,JPRN-jRCTs031190227,JPRN,2020-02-27,2020-04-01,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,Drug,Combination: Lopinavir/ritonavir + hydroxychloroquine (w/ and w/o oseltamivir),50,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,No Results,No Results,No Results,2020-04-20,2020-03-25,None
1442,JPRN-UMIN000039997,JPRN,2020-04-01,2020-04-01,False,Jichi Medical University,Not Recruiting,Not Applicable,Observational,Japan,"Prevention of COVID-19 infection in a medical institution 
and maintenance of medical system",Other,No Intervention,3700,Not Available,2021-12-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045600,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1443,RBR-3cbs3w,REBEC,2020-04-08,2020-04-10,False,EMS Pharmaceuticals,Not Recruiting,Phase 3,Interventional,Brazil,Evaluation of Hydroxychloroquine for prevention of hospitalization and respiratory complications in patients with confirmed diagnosis or suspected infection by (COVID-19),Drug,Hydroxychloroquine,1300,Not Available,Not Available,http://www.ensaiosclinicos.gov.br/rg/RBR-3cbs3w/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1444,JPRN-UMIN000040162,JPRN,2020-04-15,2020-04-14,True,Tokyo University,Recruiting,Not Applicable,Observational,Japan,Multicenter observational study to examine the efficacy of protection during endoscopy examination for Covid-19 infection,Other,No Intervention,1000,Not Available,2021-03-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045790,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1445,RBR-9d8z6m,REBEC,2020-03-27,2020-03-30,False,Hospital do Corao,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine ,630,Not Available,Not Available,http://www.ensaiosclinicos.gov.br/rg/RBR-9d8z6m/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1446,JPRN-UMIN000039986,JPRN,2020-03-31,2020-03-28,True,Yokohama City University,Not Recruiting,Not Applicable,Other,Japan,Risk factors of death from coronavirus disease 2019,Prognosis,No Intervention,Not Available,Not Available,2020-03-28,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1447,TCTR20200409006,TCTR,2020-04-03,2020-05-01,False,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19,Other (device),HA330,206,2020-05-01,2020-05-01,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1448,PACTR202004801273802,PACTR,2020-04-02,2020-04-17,False,Lagos State Government,Not Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",Drug,Chloroquine vs. Hydroxychloroquine,600,Not Available,2020-10-16,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1449,JPRN-UMIN000040185,JPRN,2020-04-17,2020-04-17,False,Keio University School of Medicine,Recruiting,Not Applicable,Observational,Japan,Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease,Clinical Presentation,No Intervention,600,Not Available,2020-04-17,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045820,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1450,TCTR20200405001,TCTR,2020-04-05,2020-03-19,True,Chulalongkorn University,Recruiting,Not Applicable,Observational,Thailand,Use of Covid-19 Rapid Test for Hospital Care: GI Procedure,Diagnostics,Diagnostic Test or Assessment,20,2020-06-30,2020-06-30,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6023,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1451,TCTR20200404004,TCTR,2020-03-31,2020-04-27,False,Health Systems Research Institute (HSRI),Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patients,Drug,Chloroquine + Vitamin C,400,2020-07-31,2020-07-31,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1452,RBR-6m69fc,REBEC,2020-04-02,2020-04-01,True,Universidad de Sevilla,Recruiting,Not Applicable,Interventional,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Telehealth,Rehabilitation,99,Not Available,Not Available,http://www.ensaiosclinicos.gov.br/rg/RBR-6m69fc/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1453,TCTR20200324001,TCTR,2020-03-21,2020-03-24,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,Covid-19 preparedness among Emergency Departments: a cross-sectional study in France.,Health System,No Intervention,650,2020-03-31,2020-03-31,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5976,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1454,RBR-9pgwfc,REBEC,2020-04-09,2020-04-07,True,Hospital Universitrio Bettina Ferro de Souza,Recruiting,Not Applicable,Observational,"Canada, United States, United Kingdom, France, Portugal, Colombia, Spain, Chile, Brazil",Psychological effects of social isolation in the coronavirus pandemic,Other (psych),No Intervention,2300,Not Available,Not Available,http://www.ensaiosclinicos.gov.br/rg/RBR-9pgwfc/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1455,RPCEC00000306,RPCEC,2020-04-13,2020-03-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,ATMP,Vaccine,80,Not Available,2020-07-15,http://rpcec.sld.cu/en/trials/RPCEC00000306-En,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1456,TCTR20200321001,TCTR,2020-03-20,2020-03-20,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,ED Response against Covid-19 pandemic,Other,No Intervention,5000,2020-04-14,2020-04-14,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5975,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1457,RBR-8969zg,REBEC,2020-04-13,2020-04-14,False,Universidade de So Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Drug,N-acetylcysteine,200,Not Available,Not Available,http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1458,TCTR20200401002,TCTR,2020-03-31,2020-06-01,False,Wellcome Trust,Not Recruiting,Not Applicable,Observational,"United Kingdom, Thailand, Malaysia, Italy","Social, ethical and behavioural aspects of the novel coronavirus pandemic",Other,No Intervention,2640,2020-12-31,2020-12-31,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5997,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1459,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-04-10,False,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2,ATMP,Cells (stem cells),20,2020-10-09,2020-11-10,https://clinicaltrials.gov/show/NCT04299152,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1460,NCT04307459,ClinicalTrials.gov,2020-03-10,2020-03-19,False,University of Milan,Not Recruiting,Not Applicable,Observational,Italy,Acute Respiratory Failure and SARS-CoV-2 Infection in Real Life,Clinical Presentation,No Intervention,50,2020-04-19,2020-12-31,https://clinicaltrials.gov/show/NCT04307459,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1461,NCT04290780,ClinicalTrials.gov,2020-02-27,2020-03-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Clinical Presentation,No Intervention,300,2020-10-10,2020-10-30,https://clinicaltrials.gov/show/NCT04290780,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1462,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-03-15,False,Rajavithi Hospital,Not Recruiting,Phase 3,Interventional,Thailand,"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",80,2020-10-31,2020-11-30,https://clinicaltrials.gov/show/NCT04303299,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1463,NCT04321369,ClinicalTrials.gov,2020-03-23,2020-03-09,True,Dr. Deneen Vojta,Not Recruiting,Not Applicable,Observational,United States,Impact of Swab Site and Sample Collector on Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,Diagnostics,Diagnostic Test or Assessment,533,2020-03-23,2020-03-23,https://clinicaltrials.gov/ct2/show/NCT04321369,Pre-Print Article,2020-04-06,https://doi.org/10.1101/2020.04.01.20050005,2020-04-14,2020-04-06,None
1464,NCT04323527,ClinicalTrials.gov,2020-03-13,2020-03-23,False,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19),Drug,Chloroquine,440,2020-08-31,2020-08-31,https://clinicaltrials.gov/ct2/show/NCT04323527,Journal Article,2020-04-24,https://doi.org/10.1001/jamanetworkopen.2020.8857,2020-04-14,2020-04-06,None
1465,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Centre Leon Berard,Not Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,273,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04333914,No Results,No Results,No Results,2020-04-14,2020-04-06,EUCTR2020-001373-70
1466,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-03-30,False,CHU de Saint Etienne,Not Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,1200,2020-11-30,2020-11-30,https://clinicaltrials.gov/show/NCT04328285,No Results,No Results,No Results,2020-04-14,2020-04-06,EUCTR2020-001188-96
1467,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,FALSE (Prospectively Registered on another registry),Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients (ONCOVID),Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,1000,2022-04-01,2022-04-01,https://clinicaltrials.gov/ct2/show/NCT04341207,No Results,No Results,No Results,2020-04-14,2020-04-15,EUCTR2020-001250-21
1468,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Hellenic Institute for the Study of Sepsis,No Status Given,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction (ESCAPE),Drug,Anakinra or Tocilizumab,20,2022-04-01,2022-04-01,https://clinicaltrials.gov/ct2/show/NCT04339712,No Results,No Results,No Results,2020-04-14,2020-04-15,EUCTR2020-001039-29
1469,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury (TACROVID),Drug,Combination: Tacrolimus + Corticosteroids,84,2020-06-01,2020-07-01,https://clinicaltrials.gov/ct2/show/NCT04341038,No Results,No Results,No Results,2020-04-14,2020-04-15,EUCTR2020-001445-39
1470,NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-01,FALSE (Prospectively Registered on another registry),Radboud University,Not Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug,Valsartan,651,2020-07-01,2021-08-01,https://clinicaltrials.gov/ct2/show/NCT04335786,No Results,No Results,No Results,2020-04-22,2020-04-15,EUCTR2020-001320-34
1471,NCT04345289,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Thomas Benfield,Not Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia (CCAP),Drug (+ ATMP),Plamsa vs. Sarilumab vs. Hydroxychloroquine vs. Baricitinib,1500,2021-06-15,2021-06-15,https://clinicaltrials.gov/ct2/show/NCT04345289,No Results,No Results,No Results,2020-04-14,2020-04-22,EUCTR2020-001367-88
1472,NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-24,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 (COVID-Aging)",Drug,Combination: Hydroxychloroquine + Telmisartan + Azithromycin,1600,2021-06-01,2021-06-01,https://clinicaltrials.gov/ct2/show/NCT04359953,No Results,No Results,No Results,2020-04-24,2020-04-22,EUCTR2020-001303-16
1473,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-01,FALSE (Prospectively Registered on another registry),Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia (MultiCov),Clinical Presentation,Other (Procedure),194,2020-07-01,2020-08-01,https://clinicaltrials.gov/ct2/show/NCT04334850,No Results,No Results,No Results,2020-04-06,2020-04-22,EUCTR2020-001324-33
1474,NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Hospices Civils de Lyon,Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection (CORTI-Covid),Drug,Prednisone,304,2020-11-01,2020-11-01,https://clinicaltrials.gov/ct2/show/NCT04344288,No Results,No Results,No Results,2020-04-20,2020-04-22,EUCTR2020-001553-48
1475,NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,False,Centre Hospitalier St Anne,Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds (ICAR),ATMP,Immunoglobulin,138,2020-06-01,2020-08-01,https://clinicaltrials.gov/ct2/show/NCT04350580,No Results,No Results,No Results,2020-04-24,2020-04-22,EUCTR2020-001570-30
1476,NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,False,"University Hospital, Angers",Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Drug,Vitamin D,260,2020-07-01,2020-07-01,https://clinicaltrials.gov/ct2/show/NCT04344041,No Results,No Results,No Results,2020-04-21,2020-04-22,EUCTR2020-001602-34
1477,NCT04335552,ClinicalTrials.gov,2020-04-03,2020-04-17,False,Duke University,Recruiting,Phase 2,Interventional,United States,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Azithormycin,500,2020-08-01,2020-08-01,https://clinicaltrials.gov/ct2/show/NCT04335552,No Results,No Results,No Results,2020-04-24,2020-04-22,None
1478,NCT04336748,ClinicalTrials.gov,2020-04-04,2020-04-01,True,Medical University of Vienna,Not Recruiting,Phase 3,Interventional,No Country Given,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,Drug,Hydroxychloroquine,440,2020-07-01,2020-08-01,https://clinicaltrials.gov/ct2/show/NCT04336748,No Results,No Results,No Results,2020-04-07,2020-04-22,None
1479,NCT04341727,ClinicalTrials.gov,2020-04-04,2020-04-04,False,Washington University in St. Louis,Recruiting,Phase 3,Interventional,United States,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin vs. Chloroquine vs. Chloroquine + Azithormycin,500,2021-04-01,2021-08-01,https://clinicaltrials.gov/ct2/show/NCT04341727,No Results,No Results,No Results,2020-04-10,2020-04-22,None
